<?xml version="1.0"?>
<rdf:RDF xmlns="http://www.science.library.com/scilib.owl#"
     xml:base="http://www.science.library.com/scilib.owl"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:terms="http://purl.org/dc/terms/"
     xmlns:scilib="http://www.science.library.com/scilib.owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#">
    <owl:Ontology rdf:about="http://www.science.library.com/scilib.owl">
        <owl:versionIRI rdf:resource="http://www.science.library.com/1.0.0/scilib.owl"/>
        <dc:creator>César Alonso</dc:creator>
        <dc:creator>María del Mar Villar</dc:creator>
        <dc:creator>Álvaro Ruiz</dc:creator>
        <dc:description>An ontology to represent drugs, diseases and treatments.</dc:description>
        <dc:title>Science Library for Drugs, Diseases and Treatments</dc:title>
        <terms:license>https://creativecommons.org/licenses/by/4.0</terms:license>
        <oboInOwl:creation_date>28-01-2021</oboInOwl:creation_date>
        <rdfs:comment>drugs, sickness, medicine, treatments</rdfs:comment>
        <owl:versionInfo>1.0.0</owl:versionInfo>
    </owl:Ontology>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->


    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115">
        <obo:IAO_0000115 xml:lang="en">The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.</obo:IAO_0000115>
        <rdfs:isDefinedBy rdf:resource="http://purl.obolibrary.org/obo/iao.owl"/>
        <rdfs:label xml:lang="en">definition</rdfs:label>
        <rdfs:label>definition</rdfs:label>
        <rdfs:label>textual definition</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/elements/1.1/creator -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/creator"/>
    


    <!-- http://purl.org/dc/elements/1.1/date -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/date">
        <dc:description xml:lang="en-us">Typically, Date will be associated with the creation or
         availability of the resource.  Recommended best practice
         for encoding the date value is defined in a profile of
         ISO 8601 [W3CDTF] and follows the YYYY-MM-DD format.</dc:description>
        <rdfs:comment xml:lang="en-us">A date associated with an event in the life cycle of the
         resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
        <rdfs:label xml:lang="en-us">Date</rdfs:label>
        <rdfs:label>Date</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/elements/1.1/description -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/description"/>
    


    <!-- http://purl.org/dc/elements/1.1/licence -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/licence"/>
    


    <!-- http://purl.org/dc/elements/1.1/title -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/title"/>
    


    <!-- http://purl.org/dc/terms/license -->


    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/license"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#created_by -->


    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#created_by"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#creation_date -->


    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#creation_date"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#creators -->


    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#creators"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#xref -->


    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#xref"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    


    <!-- http://www.science.library.com/scilib.owl#affects -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#affects">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#BodySystem"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To act on and cause a change in</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">affects</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#composes -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#composes">
        <owl:inverseOf rdf:resource="http://www.science.library.com/scilib.owl#isComposedOf"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#BodyOrgan"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#BodySystem"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To form by putting together</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">composes</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#contains -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#contains">
        <rdfs:domain rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000001"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To have within</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">contains</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#cures -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#cures">
        <rdfs:domain rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000001"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Cures</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">cures</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#generates -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#generates">
        <owl:inverseOf rdf:resource="http://www.science.library.com/scilib.owl#isGeneratedFrom"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#BodyTissue"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#BodyOrgan"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To bring into existence</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">generates</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#has -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#has">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <rdfs:range rdf:resource="http://purl.obolibrary.org/obo/NBO_0000313"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">To hold or maintain as a possession</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">has</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasVia -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#hasVia">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#ViaType"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">to hold an specific via</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasVia</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#isComposedOf -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#isComposedOf">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#BodySystem"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#BodyOrgan"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Is composed of</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">isComposedOf</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#isConstitutedBy -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#isConstitutedBy">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Is constitude by</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">isConstitutedBy</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#isGeneratedFrom -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#isGeneratedFrom">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#BodyOrgan"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#BodyTissue"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Is generated from</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">isGeneratedFrom</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#mayInduce -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#mayInduce">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#SideEffect"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To cause</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">mayInduce</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#presents -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#presents">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Disease"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Symptom"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Existing in something</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">presents</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#sells -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#sells">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Company"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To deliver services for money</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">sells</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#suffersFrom -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#suffersFrom">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">suffer from</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">suffersFrom</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://www.science.library.com/scilib.owl#treats -->


    <owl:ObjectProperty rdf:about="http://www.science.library.com/scilib.owl#treats">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdfs:range rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">To act upon with some agent especially to improve</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">treats</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Data properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    


    <!-- http://www.science.library.com/scilib.owl#hasCIF -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasCIF">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#FunctionalProperty"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Company"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Cost Insurance and Freight identification number</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasCIF</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasCommercialName -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasCommercialName">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Commercial Name</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasCommercialName</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasCompanyName -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasCompanyName">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Company"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Company name</dc:description>
        <terms:license>https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasCompanyName</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasExactMass -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasExactMass">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Molecular mass (Molar)</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasExactMass</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasFormula -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasFormula">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#FunctionalProperty"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Chemical Formula (IUPAC)</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasFormula</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasHeight -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasHeight">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#float"/>
        <obo:IAO_0000115>Height (m)</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasHeight</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasName -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasName">
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Name</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasName</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasSex -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasSex">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#FunctionalProperty"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <obo:IAO_0000115>Major forms of individuals distinguished respectively as female or male especially on the basis of their reproductive organs and structures</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasSex</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://www.science.library.com/scilib.owl#hasWeight -->


    <owl:DatatypeProperty rdf:about="http://www.science.library.com/scilib.owl#hasWeight">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#float"/>
        <obo:IAO_0000115>Weight (kg)</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">hasWeight</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    


    <!-- http://purl.obolibrary.org/obo/MAXO_0000001 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MAXO_0000001">
        <obo:IAO_0000115>A clinically prescribed procedure, therapy, intervention, or recommendation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:07:28Z</dc:date>
        <oboInOwl:created_by rdf:resource="http://orcid.org/0000-0001-7941-2961"/>
        <rdfs:label xml:lang="en">medical action</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MAXO_0000002 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MAXO_0000002">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000001"/>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:08:29Z</dc:date>
        <oboInOwl:created_by rdf:resource="http://orcid.org/0000-0001-7941-2961"/>
        <rdfs:label xml:lang="en">therapeutic procedure</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MAXO_0000017 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MAXO_0000017">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000001"/>
        <obo:IAO_0000115>A therapy or action designed to prevent disease or ailment.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:21:49Z</dc:date>
        <oboInOwl:created_by rdf:resource="http://orcid.org/0000-0001-7941-2961"/>
        <rdfs:label xml:lang="en">preventative therapeutics</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MAXO_0000021 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MAXO_0000021">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000001"/>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:23:01Z</dc:date>
        <oboInOwl:created_by rdf:resource="http://orcid.org/0000-0001-7941-2961"/>
        <rdfs:label xml:lang="en">palliative therapeutics</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NBO_0000003 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NBO_0000003">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NBO_0000313"/>
        <owl:disjointWith rdf:resource="http://purl.obolibrary.org/obo/NBO_0001845"/>
        <obo:IAO_0000115>&quot;Behavior related to the complex psychophysiological experience of an individual&apos;s state of mind as interacting with biochemical (internal) and environmental (external) influences.&quot; [wikipedia:Emotions]</obo:IAO_0000115>
        <dc:date>2011-04-14T01:03:39Z</dc:date>
        <oboInOwl:created_by>George Gkoutos</oboInOwl:created_by>
        <rdfs:label>emotional behavior</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NBO_0000313 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NBO_0000313">
        <obo:IAO_0000115>&quot;The action, reaction, or performance of an organism in response to external or internal stimuli.&quot; [GO:GO\:0007610]</obo:IAO_0000115>
        <dc:date>2011-04-05T09:53:10Z</dc:date>
        <oboInOwl:created_by>George Gkoutos</oboInOwl:created_by>
        <oboInOwl:xref>GO:0007610</oboInOwl:xref>
        <rdfs:label>behavior process</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NBO_0001845 -->


    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NBO_0001845">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NBO_0000313"/>
        <obo:IAO_0000115>&quot;Behavior related to the intake of substances.&quot; [NBOC:GVG]</obo:IAO_0000115>
        <oboInOwl:created_by>George Gkoutos</oboInOwl:created_by>
        <rdfs:label xml:lang="en">consumption behavior</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#ActiveIngredient -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#ActiveIngredient">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Ingredient that is biologically active</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">ActiveIngredient</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#BodyOrgan -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#BodyOrgan">
        <obo:IAO_0000115>Represent a human organ</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label>BodyOrgan</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#BodySystem -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#BodySystem">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Body systems are groups of organs and tissues that work together to perform relevant functions in the body.</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">BodySystem</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#BodyTissue -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#BodyTissue">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Tissue is a group of cells that have similar structure and that function together as a unit.</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">BodyTissue</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Company -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Company">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Selling entity.</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Company</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Disease -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Disease">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Illnes, failure of health.</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Disease</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Disorder -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Disorder">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">A state of untidiness</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Drug -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Drug">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Substance used as a medication or in the preparation of medication.</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Drug</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Excipient -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Excipient">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Substance included for no therapeutical reasons</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Excipient</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#InsuranceDrug -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#InsuranceDrug">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <owl:disjointWith rdf:resource="http://www.science.library.com/scilib.owl#NoInsuranceDrug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Presence of health insurance</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">InsuranceDrug</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Molecule -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Molecule">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Smallest particle of a substance that retains all the properties of the substance and is composed of one or more atoms</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Molecule</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#NoInsuranceDrug -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#NoInsuranceDrug">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Lack of health insurance</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">NoInsuranceDrug</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#NoPrenscriptionDrug -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#NoPrenscriptionDrug">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <owl:disjointWith rdf:resource="http://www.science.library.com/scilib.owl#PrenscriptionDrug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">No need for a medical prescription</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">NoPrescriptionDrug</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Patient -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Patient">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Individual awaiting or under medical care and treatment</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Patient</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#PrenscriptionDrug -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#PrenscriptionDrug">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Need for a medical prescription</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">PrescriptionDrug</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#SideEffect -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#SideEffect">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Unpleasant effect in addition to the main effect</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">SideEffect</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#Symptom -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#Symptom">
        <rdfs:subClassOf rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Physical or mental features that indicates the presence of any disorder</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Symptom</rdfs:label>
    </owl:Class>
    


    <!-- http://www.science.library.com/scilib.owl#ViaType -->


    <owl:Class rdf:about="http://www.science.library.com/scilib.owl#ViaType">
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Route type</obo:IAO_0000115>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://creativecommons.org/licenses/by/4.0/</terms:license>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T15:23:20+00:00</oboInOwl:creation_date>
        <rdfs:label rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">ViaType</rdfs:label>
    </owl:Class>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Individuals
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    


    <!-- http://www.science.library.com/scilib.owl#Bayer -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Bayer">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Company"/>
        <sells rdf:resource="http://www.science.library.com/scilib.owl#Ibuprofen"/>
        <hasCIF rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">G27818913</hasCIF>
        <hasCompanyName rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Bayer the best Company</hasCompanyName>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Carmelo -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Carmelo">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Patient"/>
        <has rdf:resource="http://www.science.library.com/scilib.owl#Nervous"/>
        <has rdf:resource="http://www.science.library.com/scilib.owl#Smoker"/>
        <hasHeight rdf:datatype="http://www.w3.org/2001/XMLSchema#float">1.79</hasHeight>
        <hasSex rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Male</hasSex>
        <hasWeight rdf:datatype="http://www.w3.org/2001/XMLSchema#float">89.0</hasWeight>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Circulatory_system -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Circulatory_system">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#BodySystem"/>
        <isComposedOf rdf:resource="http://www.science.library.com/scilib.owl#Heart"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Heart -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Heart">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#BodyOrgan"/>
        <composes rdf:resource="http://www.science.library.com/scilib.owl#Circulatory_system"/>
        <isGeneratedFrom rdf:resource="http://www.science.library.com/scilib.owl#Heart_tissues"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Heart_tissues -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Heart_tissues">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#BodyTissue"/>
        <generates rdf:resource="http://www.science.library.com/scilib.owl#Heart"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Ibuprofen -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Ibuprofen">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Drug"/>
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#InsuranceDrug"/>
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#NoPrenscriptionDrug"/>
        <hasVia rdf:resource="http://www.science.library.com/scilib.owl#Oral"/>
        <isConstitutedBy rdf:resource="http://www.science.library.com/scilib.owl#Ibuprofen_active"/>
        <isConstitutedBy rdf:resource="http://www.science.library.com/scilib.owl#Ibuprofen_excipients"/>
        <mayInduce rdf:resource="http://www.science.library.com/scilib.owl#Kidney_afection"/>
        <treats rdf:resource="http://www.science.library.com/scilib.owl#Inflamation"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Ibuprofen_active -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Ibuprofen_active">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#ActiveIngredient"/>
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <hasExactMass rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">121</hasExactMass>
        <hasFormula rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">C13H18O2</hasFormula>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Ibuprofen_excipients -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Ibuprofen_excipients">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Excipient"/>
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
        <hasExactMass rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</hasExactMass>
        <hasFormula>H20</hasFormula>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Inflamation -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Inflamation">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Disease"/>
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Disorder"/>
        <presents rdf:resource="http://www.science.library.com/scilib.owl#Pain"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Kidney_afection -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Kidney_afection">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#SideEffect"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Kidney_failure -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Kidney_failure">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Disease"/>
        <presents rdf:resource="http://www.science.library.com/scilib.owl#Pain"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Nervous -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Nervous">
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/NBO_0000003"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Oral -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Oral">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#ViaType"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Pain -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Pain">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Symptom"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Profen_moleculaname -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Profen_moleculaname">
        <rdf:type rdf:resource="http://www.science.library.com/scilib.owl#Molecule"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Relax -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Relax">
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000017"/>
    </owl:NamedIndividual>
    


    <!-- http://www.science.library.com/scilib.owl#Smoker -->


    <owl:NamedIndividual rdf:about="http://www.science.library.com/scilib.owl#Smoker">
        <rdf:type rdf:resource="http://purl.obolibrary.org/obo/NBO_0001845"/>
    </owl:NamedIndividual>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotations
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->


    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/APOLLO_SV_00000008">
        <obo:IAO_0000115 xml:lang="en">A planned process that has specified output a software product and that involves the creation of source code.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/APOLLO_SV_00000796">
        <obo:IAO_0000115 xml:lang="en">A planned process that has a data set as its specified output.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000002">
        <obo:IAO_0000115 xml:lang="en">An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000003">
        <obo:IAO_0000115 xml:lang="en">An entity that has temporal parts and that happens, unfolds or develops through time.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000004">
        <obo:IAO_0000115 xml:lang="en">A continuant that is a bearer of quality and realizable entity entities, in which other entities inhere and which itself cannot inhere in anything.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000015">
        <obo:IAO_0000115 xml:lang="en">An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000017">
        <obo:IAO_0000115 xml:lang="en">A specifically dependent continuant  that inheres in continuant  entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000020">
        <obo:IAO_0000115 xml:lang="en">A continuant that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000023">
        <obo:IAO_0000115 xml:lang="en">A realizable entity  the manifestation of which brings about some result or end that is not essential to a continuant  in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant  in some kinds of natural, social or institutional contexts.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000031">
        <obo:IAO_0000115 xml:lang="en">A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000040">
        <obo:IAO_0000115 xml:lang="en">An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000050">
        <obo:IAO_0000115 xml:lang="en">a core relation that holds between a part and its whole</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
        <obo:IAO_0000115 xml:lang="en">a core relation that holds between a whole and its part</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000062">
        <obo:IAO_0000115 xml:lang="en">x is preceded by y if and only if the time point at which y ends is before or equivalent to the time point at which x starts. Formally: x preceded by y iff ω(y) &lt;= α(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.</obo:IAO_0000115>
        <obo:IAO_0000115>X preceded_by Y iff: end(Y) before_or_simultaneous_with start(X)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000063">
        <obo:IAO_0000115 xml:lang="en">x precedes y if and only if the time point at which x ends is before or equivalent to the time point at which y starts. Formally: x precedes y iff ω(x) &lt;= α(y), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000066">
        <obo:IAO_0000115 xml:lang="en">b occurs_in c =def b is a process and c is a material entity or immaterial entity&amp; there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.&amp; forall(t) if b exists_at t then c exists_at t &amp; there exist spatial regions s and s’ where &amp; b spatially_projects_onto s at t&amp; c is occupies_spatial_region s’ at t&amp; s is a proper_continuant_part_of s’ at t</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000067">
        <obo:IAO_0000115 xml:lang="en">[copied from inverse property &apos;occurs in&apos;] b occurs_in c =def b is a process and c is a material entity or immaterial entity&amp; there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.&amp; forall(t) if b exists_at t then c exists_at t &amp; there exist spatial regions s and s’ where &amp; b spatially_projects_onto s at t&amp; c is occupies_spatial_region s’ at t&amp; s is a proper_continuant_part_of s’ at t</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BSPO_0005001">
        <obo:IAO_0000115>X intersects_median_plane of iff X crosses the midine plane of Y.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_10545">
        <obo:IAO_0000115>Elementary particle not affected by the strong force having a spin 1/2, a negative elementary charge and a rest mass of 0.000548579903(13) u, or 0.51099906(15) MeV.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_11955">
        <obo:IAO_0000115>The conjugate base of gamma-amino-beta-hydroxybutyric acid arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131604">
        <obo:IAO_0000115>Any bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131619">
        <obo:IAO_0000115>A steroid compound with a structure based on a 27-carbon (cholestane) skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131620">
        <obo:IAO_0000115>A steroid compound with a structure based on a 24-carbon (cholane) skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131657">
        <obo:IAO_0000115>Any steroid (or derivative) based on a cholane skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131878">
        <obo:IAO_0000115>Any steroid acid anion based on a cholanic acid skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_131927">
        <obo:IAO_0000115>A class of carbonyl compound encompassing dicarboxylic acids and any derivatives obtained by substitution of either one or both of the carboxy hydrogens.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_132124">
        <obo:IAO_0000115>Any member of the class of benzoquinones that is 1,4-benzoquinone or its C-substituted derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_132130">
        <obo:IAO_0000115>Any quinone in which one or more of the carbons making up the quinone moiety is substituted by a hydroxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_132544">
        <obo:IAO_0000115>Any polyunsaturated fatty acid containing 22 carbons and 6 double bonds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_132952">
        <obo:IAO_0000115>A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of oxalic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_134179">
        <obo:IAO_0000115>Any organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_134363">
        <obo:IAO_0000115>An N-oxide where there are three organic groups bonded to the nitrogen atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_136859">
        <obo:IAO_0000115>A compound that, on administration, undergoes conversion by biochemical (enzymatic), chemical (possibly following an enzymatic step), or physical (e.g. photochemical) activation processes before becoming the active agent for which it is a pro-agent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_136889">
        <obo:IAO_0000115>Any steroid that has beta-configuration at position 5.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_137431">
        <obo:IAO_0000115>A cardiovascular drug that tends to raise reduced blood pressure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_137982">
        <obo:IAO_0000115>An organic cation obtained by protonation of the amino group of any tertiary amino compound.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_137983">
        <obo:IAO_0000115>A quaternary ammonium ion obtained by methylation of any tertiary amine</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_138015">
        <obo:IAO_0000115>Any compound that can disrupt the functions of the endocrine (hormone) system</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_138103">
        <obo:IAO_0000115>A Bronsted acid derived from one or more inorganic compounds. Inorganic acids (also known as mineral acids) form hydrons and conjugate base ions when dissolved in water.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_138366">
        <obo:IAO_0000115>Any member of a group of hydroxy steroids occuring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In mammals bile acids almost invariably have 5beta-configuration, while in lower vertebrates, some bile acids, known as allo-bile acids, have 5alpha-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_138675">
        <obo:IAO_0000115>Any main group molecular entity that is gaseous at standard temperature and pressure (STP; 0degreeC and 100 kPa).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_139120">
        <obo:IAO_0000115>Any carotenoid derivative with an beta-end group</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_139588">
        <obo:IAO_0000115>An alpha-oxyketone that has a hydroxy group as the alpha-oxy moiety.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_139592">
        <obo:IAO_0000115>An alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing two organyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_140601">
        <obo:IAO_0000115>Any saturated fatty acid containing 4 carbons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_142839">
        <obo:IAO_0000115>An organic anion arising from deprotonation of the hydroxy group of an enol.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_14321">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of glutamic acid, having anionic carboxy groups and a cationic amino group</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_145947">
        <obo:IAO_0000115>A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_147289">
        <obo:IAO_0000115>Any EC 3.4.17.* (metallocarboxypeptidase) inhibitor that inhibits the action of angiotensin-converting enzyme 2 (EC 3.4.17.23).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_147290">
        <obo:IAO_0000115>Any EC 3.4.* (hydrolases acting on peptide bond) inhibitor that inhibits the action of a metallocarboxypeptidase (EC 3.4.17.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_149552">
        <obo:IAO_0000115>Any agent that induces nausea and vomiting.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15339">
        <obo:IAO_0000115>A molecular entity that can accept an electron, a pair of electrons, an atom or a group from another molecular entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15354">
        <obo:IAO_0000115>A choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15356">
        <obo:IAO_0000115>A sulfur-containing amino acid that is propanoic acid with an amino group at position 2 and a sulfanyl group at position 3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15361">
        <obo:IAO_0000115>A 2-oxo monocarboxylic acid anion that is the conjugate base of pyruvic acid, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15366">
        <obo:IAO_0000115>A simple monocarboxylic acid containing two carbons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15414">
        <obo:IAO_0000115>A sulfonium compound that is the S-adenosyl derivative of L-methionine. It is an intermediate in the metabolic pathway of methionine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15428">
        <obo:IAO_0000115>The simplest (and the only achiral) proteinogenic amino acid, with a hydrogen atom as its side chain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15693">
        <obo:IAO_0000115>Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n &gt;= 2) and their intramolecular hemiacetals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15705">
        <obo:IAO_0000115>Any alpha-amino acid having L-configuration at the alpha-carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15724">
        <obo:IAO_0000115>A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15734">
        <obo:IAO_0000115>A primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15756">
        <obo:IAO_0000115>A straight-chain, sixteen-carbon, saturated long-chain fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15778">
        <obo:IAO_0000115>Any N-acyl-amino acid in which the amino acid moiety has D configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15889">
        <obo:IAO_0000115>Any 3-hydroxy steroid whose skeleton is closely related to cholestan-3-ol (additional carbon atoms may be present in the side chain).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15904">
        <obo:IAO_0000115>A fatty acid with a chain length ranging from C13 to C22.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15940">
        <obo:IAO_0000115>A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_15966">
        <obo:IAO_0000115>An optically active form of glutamic acid having D-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16015">
        <obo:IAO_0000115>An optically active form of glutamic acid having L-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16042">
        <obo:IAO_0000115>A monoatomic monoanion resulting from the addition of an electron to any halogen atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16080">
        <obo:IAO_0000115>A gamma-amino acid comprising 4-aminobutyric acid having a 2-hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16113">
        <obo:IAO_0000115>A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16134">
        <obo:IAO_0000115>An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16199">
        <obo:IAO_0000115>A carbonyl group with two C-bound amine groups. The commercially available fertilizer has an analysis of 46-0-0 (N-P2O5-K2O).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16285">
        <obo:IAO_0000115>A branched-chain saturated fatty acid consisting of hexadecanoic acid carrying methyl substituents at positions 3, 7, 11 and 15.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16375">
        <obo:IAO_0000115>An optically active form of cysteine having D-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16389">
        <obo:IAO_0000115>Any benzoquinone derived from 2,3-dimethoxy-5-methylbenzoquinone; one of a group of naturally occurring homologues. The redox-active quinoid moiety usually carries a polyprenoid side chain at position 6, the number of isoprenoid units in which is species-specific. Ubiquinones are involved in the control of mitochondrial electron transport, and are also potent anti-oxidants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16523">
        <obo:IAO_0000115>The R-enantiomer of serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16643">
        <obo:IAO_0000115>The L-enantiomer of methionine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16646">
        <obo:IAO_0000115>Any member of the class of organooxygen compounds that is a polyhydroxy-aldehyde or -ketone or a lactol resulting from their intramolecular condensation (monosaccharides); substances derived from these by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom; and polymeric products arising by intermolecular acetal formation between two or more such molecules (disaccharides, polysaccharides and oligosaccharides). Carbohydrates contain only carbon, hydrogen and oxygen atoms; prior to any oxidation or reduction, most have the empirical formula Cm(H2O)n. Compounds obtained from carbohydrates by substitution, etc., are known as carbohydrate derivatives and may contain other elements. Cyclitols are generally not regarded as carbohydrates.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16670">
        <obo:IAO_0000115>Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_166856">
        <obo:IAO_0000115>A methylated tertiary amine that is  trimethylammonium in which the hydrogen attached to the nitrogen is replaced by a hydroxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16704">
        <obo:IAO_0000115>A ribonucleoside composed of a molecule of uracil attached to a ribofuranose moiety via a beta-N(1)-glycosidic bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16705">
        <obo:IAO_0000115>A penicillanic acid compound having a (6R)-amino substituent. The active nucleus common to all penicillins, it may be substituted at the 6-amino position to form the semisynthetic penicillins, resulting in a variety of antibacterial and pharmacologic characteristics.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16709">
        <obo:IAO_0000115>A hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2. The 4-methanol form of vitamin B6, it is converted intoto pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16716">
        <obo:IAO_0000115>A six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised pi system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. Benzene is a carcinogen that also damages bone marrow and the central nervous system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16755">
        <obo:IAO_0000115>A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16811">
        <obo:IAO_0000115>A sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16867">
        <obo:IAO_0000115>An optically active form of methionine having D-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16919">
        <obo:IAO_0000115>A glycine derivative having methyl and amidino groups attached to the nitrogen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_16995">
        <obo:IAO_0000115>An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17015">
        <obo:IAO_0000115>D-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17087">
        <obo:IAO_0000115>A compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17115">
        <obo:IAO_0000115>The L-enantiomer of serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17120">
        <obo:IAO_0000115>A short-chain fatty acid anion that is the conjugate base of hexanoic acid (also known as caproic acid).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17126">
        <obo:IAO_0000115>An amino-acid betaine that is butanoate substituted with a hydroxy group at position C-3 and a trimethylammonium group at C-4.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_1722">
        <obo:IAO_0000115>Any 3beta-hydroxy-steroid that contains a double bond between positions 5 and 6.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17234">
        <obo:IAO_0000115>An aldohexose used as a source of energy and metabolic intermediate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17272">
        <obo:IAO_0000115>The conjugate base of propionic acid; a key precursor in lipid biosynthesis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17334">
        <obo:IAO_0000115>Any member of the group of substituted penams containing two methyl substituents at position 2, a carboxylate substituent at position 3 and a carboxamido group at position 6.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17359">
        <obo:IAO_0000115>A sulfur oxoanion that is the conjugate base of hydrogen sulfite (H2SO3).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17418">
        <obo:IAO_0000115>A straight-chain saturated fatty acid containing five carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17439">
        <obo:IAO_0000115>A complex cob(III)alamin in which cobalt is positioned in the centre of a planar corrin tetrapyrrole ring and bound axially to a 5,6-dimethylbenzimidazole moiety and a cyano group. It is one of several forms of the vitamin known as vitamin B12.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17522">
        <obo:IAO_0000115>A carbohydrate that is an acyclic polyol having the general formula HOCH2[CH(OH)]nCH2OH (formally derivable from an aldose by reduction of the carbonyl group).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17544">
        <obo:IAO_0000115>The carbon oxoanion resulting from the removal of a proton from carbonic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17561">
        <obo:IAO_0000115>An optically active form of cysteine having L-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17568">
        <obo:IAO_0000115>A common and naturally occurring pyrimidine nucleobase in which the pyrimidine ring is substituted with two oxo groups at positions 2 and 4. Found in RNA, it base pairs with adenine and replaces thymine during DNA transcription.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17578">
        <obo:IAO_0000115>The simplest member of the class toluenes consisting of a benzene core which bears a single methyl substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17716">
        <obo:IAO_0000115>A  glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1-&gt;4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17754">
        <obo:IAO_0000115>A triol with a structure of propane substituted at positions 1, 2 and 3 by hydroxy groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17781">
        <obo:IAO_0000115>A compound showing blue fluorescence, formed by a photolysis of riboflavin in acid or neutral solution.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17790">
        <obo:IAO_0000115>The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17822">
        <obo:IAO_0000115>An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17855">
        <obo:IAO_0000115>Any glyceride resulting from the condensation of all three hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17891">
        <obo:IAO_0000115>A molecular entity that can transfer (&quot;donate&quot;) an electron, a pair of electrons, an atom or a group to another molecular entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17968">
        <obo:IAO_0000115>A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_17992">
        <obo:IAO_0000115>A glycosyl glycoside formed by glucose and fructose units joined by an acetal oxygen bridge from hemiacetal of glucose to the hemiketal of the fructose.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18059">
        <obo:IAO_0000115>&apos;Lipids&apos; is a loosely defined term for substances of biological origin that are soluble in nonpolar solvents. They consist of saponifiable lipids, such as glycerides (fats and oils) and phospholipids, as well as nonsaponifiable lipids, principally steroids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18133">
        <obo:IAO_0000115>Any six-carbon monosaccharide which in its linear form contains either an aldehyde group at position 1 (aldohexose) or a ketone group at position 2 (ketohexose).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18139">
        <obo:IAO_0000115>A tertiary amine that is ammonia in which each hydrogen atom is substituted by an methyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18186">
        <obo:IAO_0000115>An alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18211">
        <obo:IAO_0000115>The parent compound of the citrulline class consisting of ornithine having a carbamoyl group at the N(5)-position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18237">
        <obo:IAO_0000115>An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18248">
        <obo:IAO_0000115>An iron group element atom that has atomic number 26.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18254">
        <obo:IAO_0000115>Any nucleoside where the sugar component is D-ribose.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18257">
        <obo:IAO_0000115>An alpha-amino acid that is pentanoic acid bearing two amino substituents at positions 2 and 5.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18282">
        <obo:IAO_0000115>That part of DNA or RNA that may be involved in pairing.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18310">
        <obo:IAO_0000115>An acyclic branched or unbranched hydrocarbon having the general formula CnH2n+2, and therefore consisting entirely of hydrogen atoms and saturated carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_18367">
        <obo:IAO_0000115>A phosphate ion that is the conjugate base of hydrogenphosphate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_21501">
        <obo:IAO_0000115>An N-acetyl-amino acid having D-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_21545">
        <obo:IAO_0000115>An L-amino acid having an N-acetyl substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_21575">
        <obo:IAO_0000115>An N-acyl-amino acid that has acetyl as the acyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_21644">
        <obo:IAO_0000115>Any N-acylamino acid having L-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_21731">
        <obo:IAO_0000115>A glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a nitrogen atom, thus creating a C-N bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22160">
        <obo:IAO_0000115>Compounds with the general formula RNHC(=O)CH3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22195">
        <obo:IAO_0000115>Any amino acid derivative that is the N-acetyl or O-acetyl derivative of an amino acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22221">
        <obo:IAO_0000115>An organic group formed by removing one or more hydroxy groups from an oxoacid that has the general structure RkE(=O)l(OH)m (l =/= 0). Although the term is almost always applied to organic compounds, with carboxylic acid as the oxoacid, acyl groups can in principle be derived from other types of acids such as sulfonic acids or phosphonic acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22315">
        <obo:IAO_0000115>Any of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is  exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22323">
        <obo:IAO_0000115>A univalent group -CnH2n+1 derived from an alkane by removal of a hydrogen atom from any carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22331">
        <obo:IAO_0000115>Any amine formally derived from ammonia by replacing one, two or three hydrogen atoms by alkyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22333">
        <obo:IAO_0000115>Highly reactive chemical that introduces alkyl radicals into biologically active molecules and thereby prevents their proper functioning. It could be used as an antineoplastic agent, but it might be very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. It could also be used as a component of poison gases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22563">
        <obo:IAO_0000115>A monoatomic or polyatomic species having one or more elementary charges of the electron.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22586">
        <obo:IAO_0000115>A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22587">
        <obo:IAO_0000115>A substance that destroys or inhibits replication of viruses.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22651">
        <obo:IAO_0000115>A ketoaldonate that is the conjugate base of ascorbic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22658">
        <obo:IAO_0000115>An L-alpha-amino acid which is L-aspartic acid or any of the essential amino acids biosynthesised from it (asparagine, lysine, methionine, threonine and isoleucine). A closed class.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22695">
        <obo:IAO_0000115>A molecular entity having an available pair of electrons capable of forming a covalent bond with a hydron (Bronsted base) or with the vacant orbital of some other molecular entity (Lewis base).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22712">
        <obo:IAO_0000115>Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22718">
        <obo:IAO_0000115>A monocarboxylic acid anion obtained by deprotonation of the carboxy group of any benzoic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22729">
        <obo:IAO_0000115>Any quinone resulting from the formal oxidation of catechol, hydroquinone, or their C-substituted derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22860">
        <obo:IAO_0000115>Any amino acid-derived zwitterion - such as glycine betaine (N,N,N-trimethylammonioacetate) - in which the ammonium nitrogen carries three methyl substituents.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_22918">
        <obo:IAO_0000115>Any  amino acid  in which the parent hydrocarbon chain has one or more alkyl substituents</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23004">
        <obo:IAO_0000115>The univalent carboacyl group formed by loss of -OH from the carboxy group of carbamic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23016">
        <obo:IAO_0000115>Organooxygen compounds that are salts or esters of carbonic acid, H2CO3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23042">
        <obo:IAO_0000115>Hydrocarbon carotenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23044">
        <obo:IAO_0000115>One of a class of tetraterpenoids (C40), formally derived from the acyclic parent, psi,psi-carotene by hydrogenation, dehydrogenation, cyclization, oxidation, or combination of these processes. This class includes carotenes, xanthophylls and certain compounds that arise from rearrangement of the skeleton of psi,psi-carotene or by loss of part of this structure. Retinoids are excluded.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23066">
        <obo:IAO_0000115>A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring.  Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23217">
        <obo:IAO_0000115>A quaternary ammonium ion based on the choline ion and its substituted derivatives thereof.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23354">
        <obo:IAO_0000115>A low-molecular-weight, non-protein organic compound participating in enzymatic reactions as dissociable acceptor or donor of chemical groups or electrons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23357">
        <obo:IAO_0000115>An organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23509">
        <obo:IAO_0000115>An amino acid derivative resulting from reaction of cysteine at the amino group, carboxy group, or thiol group, or from the replacement of any hydrogen of cysteine by a heteroatom. The definition normally excludes peptides containing cysteine residues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23775">
        <obo:IAO_0000115>A hydroxy-5beta-cholanic acid carrying two hydroxy groups at unspecified positions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23888">
        <obo:IAO_0000115>Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_23924">
        <obo:IAO_0000115>A compound or agent that combines with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24020">
        <obo:IAO_0000115>Vitamins like A, D, E and K that dissolve in fats and are stored in body tissues. Unlike the water-soluble vitamins, these are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24261">
        <obo:IAO_0000115>Glucocorticoids are a class of steroid hormones that regulate a variety of physiological processes, in particular control of the concentration of glucose in blood.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24315">
        <obo:IAO_0000115>An amino acid derivative resulting from reaction of glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing glutamic acid residues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24318">
        <obo:IAO_0000115>An L-alpha-amino acid which is L-glutamic acid or any of the essential amino acids biosynthesised from it (glutamine, proline and arginine). A closed class.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24319">
        <obo:IAO_0000115>An EC 6.3.* (C-N bond-forming ligase) inhibitor that interferes with the action of glutamate--ammonia ligase (EC 6.3.1.2).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24373">
        <obo:IAO_0000115>A proteinogenic amino acid derivative resulting from reaction of glycine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24407">
        <obo:IAO_0000115>Any disaccharide in which the two monosaccharide components are connected by a glycosidic linkage between their anomeric centres.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24431">
        <obo:IAO_0000115>A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24432">
        <obo:IAO_0000115>A role played by the molecular entity or part thereof within a biological context.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24433">
        <obo:IAO_0000115>A defined linked collection of atoms or a single atom within a molecular entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24436">
        <obo:IAO_0000115>Any organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24532">
        <obo:IAO_0000115>A cyclic compound having as ring members atoms of carbon and at least of one other element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24621">
        <obo:IAO_0000115>Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24632">
        <obo:IAO_0000115>A compound consisting of carbon and hydrogen only.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24651">
        <obo:IAO_0000115>Hydroxides are chemical compounds containing a hydroxy group or salts containing hydroxide (OH(-)).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24663">
        <obo:IAO_0000115>Any member of the class of 5beta-cholanic acids carrying at least one hydroxy group at unspecified position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24669">
        <obo:IAO_0000115>Any carboxylic acid with at least one hydroxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24745">
        <obo:IAO_0000115>Any member of the class of pyridines with at least one hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24833">
        <obo:IAO_0000115>A compound which contains oxygen, at least one other element, and at least one hydrogen bound to oxygen, and which produces a conjugate base by loss of positive hydrogen ion(s) (hydrons).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24835">
        <obo:IAO_0000115>A molecular entity that contains no carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24866">
        <obo:IAO_0000115>A salt is an assembly of cations and anions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24870">
        <obo:IAO_0000115>A molecular entity having a net electric charge.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24898">
        <obo:IAO_0000115>A 2-amino-3-methylpentanoic acid having either (2R,3R)- or (2S,3S)-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24913">
        <obo:IAO_0000115>Any lipid formally derived from isoprene (2-methylbuta-1,3-diene), the skeleton of which can generally be discerned in repeated occurrence in the molecule. The skeleton of isoprenoids may differ from strict additivity of isoprene units by loss or shift of a fragment, commonly a methyl group. The class includes both hydrocarbons and oxygenated derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24963">
        <obo:IAO_0000115>Oxo carboxylic acids formally derived from aldonic acids by replacement of a secondary CHOH group by a carbonyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24973">
        <obo:IAO_0000115>Any hexose containing a single ketone group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24978">
        <obo:IAO_0000115>Ketonic parent sugars (polyhydroxy ketones H[CH(OH)]nC(=O)[CH(OH)]mH) and their intramolecular hemiketals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_24995">
        <obo:IAO_0000115>Cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25000">
        <obo:IAO_0000115>Any cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25017">
        <obo:IAO_0000115>A branched-chain amino acid that consists of glycine in which one of the hydrogens attached to the alpha-carbon is substituted by an isobutyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25094">
        <obo:IAO_0000115>A diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25105">
        <obo:IAO_0000115>A macrocyclic lactone with a ring of twelve or more members which exhibits antibiotic activity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25106">
        <obo:IAO_0000115>A macrocyclic lactone with a ring of twelve or more members derived from a polyketide.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25212">
        <obo:IAO_0000115>Any intermediate or product resulting from metabolism. The term &apos;metabolite&apos; subsumes the classes commonly known as primary and secondary metabolites.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25340">
        <obo:IAO_0000115>Any member of the class of pyridines that carries at least one methyl substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25367">
        <obo:IAO_0000115>Any polyatomic entity that is an electrically neutral entity consisting of more than one atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25384">
        <obo:IAO_0000115>An oxoacid containing a single carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25435">
        <obo:IAO_0000115>An agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25512">
        <obo:IAO_0000115>An endogenous compound that is used to transmit information across the synapse between a neuron and another cell.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25681">
        <obo:IAO_0000115>A family of polyunsaturated fatty acids that have in common a final carbon-carbon double bond in the omega-3 position, i.e., the third bond from the methyl end of the fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25696">
        <obo:IAO_0000115>Any organic ion with a net negative charge.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25697">
        <obo:IAO_0000115>Any organic ion with a net positive charge.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_2571">
        <obo:IAO_0000115>An  alcohol derived from an aliphatic compound.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25728">
        <obo:IAO_0000115>A solute used by a cell under water stress to maintain cell volume.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25741">
        <obo:IAO_0000115>An oxide is a chemical compound of oxygen with other chemical elements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25754">
        <obo:IAO_0000115>Any compound that has an aldehydic or ketonic group as well as a carboxylic acid group in the same molecule.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_2580">
        <obo:IAO_0000115>Any fatty acid anion containing at least one C-C unsaturated bond; formed by deprotonation of the carboxylic acid moiety.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25830">
        <obo:IAO_0000115>A quinone in which the two oxo groups of the quinone are located para to each other on the 6-membered quinonoid ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25901">
        <obo:IAO_0000115>A five-carbon monosaccharide which in its linear form contains either an aldehyde group at position 1 (aldopentose) or a ketone group at position 2 (ketopentose).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26020">
        <obo:IAO_0000115>Salts and esters of phosphoric and oligophosphoric acids and their chalcogen analogues. In inorganic chemistry, the term is also used to describe anionic coordination entities with phosphorus as central atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26078">
        <obo:IAO_0000115>A phosphorus oxoacid that consists of one oxo and three hydroxy groups joined covalently to a central phosphorus atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26167">
        <obo:IAO_0000115>Any amino acid whose side chain is capable of forming one or more hydrogen bonds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26188">
        <obo:IAO_0000115>Natural and synthetic compounds containing alternating carbonyl and methylene groups (&apos;beta-polyketones&apos;), biogenetically derived from repeated condensation of acetyl coenzyme A (via malonyl coenzyme A), and usually the compounds derived from them by further condensations, etc. Considered by many to be synonymous with the less frequently used terms acetogenins and ketides.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26191">
        <obo:IAO_0000115>A compound that contains two or more hydroxy groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26208">
        <obo:IAO_0000115>Any fatty acid containing more than one double bond. Acids in this group are reported to have cardioprotective effects; and levels are lowered in chronic fatigue syndrome.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26255">
        <obo:IAO_0000115>A quinone substituted by a polyprenyl-derived side-chain. Prenylquinones occur in all living cells. Due to their amphiphilic character, they are mainly located in biological membranes where they function as electron and proton carriers in the photosynthetic and respiratory electron transport chains. Some prenylquinones also perform more specialised roles sucy as antioxidants and enzyme cofactors. Prenylquinones are classified according to ring structure: the main classes are menaquinones, phylloquinones, ubiquinones and plastoquinones.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26348">
        <obo:IAO_0000115>A tightly bound, specific nonpolypeptide unit in a protein determining and involved in its biological activity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26401">
        <obo:IAO_0000115>A class of imidazopyrimidines that consists of purine and its substituted derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26420">
        <obo:IAO_0000115>A monocarboxylic acid in which the carboxy group is attached to a pyridine (or substituted pyridine) ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26421">
        <obo:IAO_0000115>Any organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26432">
        <obo:IAO_0000115>A nucleobase whose skeleton is derived from pyrimidine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26469">
        <obo:IAO_0000115>A nitrogen molecular entity that is electronically neutral but which contains a quaternary nitrogen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26607">
        <obo:IAO_0000115>Any fatty acid containing no carbon to carbon multiple bonds. Known to produce adverse biological effects when ingested to excess.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26650">
        <obo:IAO_0000115>An L-alpha-amino acid which is biosynthesised from 3-phosphoglycerate (i.e. serine, glycine, cysteine and homocysteine). A closed class.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26666">
        <obo:IAO_0000115>An aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26714">
        <obo:IAO_0000115>Any alkali metal salt having sodium(1+) as the cation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26764">
        <obo:IAO_0000115>Any steroid that acts as hormone.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26873">
        <obo:IAO_0000115>Any isoprenoid that is a natural product or related compound formally derived from isoprene units. Terpenoids may contain oxygen in various functional groups. This class is subdivided according to the number of carbon atoms in the parent terpene. The skeleton of terpenoids may differ from strict additivity of isoprene units by the loss or shift of a fragment, generally a methyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26878">
        <obo:IAO_0000115>A tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26895">
        <obo:IAO_0000115>A subclass of polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26912">
        <obo:IAO_0000115>Any oxacycle having an oxolane (tetrahydrofuran) skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26932">
        <obo:IAO_0000115>A natural pigment containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26935">
        <obo:IAO_0000115>Any terpenoid derived from a tetraterpene. The term includes compounds in which the C40 skeleton of the parent tetraterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_26979">
        <obo:IAO_0000115>An organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27024">
        <obo:IAO_0000115>Any member of the class of benzenes that is a substituted benzene in which the substituents include one (and only one) methyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27027">
        <obo:IAO_0000115>Any nutrient required in small quantities by organisms throughout their life in order to orchestrate a range of physiological functions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27081">
        <obo:IAO_0000115>An element whose atom has an incomplete d sub-shell, or which can give rise to cations with an incomplete d sub-shell.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27136">
        <obo:IAO_0000115>A chemical compound containing three hydroxy groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27207">
        <obo:IAO_0000115>A univalent carboacyl group is a group formed by loss of OH from the carboxy group of a carboxylic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27208">
        <obo:IAO_0000115>Any fatty acid containing at least one C=C or C#C bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27266">
        <obo:IAO_0000115>A branched-chain amino acid that consists of glycine in which one of the hydrogens attached to the alpha-carbon is substituted by an isopropyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27300">
        <obo:IAO_0000115>Vitamin D is a group of fat-soluble prohormones, which can be obtained from sun exposure, food and supplements. Vitamin D is biologically inactive and converted into the biologically active calcitriol via double hydroxylation in the body.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27325">
        <obo:IAO_0000115>A subclass of carotenoids consisting of the oxygenated carotenes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27369">
        <obo:IAO_0000115>A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27470">
        <obo:IAO_0000115>An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27638">
        <obo:IAO_0000115>A cobalt group element atom that has atomic number 27.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27780">
        <obo:IAO_0000115>A surfactant (or a mixture containing one or more surfactants) having cleaning properties in dilute solutions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27902">
        <obo:IAO_0000115>A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_27933">
        <obo:IAO_0000115>An organonitrogen heterocyclic antibiotic that contains a beta-lactam ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28044">
        <obo:IAO_0000115>An aromatic amino acid that is alanine in which one of the methyl hydrogens is substituted by a phenyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28260">
        <obo:IAO_0000115>An aldohexose that is the C-4 epimer of glucose.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28425">
        <obo:IAO_0000115>A cyclic carotene with a beta- and an epsilon-ring at opposite ends respectively.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28616">
        <obo:IAO_0000115>A one-carbon compound that is ammonia in which one of the hydrogens is replaced by a carboxy group. Although carbamic acid derivatives are common, carbamic acid itself has never been synthesised.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28757">
        <obo:IAO_0000115>A ketohexose that is an isomer of glucose.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28868">
        <obo:IAO_0000115>The conjugate base of a fatty acid, arising from deprotonation of the carboxylic acid group of the corresponding fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28938">
        <obo:IAO_0000115>An onium cation obtained by protonation of ammonia.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28939">
        <obo:IAO_0000115>An  N-acetyl-L-amino acid that is the N-acetylated derivative of the natural amino acid L-cysteine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_28965">
        <obo:IAO_0000115>A carboxylic acid dianion obtained by deprotonation of both carboxy groups of any dicarboxylic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29016">
        <obo:IAO_0000115>An alpha-amino acid that is glycine in which the alpha-is substituted by a 3-guanidinopropyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29067">
        <obo:IAO_0000115>The conjugate base formed when the carboxy group of a carboxylic acid is deprotonated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29101">
        <obo:IAO_0000115>A monoatomic monocation obtained from sodium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29103">
        <obo:IAO_0000115>A monoatomic monocation obtained from potassium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29228">
        <obo:IAO_0000115>A diatomic molecule containing covalently bonded hydrogen and fluorine atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29340">
        <obo:IAO_0000115>A divalent inorganic anion resulting from the removal of two protons from ammonia.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29347">
        <obo:IAO_0000115>A carboxamide derived from a monocarboxylic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29985">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of L-glutamic acid, having anionic carboxy groups and a cationic amino group</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29986">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of D-glutamic acid, having anionic carboxy groups and a cationic amino group</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29987">
        <obo:IAO_0000115>A dicarboxylic acid dianion that is the conjugate base of glutamate(1-).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_29988">
        <obo:IAO_0000115>An L-alpha-amino acid anion that is the dianion obtained by the deprotonation of the both the carboxy groups of L-glutamic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30089">
        <obo:IAO_0000115>A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of acetic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30363">
        <obo:IAO_0000115>An alkane that is propane substituted by a methyl group at position 2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30411">
        <obo:IAO_0000115>A cobalt-corrinoid hexaamide that is cobalamin with the oxidation state of the central cobalt atom unspecified.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30527">
        <obo:IAO_0000115>A derivative of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton, with a substituent on the 10 position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30623">
        <obo:IAO_0000115>A dicarboxylic acid dianion obtained by deprotonation of both carboxy groups of oxalic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30768">
        <obo:IAO_0000115>A short-chain saturated fatty acid comprising ethane attached to the carbon of a carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30772">
        <obo:IAO_0000115>A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30776">
        <obo:IAO_0000115>A C6, straight-chain saturated fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_30879">
        <obo:IAO_0000115>A compound in which a hydroxy group, -OH, is attached to a saturated carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_3098">
        <obo:IAO_0000115>Any member of a group of hydroxy-5beta-cholanic acids occuring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In mammals bile acids almost invariably have 5beta-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_31011">
        <obo:IAO_0000115>A short-chain fatty acid anion that is the conjugate base of valeric acid; present in ester form as component of many steroid-based pharmaceuticals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32442">
        <obo:IAO_0000115>The L-enantiomer of cysteinate(1-).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32443">
        <obo:IAO_0000115>The L-enantiomer of cysteinate(2-).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32445">
        <obo:IAO_0000115>The L-enantiomer of cysteinium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32449">
        <obo:IAO_0000115>The D-enantiomer of cysteinate(1-).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32450">
        <obo:IAO_0000115>The D-enantiomer of cysteinate(2-).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32451">
        <obo:IAO_0000115>The D-enantiomer of cysteinium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32456">
        <obo:IAO_0000115>A sulfur-containing amino-acid anion that is the conjugate base of cysteine, obtained by deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32504">
        <obo:IAO_0000115>An aromatic amino-acid anion that is the conjugate base of phenylalanine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32505">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of phenylalanine, arising from protonation of the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32507">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of glycine, arising from protonation of the amino.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32508">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of glycine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32544">
        <obo:IAO_0000115>A pyridinemonocarboxylate that is the conjugate base of nicotinic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32563">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of lysine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32564">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of lysine, having two cationic amino groups and an anionic carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32565">
        <obo:IAO_0000115>An alpha-amino-acid cation obtained by protonation of both amino groups of lysine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32600">
        <obo:IAO_0000115>An acene that consists of four ortho-fused benzene rings in a rectilinear arrangement.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32627">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of leucine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32628">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of leucine, arising from protonation of the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32631">
        <obo:IAO_0000115>The L-enantiomer of  methioninate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32632">
        <obo:IAO_0000115>The L-enantiomer of methioninium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32637">
        <obo:IAO_0000115>The D-enantiomer of methioninate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32638">
        <obo:IAO_0000115>The D-enantiomer of methioninium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32644">
        <obo:IAO_0000115>A sulfur-containing amino-acid anion that is the conjugate base of methionine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32646">
        <obo:IAO_0000115>A sulfur-containing amino-acid anion that is the conjugate acid of methionine, arising from protonation of the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32784">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of tyrosine, arising from deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32786">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of tyrosine, arising from protonation of the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32816">
        <obo:IAO_0000115>A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32836">
        <obo:IAO_0000115>A serinate that is the conjugate base of L-serine, obtained by deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32837">
        <obo:IAO_0000115>A serinium that is the conjugate acid of L-serine, obtained by protonation of the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32840">
        <obo:IAO_0000115>The D-enantiomer of serinate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32841">
        <obo:IAO_0000115>The D-enantiomer of serinium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32845">
        <obo:IAO_0000115>An alpha-amino-acid anion that is the conjugate base of serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32846">
        <obo:IAO_0000115>An alpha-amino-acid cation that is the conjugate acid of serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32876">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32877">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing one hydrogen atom by a hydrocarbyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32952">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_32988">
        <obo:IAO_0000115>An amide is a derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_3311">
        <obo:IAO_0000115>A calcium salt with formula CCaO3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33229">
        <obo:IAO_0000115>A biochemical role played by any micronutrient that is an organic compound. Vitamins are present in foods in small amounts and are essential to normal metabolism and biochemical functions, usually as coenzymes. The term &quot;vitamines&quot; (from vita + amines) was coined in 1912 by Casimir Funk, who believed that these compounds were amines.</obo:IAO_0000115>
        <obo:IAO_0000115>Any micronutrient that is an organic compound. The term &quot;vitamines&quot; (from vita + amines) was coined in 1912 by Casimir Funk, who believed that these compounds were amines.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33231">
        <obo:IAO_0000115>A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33232">
        <obo:IAO_0000115>Intended use of the molecular entity or part thereof by humans.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33233">
        <obo:IAO_0000115>A particle not known to have substructure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33238">
        <obo:IAO_0000115>A monoatomic entity is a molecular entity consisting of a single atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33240">
        <obo:IAO_0000115>An assembly consisting of a central atom (usually metallic) to which is attached a surrounding array of other groups of atoms (ligands).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33245">
        <obo:IAO_0000115>An organic fundamental parent is a structure used as a basis for substitutive names in organic nomenclature, containing, in addition to one or more hydrogen atoms, a single atom of an element, a number of atoms (alike or different) linked together to form an unbranched chain, a monocyclic or polycyclic ring system, or a ring assembly or ring/chain system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33246">
        <obo:IAO_0000115>Any substituent group which does not contain carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33247">
        <obo:IAO_0000115>Any substituent group or skeleton containing carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33248">
        <obo:IAO_0000115>A univalent group formed by removing a hydrogen atom from a hydrocarbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33249">
        <obo:IAO_0000115>Any organic substituent group, regardless of functional type, having one free valence at a carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33250">
        <obo:IAO_0000115>A chemical entity constituting the smallest component of an element having the chemical properties of the element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33252">
        <obo:IAO_0000115>A nucleus is the positively charged central portion of an atom, excluding the orbital electrons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33253">
        <obo:IAO_0000115>Heavy nuclear particle: proton or neutron.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33256">
        <obo:IAO_0000115>A derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33259">
        <obo:IAO_0000115>A molecular entity all atoms of which have the same atomic number.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33261">
        <obo:IAO_0000115>An organosulfur compound is a compound containing at least one carbon-sulfur bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33273">
        <obo:IAO_0000115>An anion consisting of more than one atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33281">
        <obo:IAO_0000115>A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33282">
        <obo:IAO_0000115>A substance (or active part thereof) that kills or slows the growth of bacteria.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33284">
        <obo:IAO_0000115>A nutrient is a food component that an organism uses to survive and grow.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33285">
        <obo:IAO_0000115>A heteroorganic entity is an organic molecular entity in which carbon atoms or organic groups are bonded directly to one or more heteroatoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33286">
        <obo:IAO_0000115>An agrochemical is a substance that is used in agriculture or horticulture.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33287">
        <obo:IAO_0000115>A fertilizer is any substance that is added to soil or water to assist the growth of plants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33290">
        <obo:IAO_0000115>Any material that can be ingested by an organism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33292">
        <obo:IAO_0000115>An energy-rich substance that can be transformed with release of usable energy.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33296">
        <obo:IAO_0000115>A molecular entity containing one or more atoms of an alkali metal.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33299">
        <obo:IAO_0000115>An alkaline earth molecular entity is a molecular entity containing one or more atoms of an alkaline earth metal.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33300">
        <obo:IAO_0000115>Any p-block element atom that is in group 15 of the periodic table: nitrogen, phosphorus, arsenic, antimony and bismuth.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33302">
        <obo:IAO_0000115>A p-block molecular entity containing any pnictogen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33303">
        <obo:IAO_0000115>Any p-block element belonging to the group 16 family of the periodic table.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33304">
        <obo:IAO_0000115>Any p-block molecular entity containing a chalcogen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33308">
        <obo:IAO_0000115>An ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33318">
        <obo:IAO_0000115>An atom belonging to one of the main groups (found in the s- and p- blocks) of the periodic table.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33384">
        <obo:IAO_0000115>A serine zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33405">
        <obo:IAO_0000115>A hydracid is a compound which contains hydrogen that is not bound to oxygen, and which produces a conjugate base by loss of positive hydrogen ion(s) (hydrons).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33452">
        <obo:IAO_0000115>Arylmethyl groups and derivatives formed by substitution: ArCR2-.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33457">
        <obo:IAO_0000115>A pnictogen oxoacid which contains phosphorus and oxygen, at least one hydrogen atom bound to oxygen, and forms an ion by the loss of one or more protons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33497">
        <obo:IAO_0000115>A molecular entity containing one or more atoms of a transition element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33521">
        <obo:IAO_0000115>An atom of an element that exhibits typical metallic properties, being typically shiny, with high electrical and thermal conductivity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33543">
        <obo:IAO_0000115>The sulfur oxoanion formed by deprotonation of sulfonic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33558">
        <obo:IAO_0000115>An amino-acid anion obtained by deprotonation of any alpha-amino acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33560">
        <obo:IAO_0000115>Any main group element atom belonging to the p-block of the periodic table.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33575">
        <obo:IAO_0000115>A carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33576">
        <obo:IAO_0000115>Any carboxylic acid having a sulfur substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33579">
        <obo:IAO_0000115>A molecular entity containing one or more atoms from any of groups 1, 2, 13, 14, 15, 16, 17, and 18 of the periodic table.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33595">
        <obo:IAO_0000115>Any molecule that consists of a series of atoms joined together to form a ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33597">
        <obo:IAO_0000115>A cyclic compound having as ring members atoms of the same element only.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33598">
        <obo:IAO_0000115>A homocyclic compound in which all of the ring members are carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33636">
        <obo:IAO_0000115>A molecule that features two fused rings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33637">
        <obo:IAO_0000115>A polycyclic compound in which two rings have two, and only two, atoms in common. Such compounds have n common faces and 2n common atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33653">
        <obo:IAO_0000115>Any acyclic or cyclic, saturated or unsaturated carbon compound, excluding aromatic compounds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33655">
        <obo:IAO_0000115>A cyclically conjugated molecular entity with a stability (due to delocalization) significantly greater than that of a hypothetical localized structure (e.g. Kekule structure) is said to possess aromatic character.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33658">
        <obo:IAO_0000115>Any monocyclic or polycyclic aromatic hydrocarbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33662">
        <obo:IAO_0000115>A mancude monocyclic hydrocarbon without side chains of the general formula CnHn (n is an even number) or CnHn+1 (n is an odd number). In systematic nomenclature an annulene with seven or more carbon atoms may be named [n]annulene, where n is the number of carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33671">
        <obo:IAO_0000115>A polycyclic compound in which at least one of the rings contains at least one non-carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33672">
        <obo:IAO_0000115>A bicyclic compound in which at least one of the rings contains at least one skeletal heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33674">
        <obo:IAO_0000115>An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33675">
        <obo:IAO_0000115>A main group molecular entity that contains one or more atoms of a p-block element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33676">
        <obo:IAO_0000115>A d-block molecular entity is a molecular entity containing one or more atoms of a d-block element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33692">
        <obo:IAO_0000115>Hydrides are chemical compounds of hydrogen with other chemical elements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33702">
        <obo:IAO_0000115>A cation consisting of more than one atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33704">
        <obo:IAO_0000115>An amino acid in which the amino group is located on the carbon atom at the position alpha to the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33707">
        <obo:IAO_0000115>A non-proteinogenic amino-acid in which the amino group is located on the carbon atom at the position gamma to the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33709">
        <obo:IAO_0000115>A carboxylic acid containing one or more amino groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33822">
        <obo:IAO_0000115>An organic compound having at least one hydroxy group attached to a carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33823">
        <obo:IAO_0000115>Alkenols; the term refers specifically to vinylic alcohols, which have the structure HOCR&apos;=CR2. Enols are tautomeric with aldehydes (R&apos; = H) or ketones (R&apos; =/= H).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33832">
        <obo:IAO_0000115>Any organic molecule that consists of atoms connected in the form of a ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33833">
        <obo:IAO_0000115>A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33838">
        <obo:IAO_0000115>An N-glycosyl compound that has both a nucleobase, normally adenine, guanine, xanthine, thymine, cytosine or uracil, and either a ribose or deoxyribose as functional parents.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33839">
        <obo:IAO_0000115>A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33847">
        <obo:IAO_0000115>A monocyclic aromatic hydrocarbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33848">
        <obo:IAO_0000115>A polycyclic aromatic hydrocarbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33856">
        <obo:IAO_0000115>An amino acid whose structure includes an aromatic ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33859">
        <obo:IAO_0000115>Any carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33860">
        <obo:IAO_0000115>An amino compound in which the amino group is linked directly to an aromatic system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33893">
        <obo:IAO_0000115>A substance used in a chemical reaction to detect, measure, examine, or produce other substances.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33913">
        <obo:IAO_0000115>A derivative of the corrin nucleus, which contains four reduced or partly reduced pyrrole rings joined in a macrocycle by three =C- groups and one direct carbon-carbon bond linking alpha positions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33916">
        <obo:IAO_0000115>A pentose with a (potential) aldehyde group at one end.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33917">
        <obo:IAO_0000115>A hexose with a (potential) aldehyde group at one end.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_33942">
        <obo:IAO_0000115>Any aldopentose where the open-chain form has all the hydroxy groups on the same side in the Fischer projection. Occurrs in two enantiomeric forms, D- and L-ribose, of which only the former is found in nature.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_3424">
        <obo:IAO_0000115>A quaternary ammonium ion that is the the conjugate acid of carnitine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35107">
        <obo:IAO_0000115>Saturated acyclic nitrogen hydrides having the general formula NnHn+2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35179">
        <obo:IAO_0000115>An oxo monocarboxylic acid anion in which the oxo group is located at the 2-position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35186">
        <obo:IAO_0000115>A hydrocarbon of biological origin having carbon skeleton formally derived from isoprene [CH2=C(CH3)CH=CH2].</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35190">
        <obo:IAO_0000115>A C20 terpene.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35193">
        <obo:IAO_0000115>A C40 terpene.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35195">
        <obo:IAO_0000115>A substance which lowers the surface tension of the medium in which it is dissolved, and/or the interfacial tension with other phases, and, accordingly, is positively adsorbed at the liquid/vapour and/or at other interfaces.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35222">
        <obo:IAO_0000115>A substance that diminishes the rate of a chemical reaction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35238">
        <obo:IAO_0000115>The zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35243">
        <obo:IAO_0000115>An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amnio group of serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35247">
        <obo:IAO_0000115>A serine zwitterion obtained by transfer of a proton from the carboxy to the amino group of D-serine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35267">
        <obo:IAO_0000115>A derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35274">
        <obo:IAO_0000115>A derivative of ammonium, NH4(+), in which one (or more) of the hydrogens bonded to the nitrogen have been replaced with univalent organyl groups. The substituting carbon of the organyl group must not itself be directly attached to a heteroatom (thereby excluding protonated amides, hemiaminals, etc).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35281">
        <obo:IAO_0000115>Neutral molecules having charge-separated forms with an onium atom which bears no hydrogen atoms and that is not adjacent to the anionic atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35282">
        <obo:IAO_0000115>Neutral molecules having charge-separated forms with an sulfonium atom which bears no hydrogen atoms and that is not adjacent to the anionic atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35284">
        <obo:IAO_0000115>Any neutral molecule having charge-separated forms with a quaternary ammonium atom which bears no hydrogen atoms and that is not adjacent to the anionic atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35294">
        <obo:IAO_0000115>A polyclic compound in which all of the ring members are carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35297">
        <obo:IAO_0000115>A polycyclic aromatic hydrocarbon consisting of fused benzene rings in a rectilinear arrangement.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35337">
        <obo:IAO_0000115>Any drug that enhances the activity of the central nervous system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35338">
        <obo:IAO_0000115>Amines that constitute a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35341">
        <obo:IAO_0000115>Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene, so may be considered as triterpenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35348">
        <obo:IAO_0000115>A sterol in which the hydroxy group at position 3 has beta- configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35352">
        <obo:IAO_0000115>Any heteroorganic entity containing at least one carbon-nitrogen bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35358">
        <obo:IAO_0000115>An amide of a sulfonic acid RS(=O)2NR&apos;2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35366">
        <obo:IAO_0000115>Any aliphatic monocarboxylic acid derived from or contained in esterified form in an animal or vegetable fat, oil or wax.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35381">
        <obo:IAO_0000115>Parent monosaccharides are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H-[CHOH]n-C(=O)[CHOH]m-H with three or more carbon atoms. The generic term &apos;monosaccharide&apos; (as opposed to oligosaccharide or polysaccharide) denotes a single unit, without glycosidic connection to other such units. It includes aldoses, dialdoses, aldoketoses, ketoses and diketoses, as well as deoxy sugars, provided that the parent compound has a (potential) carbonyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35406">
        <obo:IAO_0000115>An oxoanion is an anion derived from an oxoacid by loss of hydron(s) bound to oxygen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35441">
        <obo:IAO_0000115>A substance used in the prophylaxis or therapy of infectious diseases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35442">
        <obo:IAO_0000115>A substance used to treat or prevent parasitic infections.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35457">
        <obo:IAO_0000115>An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35469">
        <obo:IAO_0000115>Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35470">
        <obo:IAO_0000115>A class of drugs producing both physiological and psychological effects through a variety of mechanisms involving the central nervous system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35471">
        <obo:IAO_0000115>A loosely defined grouping of drugs that have effects on psychological function.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35472">
        <obo:IAO_0000115>A substance that reduces or suppresses inflammation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35473">
        <obo:IAO_0000115>A traditional grouping of drugs said to have a soothing or calming effect on mood, thought or behaviour.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35474">
        <obo:IAO_0000115>Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35476">
        <obo:IAO_0000115>Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35477">
        <obo:IAO_0000115>Antimanic drugs are agents used to treat bipolar disorders or mania associated with other affective disorders.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35480">
        <obo:IAO_0000115>An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35481">
        <obo:IAO_0000115>A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35482">
        <obo:IAO_0000115>A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35488">
        <obo:IAO_0000115>A loosely defined group of drugs that tend to reduce the activity of the central nervous system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35497">
        <obo:IAO_0000115>A compound which inhibits or antagonises the biosynthesis or actions of androgens.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35498">
        <obo:IAO_0000115>An agent that promotes the excretion of urine through its effects on kidney function.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35522">
        <obo:IAO_0000115>An agent that selectively binds to and activates beta-adrenergic receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35523">
        <obo:IAO_0000115>An agent that causes an increase in the expansion of a bronchus or bronchial tubes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35526">
        <obo:IAO_0000115>A drug which lowers the blood glucose level.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35530">
        <obo:IAO_0000115>An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35554">
        <obo:IAO_0000115>A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35568">
        <obo:IAO_0000115>Any molecular entity that consists of a ring having (formally) the maximum number of noncumulative double bonds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35584">
        <obo:IAO_0000115>A heterobicyclic aromatic organic compound comprising a pyrimidine ring fused to an imidazole ring; the parent compound of the purines.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35604">
        <obo:IAO_0000115>A negative ion consisting solely of carbon and oxygen  atoms, and therefore having the general formula CxOy(n-) for some integers x, y and n.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35610">
        <obo:IAO_0000115>A substance that inhibits or prevents the proliferation of neoplasms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35617">
        <obo:IAO_0000115>A food additive that is used to added improve the taste or odour of a food.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35620">
        <obo:IAO_0000115>A drug used to cause dilation of the blood vessels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35623">
        <obo:IAO_0000115>A drug used to prevent seizures or reduce their severity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35627">
        <obo:IAO_0000115>A lactam in which the amide bond is contained within a four-membered ring, which includes the amide nitrogen and the carbonyl carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35660">
        <obo:IAO_0000115>An inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35664">
        <obo:IAO_0000115>Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35674">
        <obo:IAO_0000115>Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35679">
        <obo:IAO_0000115>A substance used to treat hyperlipidemia (an excess of lipids in the blood).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35681">
        <obo:IAO_0000115>A secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35692">
        <obo:IAO_0000115>Any carboxylic acid containing two carboxy groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35695">
        <obo:IAO_0000115>Any dicarboxylic acid anion that is a monoanion obtained by the deprotonation of only one of the carboxy groups of the dicarboxylic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35701">
        <obo:IAO_0000115>A compound formally derived from an oxoacid RkE(=O)l(OH)m (l &gt; 0) and an alcohol, phenol, heteroarenol, or enol by linking with formal loss of water from an acidic hydroxy group of the former and a hydroxy group of the latter.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35705">
        <obo:IAO_0000115>An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35717">
        <obo:IAO_0000115>A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35718">
        <obo:IAO_0000115>An  antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35741">
        <obo:IAO_0000115>Any member of the group of lipids containing a common glycerol backbone to which at least one fatty acid-derived group is attached.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35757">
        <obo:IAO_0000115>A carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35780">
        <obo:IAO_0000115>A phosphorus oxoanion that is the conjugate base of phosphoric acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35816">
        <obo:IAO_0000115>A substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35819">
        <obo:IAO_0000115>Any fatty acid in which the parent hydrocarbon chain has one or more alkyl substituents; a common component in animal and bacterial lipids. The fatty acyl chain is usually saturated and the substituent a methyl group; however, unsaturated BCFAs are found in marine animals, and branches other than methyl are found in microbial lipids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35820">
        <obo:IAO_0000115>Any antimicrobial drug which is used to treat or prevent protozoal infections.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35821">
        <obo:IAO_0000115>A substance used to lower plasma cholesterol levels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35841">
        <obo:IAO_0000115>A gout suppressant that acts directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35842">
        <obo:IAO_0000115>A drug used to treat rheumatoid arthritis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35845">
        <obo:IAO_0000115>A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35846">
        <obo:IAO_0000115>A drug used for its effect on the kidneys&apos; regulation of body fluid composition and volume.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35868">
        <obo:IAO_0000115>Any monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35871">
        <obo:IAO_0000115>Any monocarboxylic acid having at least one additional oxo functional group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35903">
        <obo:IAO_0000115>Any carboxylic acid anion containing at least one oxo group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35910">
        <obo:IAO_0000115>Any monocarboxylic acid having a 2-oxo substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35942">
        <obo:IAO_0000115>A substance used for its pharmacological action on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35969">
        <obo:IAO_0000115>A hydroxy monocarboxylic acid that has a hydroxy group beta to the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35987">
        <obo:IAO_0000115>Any amino acid carrying two amino groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_35992">
        <obo:IAO_0000115>Natural and synthetic antibiotics containing the 4-thia-1-azabicyclo[3.2.0]heptan-7-one structure, generally assumed to have the 5R configuration unless otherwise specified.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36005">
        <obo:IAO_0000115>Any C22 polyunsaturated fatty acid containing six double bonds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36043">
        <obo:IAO_0000115>A drug used to treat or prevent microbial infections.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36044">
        <obo:IAO_0000115>A substance used in the prophylaxis or therapy of virus diseases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36047">
        <obo:IAO_0000115>A drug used to treat or prevent bacterial infections.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36059">
        <obo:IAO_0000115>Any monocarboxylic acid anion carrying at least one hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36141">
        <obo:IAO_0000115>Compounds having a fully conjugated cyclic dione structure, such as that of benzoquinones, derived from aromatic compounds by conversion of an even number of -CH= groups into -C(=O)- groups with any necessary rearrangement of double bonds (polycyclic and heterocyclic analogues are included).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36233">
        <obo:IAO_0000115>A compound in which two monosaccharides are joined by a glycosidic bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36234">
        <obo:IAO_0000115>Conjugate base of chenodeoxycholic acid; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36237">
        <obo:IAO_0000115>A steroid acid that consists of cholane having a carboxy group in place of the methyl group at position 24.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36248">
        <obo:IAO_0000115>Members of the class of cholanic acids based on a 5beta-cholane skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36333">
        <obo:IAO_0000115>Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36338">
        <obo:IAO_0000115>Lepton is a fermion that does not experience the strong force (strong interaction). The term is derived from the Greek lambdaepsilonpitauomicronsigma (small, thin).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36339">
        <obo:IAO_0000115>Baryon is a fermion that does experience the strong force (strong interaction). The term is derived from the Greek betaalpharhoupsilonsigma (heavy).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36340">
        <obo:IAO_0000115>Particle of half-integer spin quantum number following Fermi-Dirac statistics. Fermions are named after Enrico Fermi.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36342">
        <obo:IAO_0000115>A particle smaller than an atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36343">
        <obo:IAO_0000115>A subatomic particle known to have substructure (i.e. consisting of smaller particles).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36344">
        <obo:IAO_0000115>Hadron is a subatomic particle which experiences the strong force.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36347">
        <obo:IAO_0000115>A nucleus or any of its constituents in any of their energy states.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36357">
        <obo:IAO_0000115>Any molecular entity consisting of more than one atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36358">
        <obo:IAO_0000115>An ion consisting of more than one atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36586">
        <obo:IAO_0000115>Any compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36587">
        <obo:IAO_0000115>Organic compounds containing an oxygen atom, =O, doubly bonded to carbon or another element.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36699">
        <obo:IAO_0000115>Any of a class of steroid hormones that are produced in the adrenal cortex.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36834">
        <obo:IAO_0000115>Any hydroxy steroid carrying a hydroxy group at position 3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36836">
        <obo:IAO_0000115>A 3-hydroxy steroid in which the 3-hydroxy substituent is in the  beta-position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36916">
        <obo:IAO_0000115>A monoatomic or polyatomic species having one or more elementary charges of the proton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36962">
        <obo:IAO_0000115>An organochalcogen compound is a compound containing at least one carbon-chalcogen bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_36963">
        <obo:IAO_0000115>An organochalcogen compound containing at least one carbon-oxygen bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37257">
        <obo:IAO_0000115>A branched-chain saturated fatty acid anion that is the conjugate base of phytanic acid, arising from deprotonation of the carboxylic acid group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37323">
        <obo:IAO_0000115>A 7,8-dimethylbenzo[g]pteridine-2,4-dione that is  isoalloxazine substituted by methyl groups at positions 7 and 8.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37445">
        <obo:IAO_0000115>A group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid units.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37527">
        <obo:IAO_0000115>An acid is a molecular entity capable of donating a hydron (Bronsted acid) or capable of forming a covalent bond with an electron pair (Lewis acid).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37577">
        <obo:IAO_0000115>A molecular entity consisting of two or more chemical elements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37622">
        <obo:IAO_0000115>An amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37670">
        <obo:IAO_0000115>A compound which inhibits or antagonizes the biosynthesis or actions of proteases (endopeptidases).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37733">
        <obo:IAO_0000115>An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37806">
        <obo:IAO_0000115>A penam that consists of 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane bearing a carboxy group at position 2 and having (2S,5R)-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37808">
        <obo:IAO_0000115>A straight chain alkane composed of 4 carbon atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37838">
        <obo:IAO_0000115>A carboacyl group is a group formed by loss of at least one OH from the carboxy group of a carboxylic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37886">
        <obo:IAO_0000115>An agent that selectively binds to and activates adrenergic receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37887">
        <obo:IAO_0000115>An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37890">
        <obo:IAO_0000115>An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37956">
        <obo:IAO_0000115>Histamine antagonists are the drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37957">
        <obo:IAO_0000115>Drugs used for their actions on histaminergic systems.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_37962">
        <obo:IAO_0000115>Any agent that acts on an adrenergic receptor or affects the life cycle of an adrenergic transmitter.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38070">
        <obo:IAO_0000115>A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38077">
        <obo:IAO_0000115>A compound composed of two or more pyrrole units.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38101">
        <obo:IAO_0000115>Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38104">
        <obo:IAO_0000115>Any organic heterocyclic compound containing at least one ring oxygen atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38181">
        <obo:IAO_0000115>A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of a pyridinemonocarboxylic acid. A &apos;closed class&apos;.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38182">
        <obo:IAO_0000115>A hydroxypyridine carrying a single hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38196">
        <obo:IAO_0000115>Any member of the class of  pyridines carrying a hydroxymethyl substituent at unspecified position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38215">
        <obo:IAO_0000115>One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38264">
        <obo:IAO_0000115>A branched chain amino acid that consists of 3-methylpentanoic acid bearing an amino substituent at position 2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38313">
        <obo:IAO_0000115>Any organic heterocyclic compound containing a benzene ring in which two of the C-H fragments have been replaced by isolobal nitrogens (the diazine parent structure).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38323">
        <obo:IAO_0000115>Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38337">
        <obo:IAO_0000115>A pyrimidine carrying one or more oxo substituents.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38338">
        <obo:IAO_0000115>A member of the class of  pyrimidines that is pyrimidine substituted by at least one amino group and its derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38462">
        <obo:IAO_0000115>An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38623">
        <obo:IAO_0000115>An EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor that interferes with the action of monoamine oxidase (EC 1.4.3.4).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38632">
        <obo:IAO_0000115>Any agent that affects the transport of molecular entities across a biological membrane.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38633">
        <obo:IAO_0000115>An agent that inhibits sodium influx through cell membranes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38716">
        <obo:IAO_0000115>Any dianion containing at least one carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38808">
        <obo:IAO_0000115>A membrane transport modulator that is able to regulate intracellular calcium levels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38867">
        <obo:IAO_0000115>Substance which produces loss of feeling or sensation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38869">
        <obo:IAO_0000115>Substance that produces loss of consciousness.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38975">
        <obo:IAO_0000115>Any alkylbenzene that is benzene substituted with one or more methyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_38976">
        <obo:IAO_0000115>A  monocyclic arene that is benzene substituted with one or more alkyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39141">
        <obo:IAO_0000115>A molecular entity capable of donating a hydron to an acceptor (Bronsted base).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39142">
        <obo:IAO_0000115>A molecular entity capable of accepting a hydron from a donor (Bronsted acid).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39144">
        <obo:IAO_0000115>A molecular entity able to provide a pair of electrons and thus capable of forming a covalent bond with an electron-pair acceptor (Lewis acid), thereby producing a Lewis adduct.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39417">
        <obo:IAO_0000115>Any saturated fatty acid with a carbon side-chain or isopropyl termination.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39418">
        <obo:IAO_0000115>Any saturated fatty acid lacking a side-chain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39447">
        <obo:IAO_0000115>Any compound having a pyrimidine as part of its structure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39456">
        <obo:IAO_0000115>Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_39745">
        <obo:IAO_0000115>A monovalent inorganic anion that consists of phosphoric acid in which one of the three OH groups has been deprotonated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_43474">
        <obo:IAO_0000115>A phosphate ion that is the conjugate base of dihydrogenphosphate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_43799">
        <obo:IAO_0000115>A primary aliphatic amine that is butane substituted by an amino group at position 1.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_46245">
        <obo:IAO_0000115>A ubiquinone having a side chain of 10 isoprenoid units. In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_46787">
        <obo:IAO_0000115>A liquid that can dissolve other substances (solutes) without any change in their chemical composition.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_46904">
        <obo:IAO_0000115>A dicarboxylic acid monoanion that is the conjugate base of oxalic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_47778">
        <obo:IAO_0000115>Any ester resulting from the condensation of one or more of the hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_47868">
        <obo:IAO_0000115>A chemical compound that can be excited by light of a specific wavelength and subsequently transfer energy to a chosen reactant. This is commonly molecular oxygen within a cancer tissue, which is converted to (highly rective) singlet state oxygen. This rapidly reacts with any nearby biomolecules, ultimately killing the cancer cells.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_47891">
        <obo:IAO_0000115>Any steroid substituted by at least one carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48001">
        <obo:IAO_0000115>A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48354">
        <obo:IAO_0000115>A solvent that is composed of polar molecules. Polar solvents can dissolve ionic compounds or ionisable covalent compounds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48356">
        <obo:IAO_0000115>A polar solvent that is capable of acting as a hydron (proton) donor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48359">
        <obo:IAO_0000115>Solvent that is capable of acting as a hydron (proton) acceptor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48360">
        <obo:IAO_0000115>Self-ionizing solvent possessing both characteristics of Bronsted acids and bases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48377">
        <obo:IAO_0000115>Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing =O by =NR; thus tautomers of amides. In organic chemistry an unspecified imidic acid is generally a carboximidic acid, RC(=NR)(OH).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48379">
        <obo:IAO_0000115>A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48407">
        <obo:IAO_0000115>A drug used in the treatment of Parkinson&apos;s disease.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48422">
        <obo:IAO_0000115>An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48425">
        <obo:IAO_0000115>A local anesthetic that is used to numb the surface of a body part.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48539">
        <obo:IAO_0000115>Any drug that acts on an alpha-adrenergic receptor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48540">
        <obo:IAO_0000115>Any of the drugs that act on beta-adrenergic receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48578">
        <obo:IAO_0000115>A role played by a substance that can react readily with, and thereby eliminate, radicals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48705">
        <obo:IAO_0000115>Substance which binds to cell receptors normally responding to naturally occurring substances and which produces a response of its own.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48706">
        <obo:IAO_0000115>Substance that attaches to and blocks cell receptors that normally bind naturally occurring substances.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48873">
        <obo:IAO_0000115>Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48901">
        <obo:IAO_0000115>An azole in which the five-membered heterocyclic aromatic skeleton contains a N atom and one S atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_48927">
        <obo:IAO_0000115>Any L-alpha-amino acid carrying an N-acyl substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_49020">
        <obo:IAO_0000115>A chemical substance which inhibits the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_49159">
        <obo:IAO_0000115>A drug designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_49167">
        <obo:IAO_0000115>A drug used to treat asthma.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_49201">
        <obo:IAO_0000115>One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50047">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing one, two or three hydrogen atoms by organyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50103">
        <obo:IAO_0000115>An agent that binds to and activates excitatory amino acid receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50160">
        <obo:IAO_0000115>Any anion formed by loss of a proton from a steroid acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50177">
        <obo:IAO_0000115>A drug used to treat or prevent skin disorders or for the routine care of skin.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50188">
        <obo:IAO_0000115>A substance that can be converted into a vitamin by animal tissues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50247">
        <obo:IAO_0000115>Any protective agent counteracting or neutralizing the action of poisons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50248">
        <obo:IAO_0000115>Drug that acts on blood and blood-forming organs and those that affect the hemostatic system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50249">
        <obo:IAO_0000115>An agent that prevents blood clotting.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50266">
        <obo:IAO_0000115>A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50267">
        <obo:IAO_0000115>Synthetic or natural substance which is given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50313">
        <obo:IAO_0000115>Mononuclear cations derived by addition of a hydron to a mononuclear parent hydride of the pnictogen, chalcogen and halogen families.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50325">
        <obo:IAO_0000115>A univalent organyl group obtained by cleaving the bond from C-2 to the side chain of a proteinogenic amino-acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50401">
        <obo:IAO_0000115>Any steroid based on a cholestane skeleton and its derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50427">
        <obo:IAO_0000115>A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50505">
        <obo:IAO_0000115>Substance that sweeten food, beverages, medications, etc.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50584">
        <obo:IAO_0000115>An aliphatic alcohol in which the aliphatic alkane chain is substituted by a hydroxy group at unspecified position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50699">
        <obo:IAO_0000115>A compound in which monosaccharide units are joined by glycosidic linkages. The term is commonly used to refer to a defined structure as opposed to a polymer of unspecified length or a homologous mixture. When the linkages are of other types the compounds are regarded as oligosaccharide analogues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50733">
        <obo:IAO_0000115>A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50739">
        <obo:IAO_0000115>A substance that possess antiestrogenic actions but can also produce estrogenic effects as well. It acts as complete or partial agonist or as antagonist. It can be either steroidal or nonsteroidal in structure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50790">
        <obo:IAO_0000115>An EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor which interferes with the action of aromatase (EC 1.14.14.14) and so reduces production of estrogenic steroid hormones.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50827">
        <obo:IAO_0000115>A drug used to treat hyperparathyroidism by reducing the excessive production of parathyroid hormones.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50837">
        <obo:IAO_0000115>A compound which inhibits or antagonises the biosynthesis or actions of estrogens.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50846">
        <obo:IAO_0000115>Biologically active substance whose activity affects or plays a role in the functioning of the immune system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50847">
        <obo:IAO_0000115>A substance that augments, stimulates, activates, potentiates, or modulates the immune response at either the cellular or humoral level. A classical agent (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contains bacterial antigens. It could also be endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Its mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy is related to its antigen-specific immunoadjuvanticity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50855">
        <obo:IAO_0000115>A cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries. Compare with antiatherosclerotic agent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50857">
        <obo:IAO_0000115>A drug used to treat allergic reactions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50858">
        <obo:IAO_0000115>A natural or synthetic analogue of the hormones secreted by the adrenal gland.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50860">
        <obo:IAO_0000115>Any molecular entity that contains carbon.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50902">
        <obo:IAO_0000115>A role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50903">
        <obo:IAO_0000115>A role played by a chemical compound which is known to  induce a process of carcinogenesis  by corrupting  normal cellular pathways, leading to the acquistion of tumoral capabilities.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50904">
        <obo:IAO_0000115>A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50906">
        <obo:IAO_0000115>A role is particular behaviour which a material entity may exhibit.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50910">
        <obo:IAO_0000115>A poison that interferes with the functions of the nervous system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50919">
        <obo:IAO_0000115>A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50926">
        <obo:IAO_0000115>An agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50927">
        <obo:IAO_0000115>An agent that induces or stimulates the physiologic angiogenesis process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50949">
        <obo:IAO_0000115>A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50994">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_50996">
        <obo:IAO_0000115>A compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51026">
        <obo:IAO_0000115>A cyclic compound containing nine or more atoms as part of the cyclic system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51061">
        <obo:IAO_0000115>A drug that modulates the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51086">
        <obo:IAO_0000115>A role played by the molecular entity or part thereof within a chemical context.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51151">
        <obo:IAO_0000115>An  organic molecule that is electrically neutral carrying a positive and a negative charge in one of its major canonical descriptions. In most dipolar compounds the charges are delocalized; however the term is also applied to species where this is not the case.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51269">
        <obo:IAO_0000115>Polycyclic aromatic hydrocarbons consisting of fused benzene rings in a rectilinear arrangement and their substitution derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51270">
        <obo:IAO_0000115>Compounds containing a tetracene skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51356">
        <obo:IAO_0000115>Any anion formed by loss of a proton from the carboxy group of a penicillin.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51371">
        <obo:IAO_0000115>A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51372">
        <obo:IAO_0000115>A drug used for its actions on skeletal muscle.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51374">
        <obo:IAO_0000115>A substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51422">
        <obo:IAO_0000115>Any organic substituent group, regardless of functional type, having two free valences at carbon atom(s).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51569">
        <obo:IAO_0000115>A carboxamide resulting from the formal condensation of a carboxylic acid with the amino group of an amino acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_51570">
        <obo:IAO_0000115>Compounds containing a biotin (5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid) skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52090">
        <obo:IAO_0000115>An organic anion that is the conjugate base of methanol.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52206">
        <obo:IAO_0000115>A biological role played by the molecular entity or part thereof within a biochemical context.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52209">
        <obo:IAO_0000115>A role played by the molecular entity or part thereof which causes the development of a pathological process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52210">
        <obo:IAO_0000115>A biological role which describes how a drug interacts within a biological system and how the interactions affect its medicinal properties.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52217">
        <obo:IAO_0000115>Any substance introduced into a living organism with therapeutic or diagnostic purpose.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52395">
        <obo:IAO_0000115>A compound with the general formula R2C=O (R=/=H) where one or more of the R groups contains an oxy (-O-) group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_52396">
        <obo:IAO_0000115>An oxyketone with the general formula R2C(=O) (R=/=H) where one or more of the R groups contains an oxy (-O-) group and the oxy and carbonyl groups are bonded to the same carbon atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_53339">
        <obo:IAO_0000115>Any fatty acid containing at least one C=C double bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_55323">
        <obo:IAO_0000115>Any drug found useful in the symptomatic treatment of diarrhoea.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_55324">
        <obo:IAO_0000115>A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_5686">
        <obo:IAO_0000115>A cyclic compound having as ring members atoms of at least two different elements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57305">
        <obo:IAO_0000115>An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of glycine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57560">
        <obo:IAO_0000115>A fatty acid anion with a chain length of C13 to C22.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57630">
        <obo:IAO_0000115>Zwitterionic form of gamma-amino-beta-hydroxybutyric acid having an anionic carboxy group and a protonated amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57844">
        <obo:IAO_0000115>Zwitterionic form of L-methionine having a anionic carboxy group and a cationic amino group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57869">
        <obo:IAO_0000115>Zwitterionic form of 6-aminopenicillanic acid arising from migration of a proton from the carboxy group to the 6-amino group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57932">
        <obo:IAO_0000115>Zwitterionic form of D-methionine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57947">
        <obo:IAO_0000115>Zwitterionic form of creatine arising from transfer of a proton from the carboxy to the guanidino group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_57986">
        <obo:IAO_0000115>The anion resulting from removal of a proton from the nitrogen at the 3 position (between the two carbonyl gropus) of riboflavin.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58001">
        <obo:IAO_0000115>The conjugate acid of a primary aliphatic amine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58389">
        <obo:IAO_0000115>An ammonium ion that is the conjugate acid of trimethylamine, obtained via protonation of the nitrogen; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58496">
        <obo:IAO_0000115>The conjugate base of an N-acetyl-D-amino acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58951">
        <obo:IAO_0000115>Any fatty acid anion obtained by removal of a proton from the carboxy group of a short-chain fatty acid (chain length of less than C6).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58953">
        <obo:IAO_0000115>Any fatty acid anion in which there is no C-C unsaturation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58954">
        <obo:IAO_0000115>Any saturated fatty acid anion lacking a carbon side-chain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58955">
        <obo:IAO_0000115>Any fatty acid anion with a carbon side-chain or isopropyl termination.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_58956">
        <obo:IAO_0000115>Any saturated fatty acid anion with a carbon side-chain or isopropyl termination.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59174">
        <obo:IAO_0000115>Any substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59202">
        <obo:IAO_0000115>Any fatty acid whose skeletal carbon atoms form an unbranched open chain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59203">
        <obo:IAO_0000115>A fatty acid anion formed by deprotonation of the carboxylic acid functional group of a straight-chain fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59549">
        <obo:IAO_0000115>Any member of the sub-set of polyunsaturated fatty acid for which there is an absolute dietary requirement.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59554">
        <obo:IAO_0000115>Any fatty acid with a chain length of between C6 and C12.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59558">
        <obo:IAO_0000115>A fatty acid anion resulting from the deprotonation of the carboxylic acid moiety of a medium-chain fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59561">
        <obo:IAO_0000115>An  organic anion that is the conjugate base of diamino acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59698">
        <obo:IAO_0000115>Compounds containing one or more phosphoric acid units.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59740">
        <obo:IAO_0000115>A reagent that forms a bond to its reaction partner (the electrophile) by donating both bonding electrons.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59789">
        <obo:IAO_0000115>A zwitterionic tautomer of S-adenosyl-L-methionine arising from shift of the proton from the carboxy group to the amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59814">
        <obo:IAO_0000115>Conjugate base of an L-alpha-amino acid arising from deprotonation of the C-1 carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59869">
        <obo:IAO_0000115>Zwitterionic form of an L-alpha-amino acid having an anionic carboxy group and a protonated amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59871">
        <obo:IAO_0000115>Zwitterionic form of a D-alpha-amino acid having an anionic carboxy group and a protonated amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59874">
        <obo:IAO_0000115>A carboxylic acid anion that is the conjugate base of an N-acyl-L-alpha-amino acid arising from deprotonation of the C-1 carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59876">
        <obo:IAO_0000115>The conjugate base of an N-acyl-D-alpha-amino acid arising from deprotonation of the C-1 carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59886">
        <obo:IAO_0000115>A drug which interferes with the binding, fusion and entry of an HIV virion to a human cell. By blocking this step in HIV&apos;s replication cycle, such agents slow the progression from HIV infection to AIDS.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59999">
        <obo:IAO_0000115>A chemical substance is a portion of matter of constant composition, composed of molecular entities of the same type or of different types.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60004">
        <obo:IAO_0000115>A mixture is a chemical substance composed of multiple molecules, at least two of which are of a different kind.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60240">
        <obo:IAO_0000115>A metal cation with a valence of two.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60242">
        <obo:IAO_0000115>An atom or small molecule with a positive charge that does not contain carbon in covalent linkage, with a valency of one.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60258">
        <obo:IAO_0000115>A hydrolase inhibitor that interferes with the action of any hydrolase acting on peptide bonds (peptidase), EC 3.4.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60531">
        <obo:IAO_0000115>Flavin protonated to pH 7.3</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60643">
        <obo:IAO_0000115>Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60798">
        <obo:IAO_0000115>Any substance which inhibits the action of receptors for excitatory amino acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60809">
        <obo:IAO_0000115>Any pharmacological or immunological agent that modifies the effect of other agents such as drugs or vaccines while having few if any direct effects when given by itself.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_60895">
        <obo:IAO_0000115>Any alpha-amino acid anion in which the parent amino acid has D-configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_61016">
        <obo:IAO_0000115>A hormone antagonist that blocks angiotensin receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_61115">
        <obo:IAO_0000115>An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_61120">
        <obo:IAO_0000115>Any compound that has a nucleobase as a part.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_61355">
        <obo:IAO_0000115>Any hydroxy carboxylic acid which contains a hydroxy group located beta- to the carboxylic acid group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_61995">
        <obo:IAO_0000115>A lipid-rich mixture containing glycerol, fatty acids, phosphoric acid and other components.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_62031">
        <obo:IAO_0000115>Zwitterionic form of a polar amino acid having an anionic carboxy group and a protonated amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_62499">
        <obo:IAO_0000115>Any branched-chain fatty acid containing methyl branches only.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_62501">
        <obo:IAO_0000115>The dicarboxylic acid dianion formed from folic acid by loss of a proton from each of the two carboxy groups in the glutamic acid moiety.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_62803">
        <obo:IAO_0000115>Any additive that enhances the efficiency of fuel.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_62868">
        <obo:IAO_0000115>Any compound that is able to prevent damage to the liver.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63046">
        <obo:IAO_0000115>The chemical role played by a substance that stabilizes an emulsion by increasing its kinetic stability.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63161">
        <obo:IAO_0000115>A carbohydrate derivative arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to an oxygen, carbon, nitrogen or sulfur atom of a separate entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63299">
        <obo:IAO_0000115>Any organooxygen compound derived from a carbohydrate by replacement of one or more hydroxy group(s) by an amino group, a thiol group or similar heteroatomic groups. The term also includes derivatives of these compounds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63470">
        <obo:IAO_0000115>A sulfur-containing amino acid whose alpha-carboxylic acid group is ionized (not protonated).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63471">
        <obo:IAO_0000115>A branched-chain amino acid whose alpha-carboxylic acid group is ionized (not protonated).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63473">
        <obo:IAO_0000115>An aromatic amino acid whose alpha-carboxylic acid group is ionized (non-protonated).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63726">
        <obo:IAO_0000115>Any compound that can be used for the treatment of neurodegenerative disorders.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63944">
        <obo:IAO_0000115>Any lactone in which the cyclic carboxylic ester group forms a part of a cyclic macromolecule.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_63963">
        <obo:IAO_0000115>An antagonist at the metabotropic glutamate receptor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64047">
        <obo:IAO_0000115>Any substance which is added to food to preserve or enhance its flavour and/or appearance.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64049">
        <obo:IAO_0000115>A food additive that is used to change or otherwise control the acidity or alkalinity of foods. They may be acids, bases, neutralising agents or buffering agents.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64102">
        <obo:IAO_0000115>An agonist that selectively binds to and activates AMPA receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64558">
        <obo:IAO_0000115>An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of methionine; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64570">
        <obo:IAO_0000115>An EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitor that interferes with the action of glycine hydroxymethyltransferase (EC 2.1.2.1).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64571">
        <obo:IAO_0000115>An excitatory amino acid agonist which binds to NMDA receptors and triggers a response.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64577">
        <obo:IAO_0000115>A food additive which is added to flour or dough to improve baking quality and/or colour.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64641">
        <obo:IAO_0000115>An inorganic cation with a valency of two.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64708">
        <obo:IAO_0000115>An organic molecular entity containing a single carbon atom (C1).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64709">
        <obo:IAO_0000115>Any organic molecular entity that is acidic and contains carbon in covalent linkage.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64857">
        <obo:IAO_0000115>The role played by a substance in enhancing the appearance or odour of the human body; a name given to the substance itself or to a component of it.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64909">
        <obo:IAO_0000115>Any substance that causes disturbance to organisms by chemical reaction or other activity on the molecular scale, when a sufficient quantity is absorbed by the organism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64912">
        <obo:IAO_0000115>A drug used to treat or prevent infections caused by Mycobacteria, a genus of actinobacteria. Aerobic and nonmotile, members of the genus include the pathogens responsible for causing tuberculosis and leprosy.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64946">
        <obo:IAO_0000115>An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64952">
        <obo:IAO_0000115>An antiviral agent that destroys or inhibits the replication of the herpes simplex virus (also known as the human herpes virus).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64953">
        <obo:IAO_0000115>An anti-HSV agent agent that destroys or inhibits the replication of herpes simplex virus-1.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_64954">
        <obo:IAO_0000115>An anti-HSV agent agent that destroys or inhibits the replication of herpes simplex virus-2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65023">
        <obo:IAO_0000115>Any compound that has anti-asthmatic effects.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65190">
        <obo:IAO_0000115>Antipsychotic drugs which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson&apos;s disease-type movements; such body movements can become permanent even after treatment has ceased.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65191">
        <obo:IAO_0000115>Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson&apos;s disease-type movements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65255">
        <obo:IAO_0000115>Substances which are added to food in order to prevent decomposition caused by  microbial growth or by undesirable chemical changes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65256">
        <obo:IAO_0000115>A food preservative which prevents decomposition of food by preventing the growth of fungi or bacteria. In European countries, E-numbers for permitted food preservatives are from E200 to E299, divided into sorbates (E200-209), benzoates (E210-219), sulfites (E220-229), phenols and formates (E230-239), nitrates (E240-259), acetates (E260-269), lactates (E270-279), propionates (E280-289) and others (E290-299).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65265">
        <obo:IAO_0000115>Any substance which is used to neutralise stomach acidity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_65296">
        <obo:IAO_0000115>An ammonium ion derivative resulting from the protonation of the nitrogen atom of a primary amino compound. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_66922">
        <obo:IAO_0000115>An alpha-amino acid anion that is the conjugate base of citrulline, obtained by deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_66924">
        <obo:IAO_0000115>A monocarboxylic acid anion that is the conjugate base of creatine, obtained by deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_66956">
        <obo:IAO_0000115>Any compound which can be used to treat or alleviate the symptoms of dyskinesia.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_66981">
        <obo:IAO_0000115>Any compound used for the treatment of eye conditions or eye diseases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67011">
        <obo:IAO_0000115>An N-acyl-L-alpha-amino acid anion obtained by deprotonation of any folic acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67013">
        <obo:IAO_0000115>Any branched-chain fatty acid anion containing methyl branches only.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67040">
        <obo:IAO_0000115>A sulfonium betaine that is a conjugate base of S-adenosyl-L-methionine obtained by the deprotonation of the carboxy group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67079">
        <obo:IAO_0000115>Any compound that has anti-inflammatory effects.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67200">
        <obo:IAO_0000115>A provitamin that can be converted into vitamin A by enzymes from animal tissues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_67273">
        <obo:IAO_0000115>Any 1,4-benzoquinone carrying a single hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_68452">
        <obo:IAO_0000115>Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_71014">
        <obo:IAO_0000115>An antagonist at the AMPA receptor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_71300">
        <obo:IAO_0000115>An enzyme inhibitor that inhibits the action of a transferase (EC 2.*)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_71392">
        <obo:IAO_0000115>An organic anion that is the conjugate base of tetracycline obtained by deprotonation of the two enolic hydroxy groups and protonation of the tertiary amino group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_71648">
        <obo:IAO_0000115>Benzoquinones with at least one hydroxy substituent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_71666">
        <obo:IAO_0000115>An amino-acid anion in which the amino group is situated gamma- to the carboxylate group.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_72571">
        <obo:IAO_0000115>Any compound that promotes the growth of new blood vessels from pre-existing vessels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_72695">
        <obo:IAO_0000115>Any molecule that consists of at least one carbon atom as part of the electrically neutral entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_73336">
        <obo:IAO_0000115>A drug used in treating and healing of wounds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_74529">
        <obo:IAO_0000115>A role borne by a molecule that acts to counteract or neutralize the deleterious effects of paracetamol (acetaminophen).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_74818">
        <obo:IAO_0000115>Any organic aromatic compound having one or more hydroxy groups attached to a heteroarene ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75600">
        <obo:IAO_0000115>A ligase inhibitor that interferes with the action of a C-N bond-forming ligase (EC 6.3.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75603">
        <obo:IAO_0000115>Any enzyme inhibitor that interferes with the action of a ligase (EC 6.*.*.*). Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75763">
        <obo:IAO_0000115>Any  metabolite produced during a metabolic reaction in eukaryotes, the taxon that include members of the fungi, plantae and animalia kingdoms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75767">
        <obo:IAO_0000115>Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75768">
        <obo:IAO_0000115>Any animal metabolite produced during a metabolic reaction in mammals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75769">
        <obo:IAO_0000115>A role played by any of the group of eight water-soluble vitamins originally thought to be a single compound (vitamin B). The group comprises of vitamin B1, B2, B3, B5, B6, B7, B9, and B12 (Around 20 other compounds were once thought to be B vitamins but are no longer classified as such). B vitamins play important roles in cell metabolism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75771">
        <obo:IAO_0000115>Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75772">
        <obo:IAO_0000115>Any  fungal metabolite produced during a metabolic reaction in Baker&apos;s yeast (Saccharomyces cerevisiae).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_75787">
        <obo:IAO_0000115>Any metabolite produced during a metabolic reaction in prokaryotes, the taxon that include members of domains such as the bacteria and archaea.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76042">
        <obo:IAO_0000115>An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of any aromatic amino-acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76206">
        <obo:IAO_0000115>Any metabolite produced by metabolism of a xenobiotic compound.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76414">
        <obo:IAO_0000115>A compressed gas or liquid with a boiling point lower than room temperature which to used to propel and dispense liquids such as deodorants, insecticides, paints, etc. from aerosol cans.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76507">
        <obo:IAO_0000115>Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76567">
        <obo:IAO_0000115>Any unsaturated fatty acid anion containing more than one C-C unsaturated bond.  Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76619">
        <obo:IAO_0000115>A fatty acid anion obtained by deprotonation of the carboxy group of any omega-methyl fatty acid; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76655">
        <obo:IAO_0000115>A transferase inhibitor inhibiting the action of transferase of a one-carbon-containing group (EC 2.1.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76710">
        <obo:IAO_0000115>An enzyme inhibitor which interferes with the action of a lyase (EC 4.*.*.*). Lyases are enzymes cleaving C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76713">
        <obo:IAO_0000115>A lyase inhibitor which inhibits the action of a C-N lyase (EC 4.3.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76725">
        <obo:IAO_0000115>An enzyme inhibitor which interferes with the action of an oxidoreductase (EC 1.*.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76726">
        <obo:IAO_0000115>An oxidoreductase inhibitor which interferes with the action of an oxidoreductase acting on the CH-OH group of donors (EC 1.1.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76730">
        <obo:IAO_0000115>An oxidoreductase inhibitor which interferes with the action of an oxidoreductase acting on the CH-NH2 group of donors (EC 1.4.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76741">
        <obo:IAO_0000115>An oxidoreductase inhibitor which interferes with the action of an oxidoreductase acting on hydrogen as donors (EC 1.14.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76759">
        <obo:IAO_0000115>Any enzyme inhibitor that interferes with the action of a hydrolase (EC 3.*.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76760">
        <obo:IAO_0000115>A hydrolase inhibitor that interferes with the action of any ester hydrolase (EC 3.1.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76764">
        <obo:IAO_0000115>Any hydrolase inhibitor that interferes with the action of a hydrolase acting on C-N bonds, other than peptide bonds (EC 3.5.*.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76773">
        <obo:IAO_0000115>An EC 3.1.* (ester hydrolase) inhibitor that interferes with the action of a carboxylic ester hydrolase (EC 3.1.1.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76782">
        <obo:IAO_0000115>Any EC 3.4.* (hydrolases acting on peptide bond) inhibitor that interferes with the activity of a peptidyl dipeptidase (EC 3.4.15.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76807">
        <obo:IAO_0000115>An EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor that interferes with the action of any non-peptide linear amide C-N hydrolase (EC 3.5.1.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76823">
        <obo:IAO_0000115>An EC 6.3.* (C-N bond-forming ligase) inhibitor that interferes with the action of any acid-ammonia (or amine) ligase (EC 6.3.1.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76832">
        <obo:IAO_0000115>An EC 4.3.* (C-N lyase) inhibitor that interferes with the action of any ammonia-lyase (EC 4.3.1.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76835">
        <obo:IAO_0000115>An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76838">
        <obo:IAO_0000115>An EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of any such enzyme incorporating one atom of oxygen and using reduced flavin or flavoprotein as donor (EC 1.14.14.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76861">
        <obo:IAO_0000115>An EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor that interferes with the action of any such enzyme using oxygen as acceptor (EC 1.4.3.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76874">
        <obo:IAO_0000115>An EC 2.1.* (C1-transferase) inhibitor that interferes with the action of any hydroxymethyl-, formyl- and related transferase (EC 2.1.2.*).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76916">
        <obo:IAO_0000115>A drug which increases the blood glucose level.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76924">
        <obo:IAO_0000115>Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76932">
        <obo:IAO_0000115>An enzyme inhibitor that interferes with one or more steps in a metabolic pathway.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76946">
        <obo:IAO_0000115>Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76967">
        <obo:IAO_0000115>Any human metabolite produced by metabolism of a xenobiotic compound in humans.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76969">
        <obo:IAO_0000115>Any prokaryotic metabolite produced during a metabolic reaction in bacteria.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_76971">
        <obo:IAO_0000115>Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77034">
        <obo:IAO_0000115>A compound that alters the structure of mucus so as to decrease its viscosity and thereby facilitate its removal by ciliary action and expectoration. Compare with antitussives, which suppress the cough reflex, and expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77119">
        <obo:IAO_0000115>An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77182">
        <obo:IAO_0000115>A food additive that imparts colour to food. In European countries, E-numbers for permitted food colours are from E 100 to E 199, divided into yellows (E 100-109), oranges (E 110-119), reds (E 120-129), blues and violets (E 130-139), greens (E 140-149), browns and blacks (E 150-159), and others (E 160-199).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77608">
        <obo:IAO_0000115>A diuretic that acts on the ascending loop of Henle in the kidney.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77703">
        <obo:IAO_0000115>An EC 4.3.1.* (ammonia-lyase) inhibitor that interferes with the action of histidine ammonia-lyase (EC 4.3.1.3).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77746">
        <obo:IAO_0000115>Any mammalian metabolite  produced during a metabolic reaction in humans (Homo sapiens).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77932">
        <obo:IAO_0000115>A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of tetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77941">
        <obo:IAO_0000115>An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the action of amidase (EC 3.5.1.4).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77960">
        <obo:IAO_0000115>A food additive that is used to make or keep fruit or vegetable tissues firm and crisp. or which interacts with gelling agents such as pectin to produce or strengthen a gel.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_77962">
        <obo:IAO_0000115>An antioxidant that used as a food additives to help guard against food deterioration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78017">
        <obo:IAO_0000115>A propellant that is used to expel foods from an aerosol container.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78060">
        <obo:IAO_0000115>A polyunsaturated fatty acid anion that is the conjugate base of docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78113">
        <obo:IAO_0000115>Any saturated fatty acid anion containing 3 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78115">
        <obo:IAO_0000115>Any saturated fatty acid anion containing 4 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78116">
        <obo:IAO_0000115>Any saturated fatty acid anion containing 6 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78123">
        <obo:IAO_0000115>Any saturated fatty acid anion containing 16 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78236">
        <obo:IAO_0000115>A monocarboxylic acid anion that is the conjugate base of  N-acetyl-L-cysteine, obtained by deprotonation of the carboxy group; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78295">
        <obo:IAO_0000115>A physiological role played by any substance that is distributed in foodstuffs. It includes materials derived from plants or animals, such as vitamins or minerals, as well as environmental contaminants.</obo:IAO_0000115>
        <obo:IAO_0000115>Any substance that is distributed in foodstuffs. It includes materials derived from plants or animals, such as vitamins or minerals, as well as environmental contaminants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78298">
        <obo:IAO_0000115>Any minor or unwanted substance introduced into the environment that can have undesired effects.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78433">
        <obo:IAO_0000115>A substance used in a thermodynamic heat pump cycle or refrigeration cycle that undergoes a phase change from a gas to a liquid and back. Refrigerants are used in air-conditioning systems and freezers or refrigerators and are assigned a &quot;R&quot; number (by ASHRAE - formerly the American Society of Heating, Refrigerating and Air Conditioning Engineers), which is determined systematically according to their molecular structure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78608">
        <obo:IAO_0000115>An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of any alpha-amino acid; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78616">
        <obo:IAO_0000115>Any organooxygen compound that is a polyhydroxy-aldehyde or -ketone, or a compound derived from one. Carbohydrates contain only carbon, hydrogen and oxygen and usually have an empirical formula Cm(H2O)n; carbohydrate derivatives may contain other elements by substitution or condensation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78675">
        <obo:IAO_0000115>Any metabolite produced by all living cells.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_78840">
        <obo:IAO_0000115>Any organic molecular entity that contains at least one C=C bond.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_7896">
        <obo:IAO_0000115>A long-chain fatty acid anion that is the conjugate base of hexadecanoic acid (palmitic acid); major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_79387">
        <obo:IAO_0000115>Any inorganic anion with a valency of three.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_79388">
        <obo:IAO_0000115>Any inorganic anion with a valency of two.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_79389">
        <obo:IAO_0000115>Any inorganic anion with a valency of one.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_81667">
        <obo:IAO_0000115>A member of the class of monohydroxy-1,4-benzoquinones that is 2-hydroxy-1,4-benzoquinone carrying an additional methyl substituent at position 5.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_82663">
        <obo:IAO_0000115>An elemental molecular entity in which all of the atoms have atomic number 26.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83038">
        <obo:IAO_0000115>A Daphnia metabolite produced by the species Daphnia galeata.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83039">
        <obo:IAO_0000115>An animal metabolite produced by arthropods such as crabs, lobsters, crayfish, shrimps and krill.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83056">
        <obo:IAO_0000115>A Daphnia metabolite produced by the species Daphnia magna.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83057">
        <obo:IAO_0000115>A crustacean metabolite produced by the genus of small planktonic arthropods, Daphnia</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83811">
        <obo:IAO_0000115>Any derivative of a proteinogenic amino acid resulting from reaction at an amino group, carboxy group, or a side-chain functional group, or from the replacement of any hydrogen by a heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83812">
        <obo:IAO_0000115>Any derivative of a non-proteinogenic amino acid resulting from reaction at an amino group or carboxy group, or from the replacement of any hydrogen by a heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83813">
        <obo:IAO_0000115>Any of the 23 alpha-amino acids that are precursors to proteins, and are incorporated into proteins during translation. The group includes the 20 amino acids encoded by the nuclear genes of eukaryotes together with selenocysteine, pyrrolysine, and N-formylmethionine. Apart from glycine, which is non-chiral, all have L configuration.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83820">
        <obo:IAO_0000115>Any amino-acid that is not naturally encoded in the genetic code of any organism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83821">
        <obo:IAO_0000115>Any derivative of an amino acid resulting from reaction at an amino group, carboxy group, side-chain functional group, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing amino acid residues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83824">
        <obo:IAO_0000115>A proteinogenic amino acid derivative resulting from the formal reaction of L-cysteine at the amino group, carboxy group, or thiol group, or from the replacement of any hydrogen of L-cysteine by a heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83925">
        <obo:IAO_0000115>Any  alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83955">
        <obo:IAO_0000115>A fatty acid anion obtained by deprotonation of the carboxy group of any 2-saturated fatty acid.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83972">
        <obo:IAO_0000115>A methyl-branched fatty acid anion obtained by deprotonation of the carboxy group of any 3-methyl fatty acid; major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_83982">
        <obo:IAO_0000115>A proteinogenic amino acid derivative resulting from reaction of L-glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen of L-glutamic acid by a heteroatom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_84087">
        <obo:IAO_0000115>Any metabolite (endogenous or exogenous) found in human urine samples.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_84264">
        <obo:IAO_0000115>An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the action of nicotinamidase (EC 3.5.1.19).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_84735">
        <obo:IAO_0000115>Any eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_85046">
        <obo:IAO_0000115>Any cosmetic used to lighten the colour of skin by reducing the concentration of melanin.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_85184">
        <obo:IAO_0000115>Any member of the class of cholanic acids carrying two hydroxy substituents at unspecified positions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_86324">
        <obo:IAO_0000115>An organonitrogen heterocyclic antibiotic whose structure contains a quinolone or quinolone-related skeleton.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_86327">
        <obo:IAO_0000115>Any antifungal agent used to prevent or treat fungal infections in humans or animals.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_87228">
        <obo:IAO_0000115>A class of sulfonamides whose members generally have bacteriostatic antibiotic properties.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_88184">
        <obo:IAO_0000115>Any metal which causes the onset of an allergic reaction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_88188">
        <obo:IAO_0000115>Any drug which causes the onset of an allergic reaction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_88190">
        <obo:IAO_0000115>An organic anion obtained by deprotonation of the hydroxy group of 2-hydroxy-5-methylquinone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_90710">
        <obo:IAO_0000115>A drug that acts as an antagonist, agonist, reverse agonist, or in some other fashion when interacting with cellular receptors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_91007">
        <obo:IAO_0000115>A carboxylic acic anion obtained by deprotonation of the carboxy group of any aromatic carboxylic acid. Major species at pH 7.3.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_91025">
        <obo:IAO_0000115>Any inhibitor of erythropoietin, a glycoprotein hormone that controls erythropoiesis (red blood cell production).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CL_0001061">
        <dc:creator rdf:resource="http://orcid.org/0000-0001-9990-8331"/>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-01-30T18:53:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CL_0010002">
        <obo:IAO_0000115>An epithelial cell that is part_of a umbilical artery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CL_0011019">
        <obo:IAO_0000115>A mesothelial cell that is part of the epicardium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/ENVO_00010483">
        <obo:IAO_0000115>A portion of environmental material is a fiat object part which forms the medium or part of the medium of an environmental system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001002">
        <obo:IAO_0000115 xml:lang="en">Food material for humans and animals which is processed with the intention that it be consumable as a whole or added to other food products.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001015">
        <obo:IAO_0000115 xml:lang="en">This class includes food products which are derived from or produced by a plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001046">
        <obo:IAO_0000115 xml:lang="en">A seafood product is a vertebrate or invertibrate organism from an aquatic environment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001087">
        <obo:IAO_0000115 xml:lang="en">A lipid material derived from plants. Physically, oils are liquid at room temperature.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001092">
        <obo:IAO_0000115 xml:lang="en">A food product which is derived from or produced by an animal that has a vertibrae.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001094">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T07:25:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001105">
        <obo:IAO_0000115 xml:lang="en">A food product made from an avian egg.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001131">
        <obo:IAO_0000115 xml:lang="en">A food product made from domesticated bird meat.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001133">
        <obo:IAO_0000115>A relish, sauce, or seasoning  added to food to impart a particular flavour or to complement the dish.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001142">
        <obo:IAO_0000115 xml:lang="en">A food product deriving primarily from corn (maize).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001194">
        <obo:IAO_0000115 xml:lang="en">A product of the dry seeds of plants of the genus Pisum.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001209">
        <obo:IAO_0000115 xml:lang="de">PULSES are annual leguminous crops yielding from one to 12 grains or seeds of variable size, shape and colour within a pod. They are used for both food and feed. The term &quot;pulses&quot; is limited to crops harvested solely for dry grain, thereby excludingcrops harvested green for food (green peas, green beans, etc.) which are classified as vegetable crops. Also excluded are those crops used mainly for oil extraction (e.g.soybeand and groundnuts) and leguminous crops (e.g. seeds of clover and alfalfa) that are used exclusively for sowing purposes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001242">
        <obo:IAO_0000115 xml:lang="en">A vegetable product such as leaves, flowers, seeds and roots that is rich in essential oils and aromatic principles. Used mainly a a condiment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001248">
        <obo:IAO_0000115 xml:lang="en">A fish food product includes products made from any fish species (aquatic vertebrate with gills and fins).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001256">
        <obo:IAO_0000115 xml:lang="en">A dairy food product has mammilian milk or a milk component as an ingredient.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001261">
        <obo:IAO_0000115 xml:lang="en">Any plant food product which, typically, is constituted by intact parts from one or more annual plants cultivated as field and garden crops in the open and under glass, and used almost exclusively for food.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001264">
        <obo:IAO_0000115>A one-celled fruit (pod) usually dehiscing down both sutures, and having the seed attached along a ventral suture. (Roubik 1995)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001275">
        <obo:IAO_0000115 xml:lang="en">A hen egg food product is any food product consisting mainly of hen eggs or derivatives.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001283">
        <obo:IAO_0000115>A food product from a category of domestic birds kept for meat, eggs, and feathers including fowl such as chickens, turkeys, and waterfowls such as domestic ducks and geese and other meat birds such as pigeons and doves and games birds including pheasants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001305">
        <obo:IAO_0000115 xml:lang="en">Hoi-dong is fermented sea mussel</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001314">
        <obo:IAO_0000115 xml:lang="en">Fermented meat product is any product made primarily of meat subjected to a fermentation process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001563">
        <obo:IAO_0000115 xml:lang="en">A defining ingredient defines what a food is principally categorized as, rather than an ingredient listed by percentage of weight or volume. A food may have more than one defining ingredient.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001579">
        <obo:IAO_0000115 xml:lang="en">An alcoholic drink (or alcoholic beverage) is a drink that contains ethanol, a type of alcohol produced by fermentation of grains, fruits, or other sources of sugar.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001635">
        <obo:IAO_0000115 xml:lang="en">A bean vegetable food product is a human or animal food product - such as a snap, shell or dry bean product - derived from the fruit pod, seed, or leaf of one of several genera of the flowering plant family Fabaceae.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001665">
        <obo:IAO_0000115 xml:lang="en">A broad bean food product is a product derived from the broad bean plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001677">
        <obo:IAO_0000115 xml:lang="en">A cabbage vegetable food product is a food product derived from the head or leaf portion of a cabbage plant.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTimeStamp">2019-06-27T13:30:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001703">
        <obo:IAO_0000115 xml:lang="en">A food product that derives from a cauliflower plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001714">
        <obo:IAO_0000115 xml:lang="en">A food product which normally exists as an ingredient to another food product, rather than eaten on its own, and is more complex than a chemical food component.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00001845">
        <obo:IAO_0000115 xml:lang="en">A product made from the North American term for maize (Zea mays) grown for livestock fodder (silage), ethanol, cereal and processed food products. The principal field corn varieties are dent corn, flint corn, flour corn (also known as soft corn) which includes blue corn (Zea mays amylacea), and waxy corn.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002099">
        <obo:IAO_0000115 xml:lang="en">A food product having peanuts as an ingredient.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-19T22:56:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002139">
        <obo:IAO_0000115 xml:lang="en">An edible plant fat or oil product with characteristics that consumers desire such as bland flavour and odour, clear appearance, light colour, stability to oxidation and suitability for frying, and which is the result of a refining process that removes free fatty acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002266">
        <obo:IAO_0000115 xml:lang="en">A soybean food product is a product derived from the soybean plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002373">
        <obo:IAO_0000115 xml:lang="en">A meal type is the name of an eating occasion that may have location, food type, or other customary contextual features. (Damion&apos;s 1st draft definition)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002381">
        <obo:IAO_0000115 xml:lang="en">A food product consisting of food material derived primarily from a single organism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002403">
        <obo:IAO_0000115 xml:lang="en">Any substance that can be consumed by an organism to satisfy nutritional or other health needs, or to provide a social or organoleptic food experience</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002420">
        <obo:IAO_0000115 xml:lang="en">A relation attaching between a food material and another food material that has been added to it at some point in its history.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002451">
        <obo:IAO_0000115 xml:lang="en">A process involving the physical transformation of a food source or food product into some derived organic material or food product</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002452">
        <obo:IAO_0000115 xml:lang="en">Invertebrates are animals that neither possess nor develop a vertebral column (commonly known as a backbone or spine), derived from the notochord. This includes all animals apart from the subphylum Vertebrata.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002454">
        <obo:IAO_0000115 xml:lang="en">A class which contains food product categories qualified by a quality such as granularity or temperature, which is useful for tasks like food inspection where little prior knowledge of how the food came to be is available. Some terms like &quot;food (frozen)&quot; are both a quality descriptor and the output of a process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002501">
        <obo:IAO_0000115 xml:lang="en">A food product consisting of food material derived from ingredients sourced from multiple organisms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-23T22:40:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002505">
        <obo:IAO_0000115 xml:lang="en">Dairy cattle are a type of cattle bred for the ability to produce large quantities of milk, from which dairy products are made.  This class covers both male and female members of a dairy breed.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-26T22:49:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002507">
        <obo:IAO_0000115 xml:lang="en">Taurine cattle (Bos taurus taurus), also called European cattle, are a subspecies of domesticated cattle originating in the Near East. Both taurine cattle and indicine cattle (zebus) are descended from the aurochs. Taurine cattle were originally considered a distinct species, but are now typically grouped with zebus and aurochs into one species, Bos taurus. Most modern breeds of cattle are taurine cattle.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-28T02:41:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002581">
        <obo:IAO_0000115 xml:lang="en">An aquatic invertebrate may live entirely beneath the water, or may live upon its surface or on the plants surrounding it. Some breathe air, others breathe water. To move, they may walk, swim, float, skate, fly or glide on their bellies—or they may not move much at all.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-29T19:23:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002616">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-21T22:37:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002645">
        <obo:IAO_0000115 xml:lang="en">A food product organized by the process which it results from.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-23T23:02:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002664">
        <obo:IAO_0000115 xml:lang="en">A lipid food product is a food product made primarily of plant or animal fat or oil</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T09:18:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002700">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-27T20:39:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002753">
        <obo:IAO_0000115 xml:lang="en">A whole bean is a bean having an intact seed shape and composition.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-29T15:02:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002813">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-12T17:18:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002818">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-16T15:15:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002819">
        <obo:IAO_0000115 xml:lang="en">A liver food product is a food product that derives from one or more liver organs.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-02T18:22:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002821">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-02T18:27:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00002922">
        <obo:IAO_0000115 xml:lang="en">The red cabbage (purple-leaved varieties of Brassica oleracea Capitata Group) is a kind of cabbage, also known as purple cabbage, red kraut, or blue kraut after preparation. Its leaves are coloured dark red/purple.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-09T21:59:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003004">
        <obo:IAO_0000115 xml:lang="en">A multicellular eukaryotic heterotrophic organism within the kingdom Animalia.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-14T18:02:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003043">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-24T15:43:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003194">
        <obo:IAO_0000115 xml:lang="en">A food product not including meat and animal tissue products (such as gelatin or animal-derived rennet).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-11T21:12:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003206">
        <obo:IAO_0000115 xml:lang="en">A seed of a peanut plant (Arachis hypogaea).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003282">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-11-15T20:12:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003318">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T00:20:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003341">
        <obo:IAO_0000115 xml:lang="en">A genus of plants in the mustard family (Brassicaceae). The members of the genus are informally known as cruciferous vegetables, cabbages, or mustard plants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003368">
        <obo:IAO_0000115 xml:lang="en">Food contact materials are materials that are intended to be in contact with food. These can be things that are quite obvious like a glass or a can for soft drinks as well as machinery in a food factory or a coffee machine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-31T17:07:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_00003425">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-09-09T19:28:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301075">
        <obo:IAO_0000115 xml:lang="en">A whole raw shell-off hen egg is the egg yolk and egg white obtained from a cracked egg.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301227">
        <obo:IAO_0000115 xml:lang="en">A seed of a broad bean plant (Vicia faba).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301353">
        <obo:IAO_0000115 xml:lang="en">A pod of a peanut plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301415">
        <obo:IAO_0000115 xml:lang="en">A seed of a soyabean plant (Glycine max).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301467">
        <obo:IAO_0000115 xml:lang="en">A bean substance is a substance made by processing seed from a bean plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03301977">
        <obo:IAO_0000115 xml:lang="en">A liquid prepared for consumption, or a product that can be combined with water or milk to make one.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-12T00:00:00</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03302007">
        <obo:IAO_0000115 xml:lang="en">Fruit which has not been subjected to heat treatment, but which may have other mechanical processes such as slicing applied to it.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03303918">
        <obo:IAO_0000115 xml:lang="en">Breast milk is the milk produced by the breasts (or mammary glands) of a human female to feed a child.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03309772">
        <obo:IAO_0000115 xml:lang="en">A whole raw liver is a whole liver organ obtained from an animal during a butchery process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03310226">
        <obo:IAO_0000115 xml:lang="en">Hominy is a food produced from dried maize (corn) kernels that have been treated with an alkali, in a process called nixtamalization (nextamalli is the Nahuatl word for &quot;hominy&quot;).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03310898">
        <obo:IAO_0000115 xml:lang="en">A whole raw kidney is a kidney obtained from an animal during a butchery process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03315173">
        <obo:IAO_0000115 xml:lang="en">A fish product is a home-made or commercially produced or retail or wholesale product containing substantial amounts of freshwater or saltwater fish and/or shellfish flesh. Note that this category should avoid items that mention a particular species of fish or shellfish.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03316061">
        <obo:IAO_0000115 xml:lang="en">An egg produced by a chicken hen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03316754">
        <obo:IAO_0000115 xml:lang="en">A commercial product which is monosaccharide fructose, dried, ground, and of high purity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03317170">
        <obo:IAO_0000115 xml:lang="en">A meat product is a product organized by the form of - or processing done to - its meat component (a skeletal meat part of an animal or crustacean).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400104">
        <obo:IAO_0000115 xml:lang="en">Liquid food prepared from fruit (21 CFR 146). Products prepared from fruit juice by thickening with pectin are indexed under *FRUIT JELLY*; those thickened with gelatin are under *FRUIT BUTTER, JELLY, PRESERVE OR RELATED PRODUCT*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400105">
        <obo:IAO_0000115 xml:lang="en">Seasoned product that contains multiple ingredients and that is used in limited amounts to accompany other foods; excludes flavors, spices and herbs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400112">
        <obo:IAO_0000115 xml:lang="en">Beverage containing no more than 0.5% alcohol; it may be flavored, sweetened or carbonated; includes soft drinks and steeped beverages; excludes milk in all forms, fruit juices, diluted fruit juices and vegetable juices.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400113">
        <obo:IAO_0000115 xml:lang="en">Aromatic or pungent plant product used whole or ground as a seasoning in food products.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400118">
        <obo:IAO_0000115 xml:lang="en">A substance having greater than 2% of the caloric value of sucrose per equivalent unit of sweetening capacity. For example, the amount of such subtance having the sweetening capacity of 1 teaspoon of sucrose would have more than 0.4 calories (21 CFR 170.3(o)(21)).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400125">
        <obo:IAO_0000115 xml:lang="en">Any form of whole or milled grain, prepared grain product or starch containing product derived from non-grain sources. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400127">
        <obo:IAO_0000115 xml:lang="en">The liquid extracted or expressed from mature fruit with or without the application of heat. Includes concentrated juice and single-strength juice. If the single-strength juice is prepared from concentrate, then *WATER ADDED* should be used. Carbonated fruit juices are indexed by *FRUIT JUICE* or *FRUIT JUICE, DILUTED* and *CARBONATED* or the appropriate narrower term.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400129">
        <obo:IAO_0000115 xml:lang="en">Extract, concentrate or isolate derived from a food source through one or more refining steps (see *EXTRACT, CONCENTRATE OR ISOLATE OF PLANT OR ANIMAL*) and marketed as such. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400133">
        <obo:IAO_0000115 xml:lang="en">Product that imparts or helps to impart a taste or aroma in food (21 CFR.170.3(n)(26). [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400139">
        <obo:IAO_0000115 xml:lang="en">A multiple-component food product typically containing a protein source, a vegetable, and a potato, rice or cereal-based component packaged to be served after heating, either as separate items or courses or mixed as recipe components; see 21 CFR 102.26, 102.28 and 104.47 for nutritional quality guidelines.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400143">
        <obo:IAO_0000115 xml:lang="en">Fruit in all forms; includes fruit juices and fruit juice drinks, fruit butters, jellies, preserves, and related products.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400148">
        <obo:IAO_0000115 xml:lang="en">Milk in all forms, milk-based beverage, cultured milk product, or milk or milk product analog. Index infant formula under *MEAL REPLACEMENT*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400149">
        <obo:IAO_0000115 xml:lang="en">Food product prepared by milling a grain or by producing flour, meal or grits from a non-grain source such as beans, starchy roots or tubers. Refined starch is indexed under *REFINED OR PARTIALLY REFINED FOOD PRODUCT*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400150">
        <obo:IAO_0000115 xml:lang="en">Meat (flesh and organs including blood and bone marrow) from mammals. Used for meat in all forms including cured meat, sausage or luncheon meat and meat product analogs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400152">
        <obo:IAO_0000115 xml:lang="en">Vegetables in all forms except where a use-related product type descriptior (such as *PREPARED FOOD PRODUCT* or *SNACK FOOD*) takes precedence.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400164">
        <obo:IAO_0000115 xml:lang="en">Milk, a product derived from milk, or a dairy product analog; includes cheese and frozen dairy desserts. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400172">
        <obo:IAO_0000115 xml:lang="en">Food product that is 1) ready or nearly ready for consumption; 2) usually a composite of several foods or ingredients that often belong to distinct product types; 3) usually formulated, mixed and partially or fully cooked. Prepared foods often undergo several of the processes listed in *F. EXTENT OF HEAT TREATMENT* and *H. TREATMENT APPLIED*; these factors should be carefully considered in indexing. The classification of prepared food products emphasizes consumption characteristics. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400179">
        <obo:IAO_0000115 xml:lang="en">Food product that is usually pungent, tart, salty, or spicy and is used to enhance the flavors of other foods; includes catsup, relish, prepared mustard, prepared horseradish, and condiment sauces.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400195">
        <obo:IAO_0000115 xml:lang="en">Alcoholic beverage prepared from water, malted grain and hops (humulus) by brewing. Examples are beer, ale and malt liquor (27 CFR 7.10).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400217">
        <obo:IAO_0000115 xml:lang="en">Products of the flesh of animals. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400229">
        <obo:IAO_0000115 xml:lang="en">Alcoholic or nonalcoholic beverage; excludes milk and milk-based beverages, fruit juices and fruit juice drinks, and vegetable juices. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400237">
        <obo:IAO_0000115 xml:lang="en">A product added to a food item to achieve some degree of sweet taste; it may be nutritive or nonnutritive.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400257">
        <obo:IAO_0000115 xml:lang="en">Fruits and vegetables in all forms. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400260">
        <obo:IAO_0000115 xml:lang="en">Nuts in all forms, including nut butters and pastes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400261">
        <obo:IAO_0000115 xml:lang="en">Fresh egg in shell, liquid, frozen, dried egg or egg component, or egg product analog. Includes boiled, poached, scrambled, and fried eggs. Excludes prepared egg dishes, such as omelettes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400264">
        <obo:IAO_0000115 xml:lang="en">The liquid extracted or expressed from mature vegetables with or without optional ingredients such as seasoning or salt.  Products prepared from vegetable juice by thickening with gelatin or pectin are indexed under the broader term *VEGETABLE OR VEGETABLE PRODUCT*. For part or portion, index the part or the plant from which the juice was extracted, rather than *PLANT EXTRACT, CONCENTRATE, OR ISOLATE*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400267">
        <obo:IAO_0000115 xml:lang="en">Flesh from fish or shellfish. Includes seafood product analogs and seafood-based sausage or luncheon meat as well as such products as squid ink and clam juice.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400272">
        <obo:IAO_0000115 xml:lang="en">Any form of cacao, cacao product, chocolate, chocolate product or chocolate product analog except chocolate candy; includes such products as cacao beans, cacao nibs, chocolate liquor, sweet or milk chocolate, and chocolate syrup; excludes flavors and extracts derived from cacao beans and chocolate- or cacao-flavored foods (21 CFR 163). [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400273">
        <obo:IAO_0000115 xml:lang="en">Meat (flesh and organs including blood and bone marrow) from poultry. Used for poultry meat in all forms including poultry product analogs and poultry-based sausage or luncheon meat.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400278">
        <obo:IAO_0000115 xml:lang="en">Beverage containing more than 0.5% alcohol; includes distilled spirits, malt beverage, and wine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400289">
        <obo:IAO_0000115 xml:lang="en">Food group having common consumption, functional or manufacturing characteristics, e.g. *FRUIT OR VEGETABLE PRODUCT*, *DAIRY PRODUCT*, *CONFECTIONARY*, *PREPARED FOOD PRODUCT*, etc. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400352">
        <obo:IAO_0000115 xml:lang="en">Renamed from *PRODUCT TYPE, CODEX ALIMENTARIUS* in LanguaL 2008.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400361">
        <obo:IAO_0000115 xml:lang="en">An agency food product type is a class of food product defined by an agency or consortium.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400643">
        <obo:IAO_0000115 xml:lang="en">Codex Alimentarius, Volume 2 - 1993, Section 2:  Pesticide Residues in Food.

The Codex Classification of food and animal feed commodities moving in trade and the description of the various items and groups of food and animal feedstuffs included in the present document have been developed by the Codex Committee on Pesticide Residues. It was first adopted by the 18th Session of the Codex Alimentarius Commission, (1989).

The Codex Classification includes food commodities and animal feedstuffs for which Codex maximum residue limits will not necessarily be established. The Classification is intended to be as complete a listing of food commodities in trade as possible, classified into groups on the basis of the commodity&apos;s similar potential for pesticide residues.

The Classification may also be appropriate for other purposes such as setting maximum levels for other types of residues or for other contaminants in food. The Codex Classification should be consulted in order to obtain a precise description of the food or animal feed commodities and, especially, in cases where Codex maximum residue limits have been set for groups of food and groups of animal feedstuffs. The Codex Classification is intended to promote harmonization of the terms used to describe commodities which are subject to maximum residue limits and of the approach to grouping commodities with similar potential for residue for which a common group maximum residue limit can be set.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400650">
        <obo:IAO_0000115 xml:lang="en">Vegetables are foods derived from many different kinds of plants mostly annual and usually cultivated, commonly known by custom and tradition as &quot;vegetables&quot;.
In several countries, some of these commodities grown on large areas are distinguished as &quot;field crops&quot; or arable crops e.g. sugar beet. For the sake of convenience in this guide such crops are classified under Type 2 Vegetables.
Exposure to pesticides is dependent on the particular part of the plant used for food and the growing practices.
Vegetables may be consumed in whole or in part and in the form of fresh, dried or processed foods.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03400675">
        <obo:IAO_0000115 xml:lang="en">Brassica (cole or cabbage) vegetables and flowerhead brassicas are foods derived from the leafy heads, stems and immature inflorescences of plants belonging to the genus Brassica or the family Cruciferae. Although Kohlrabi does not comply fully with the description above, for convenience and because of the similarity in residue behaviour the commodity is classified in this group. Koblrabi is a tuber-like enlargement of the stem.
The edible part of the crop is partly protected from pesticides applied during the growing season by outer leaves, or skin (Kohlrabi).
The entire vegetable after discarding obviously decomposed or withered leaves may be consumed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03401270">
        <obo:IAO_0000115 xml:lang="en">Food and Drugs, title 21, Code of Federal Regulations. Original food classification in LanguaL.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03401298">
        <obo:IAO_0000115 xml:lang="en">Index dietary/food supplements according to legal and market definitions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03401328">
        <obo:IAO_0000115 xml:lang="en">Fibre supplements (or fiber supplements) are considered to be a form of a subgroup of functional dietary fibre, and in the United States are defined by the Institute of Medicine (IOM). According to the IOM, functional fibre &quot;consists of isolated, non-digestible carbohydrates that have beneficial physiological effects in humans&quot;.
Fibre supplements are widely available, and can be found in forms such as powders, tablets and capsules. Consumption of fibre supplements may be for: improving dietary intake, lowering blood cholesterol, alleviating irritable bowel syndrome, reducing the risk of colon cancer, and increasing feelings of satiety. [http://en.wikipedia.org/wiki/Fibre_supplements]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411021">
        <obo:IAO_0000115 xml:lang="en">An aquatic animal is an animal, either vertebrate or invertebrate, which lives in the water for most or all of its lifetime.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411041">
        <obo:IAO_0000115 xml:lang="en">Any chemical or chemical mixture that exists in a food material or was added to a food material.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411134">
        <obo:IAO_0000115 xml:lang="en">Mammals (from Latin mamma &quot;breast&quot;) are vertebrate animals constituting the class Mammalia, and characterized by the presence of mammary glands which in females produce milk for feeding (nursing) their young, a neocortex (a region of the brain), fur or hair, and three middle ear bones.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411142">
        <obo:IAO_0000115 xml:lang="en">Aquatic animals other than fish and shellfish</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411156">
        <obo:IAO_0000115 xml:lang="en">A legume  is a plant or its fruit or seed in the family *Fabaceae* (or *Leguminosae*). Legumes are grown agriculturally, primarily for their grain seed called pulse, for livestock forage and silage, and as soil-enhancing green manure. Well-known legumes include alfalfa, clover, peas, beans, chickpeas, lentils, lupin bean, mesquite, carob, soybeans, peanuts and tamarind. [https://en.wikipedia.org/wiki/Legume]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411161">
        <obo:IAO_0000115 xml:lang="en">Cattle (colloquially cows) are the most common type of large domesticated ungulates. They are a prominent modern member of the subfamily *Bovinae*, are the most widespread species of the genus *Bos*, and are most commonly classified collectively as *Bos taurus*... with three subspecies: *Bos taurus primigenius, Bos taurus indicus, Bos taurus taurus*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411189">
        <obo:IAO_0000115 xml:lang="en">Winter squash is an annual fruit representing several squash species within the genus Cucurbita. It differs from summer squash in that it is harvested and eaten in the mature fruit stage when the seeds within have matured fully and the skin has hardened into a tough rind. At this stage, most varieties of this fruit can be stored for use during the winter.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411201">
        <obo:IAO_0000115 xml:lang="en">A dairy cow is an adult female member of a dairy cattle breed</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411222">
        <obo:IAO_0000115 xml:lang="en">Fish are the gill-bearing aquatic craniate animals that lack limbs with digits. Most fish are ectothermic (&quot;cold-blooded&quot;), allowing their body temperatures to vary as ambient temperatures change, though some of the large active swimmers like white shark and tuna can hold a higher core temperature.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411223">
        <obo:IAO_0000115 xml:lang="en">Mussel is the common name used for members of several families of bivalve molluscs, from saltwater and freshwater habitats. These groups have in common a shell whose outline is elongated and asymmetrical compared with other edible clams, which are often more or less rounded or oval.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411248">
        <obo:IAO_0000115 xml:lang="en">Rapeseed (*Brassica napus*), also known as rape, oilseed rape, charlock (and, in the case of one particular group of cultivars, canola), is a bright-yellow flowering member of the family *Brassicaceae* (mustard or cabbage family), cultivated mainly for its oil-rich seed. It is the third-largest source of vegetable oil in the world. [https://en.wikipedia.org/wiki/Rapeseed]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411281">
        <obo:IAO_0000115 xml:lang="en">Kale (also called Borecole) is a form of cabbage (*Brassica oleracea* Acephala Group) in which the central leaves do not form a head. It is considered to be closer to wild cabbage than most domesticated forms. The species *Brassica oleracea* contains a wide array of vegetables, including broccoli, cauliflower, and Brussels sprouts. The Cultivar Group Acephala also includes spring greens and collard greens, which are extremely similar genetically. Kale can be classified by leaf type: Curly leaved (Scots kales), Plain leaved, Rape kale, Leaf and spear (a cross between curly leaved and plain leaved kale), Cavolo nero (also known as black cabbage, Tuscan kale, Lacinato and dinosaur kale)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411297">
        <obo:IAO_0000115 xml:lang="en">A vertebrate animal is any species of organism within the subphylum Vertebrata (chordates with backbones). Vertebrates represent the overwhelming majority of the phylum Chordata, with currently about 69,276 species described.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411324">
        <obo:IAO_0000115 xml:lang="en">Any grass cultivated (grown) for the edible components of its grain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411367">
        <obo:IAO_0000115 xml:lang="en">*Vicia faba*, the Broad Bean, is a species of bean (*Fabaceae*) native to north Africa and southwest Asia, and extensively cultivated elsewhere. A variety is provisionally recognized: Vicia faba var. equina Pers. - Horse Bean.  Although usually classified in the same genus Vicia as the vetches, some botanists treat it in a separate monotypic genus *Faba*. The term fava bean (from the Italian fava, meaning &quot;broad bean&quot;) is usually used in English speaking countries such as the US, however the term broad bean is the most common name in the UK.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411374">
        <obo:IAO_0000115 xml:lang="en">Crustaceans form a large, diverse arthropod taxon which includes such familiar animals as crabs, lobsters, crayfish, shrimp, krill, woodlice, and barnacles. [https://en.wikipedia.org/wiki/Crustacean]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411379">
        <obo:IAO_0000115 xml:lang="en">Field corn is maize of varieties that (in contrast with sweet corn and popcorn) are not, in the United States, grown primarily for consumption as human food in the form of fresh kernels. More than 98% of corn-growing land in the U.S. is in use for field-corn production. Principal field corn varieties are Dent corn, Flint corn, Flour corn (including blue corn (*Zea mays amylacea*), and Waxy corn.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411406">
        <obo:IAO_0000115 xml:lang="en">Cabbage or headed cabbage (comprising several cultivars of Brassica oleracea) is a leafy blue, red (purple), or white (pale blue) biennial plant grown as an annual vegetable crop for its dense-leaved heads.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411433">
        <obo:IAO_0000115 xml:lang="en">The term shellfish is used both broadly and specifically. For regulatory purposes it is often narrowly defined as filter-feeding molluscs such as clams, mussels, and oyster to the exclusion of crustaceans and all else. Although their shells may differ, all shellfish are invertebrates.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411443">
        <obo:IAO_0000115 xml:lang="en">Broccoli is a plant in the cabbage family, whose large flower head is used as a vegetable. The word broccoli, from the Italian plural of broccolo, refers to &quot;the flowering top of a cabbage&quot;. Broccoli is usually boiled or steamed, but may be eaten raw and has become popular as a raw vegetable in hors d&apos;oeuvre trays.
Broccoli is classified in the *Italica* cultivar group of the species *Brassica oleracea*. Broccoli has large flower heads, usually green in color, arranged in a tree-like fashion on branches sprouting from a thick, edible stalk. The mass of flower heads is surrounded by leaves. Broccoli most closely resembles cauliflower, which is a different cultivar group of the same species.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411564">
        <obo:IAO_0000115 xml:lang="en">This is a hierarchy of organisms, grouped minimally in a combination of taxonomy and consumer-oriented food groups.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411566">
        <obo:IAO_0000115 xml:lang="en">Leaf vegetables, also called leafy greens, salad greens, pot herbs, vegetable greens, or simply greens, are plant leaves eaten as a vegetable, sometimes accompanied by tender petioles and shoots.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411567">
        <obo:IAO_0000115 xml:lang="en">A bean plant is one of several genera of the flowering plant family Fabaceae, which has seed pods, seeds, and/or leaf material used for human or animal food.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03411713">
        <obo:IAO_0000115 xml:lang="en">A mature female chicken (usually more than 10 months of age) with meat less tender than that of a roaster, and with a nonflexible breastbone tip.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412091">
        <obo:IAO_0000115 xml:lang="en">Cucurbita (Latin for gourd) is a genus of herbaceous vines in the gourd family, Cucurbitaceae, also known as cucurbits, native to the Andes and Mesoamerica. Five species are grown worldwide for their edible fruit, variously known as squash, pumpkin, or gourd depending on species, variety, and local parlance, and for their seeds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412112">
        <obo:IAO_0000115 xml:lang="en">*Mollusca* is a large phylum of invertebrate animals whose members are known as molluscs or mollusks. Molluscs are the largest marine phylum, comprising about 23% of all the named marine organisms. Numerous molluscs also live in freshwater and terrestrial habitats. [https://en.wikipedia.org/wiki/Mollusca]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412113">
        <obo:IAO_0000115 xml:lang="en">*Bivalvia*, in previous centuries referred to as the *Lamellibranchiata* and *Pelecypoda*, is a class of marine and freshwater molluscs that have laterally compressed bodies enclosed by a shell consisting of two hinged parts. Bivalves as a group have no head and they lack some usual molluscan organs like the radula and the odontophore. They include the clams, oysters, cockles, mussels, scallops, and numerous other families that live in saltwater, as well as a number of families that live in freshwater.[https://en.wikipedia.org/wiki/Bivalvia]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412115">
        <obo:IAO_0000115 xml:lang="en">Echinoderm is the common name given to any member of the phylum *Echinodermata* of marine animals. The adults are recognizable by their (usually five-point) radial symmetry, and include such well-known animals as sea stars, sea urchins, sand dollars, and sea cucumbers, as well as the sea lilies or &quot;stone lilies&quot;. [https://en.wikipedia.org/wiki/Echinoderm]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412116">
        <obo:IAO_0000115 xml:lang="en">A cephalopod is any member of the molluscan class *Cephalopoda* such as a squid, octopus or nautilus. These exclusively marine animals are characterized by bilateral body symmetry, a prominent head, and a set of arms or tentacles modified from the primitive molluscan foot. Fishermen sometimes call them inkfish, referring to their common ability to squirt ink. [https://en.wikipedia.org/wiki/Cephalopod]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412409">
        <obo:IAO_0000115 xml:lang="en">*Coelenterata* is an obsolete term encompassing the animal phyla *Cnidaria* (coral animals, true jellies, sea anemones, sea pens, and their allies) and *Ctenophora* (comb jellies).  [https://en.wikipedia.org/wiki/Coelenterata]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03412974">
        <obo:IAO_0000115 xml:lang="en">A chemical food component in liquid form.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03413286">
        <obo:IAO_0000115 xml:lang="en">Food additive; technological purpose(s): bulking agent, humectant, sequestrant, stabilizer, sweetener.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03413749">
        <obo:IAO_0000115 xml:lang="en">This section list vitamins and mineral substances which may be used in the manufacture of food supplements.
DIRECTIVE 2002/46/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03414374">
        <obo:IAO_0000115 xml:lang="en">The biological subfamily *Bovinae* includes a diverse group of 10 genera of medium- to large-sized ungulates, including domestic cattle, the bison, African buffalo, the water buffalo, the yak, and the four-horned and spiral-horned antelopes. The evolutionary relationship between the members of the group is obscure, and their classification into loose tribes rather than formal subgroups reflects this uncertainty. General characteristics include cloven hoofs and usually at least one of the sexes of a species having true horns.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03414381">
        <obo:IAO_0000115 xml:lang="en">A bovid (family *Bovidae*) is any of almost 140 species of cloven-hoofed, ruminant mammal which has males with characteristic unbranching horns covered in a permanent sheath of keratin.

The family is widespread, being native to Asia, Africa, Europe and North America, and diverse: members include bison, African buffalo, water buffalo, antelopes, gazelles, sheep, goats, muskoxen, and domestic cattle.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03414460">
        <obo:IAO_0000115 xml:lang="en">The *Cucurbitaceae*, also called cucurbits and the gourd family, are a plant family consisting of about 965 species in around 95 genera, the most important of which are: 
  *Cucurbita* - squash, pumpkin, zucchini, some gourds; 
  *Lagenaria* - calabash, and others that are inedible; 
  *Citrullus* - watermelon (*C. lanatus, C. colocynthis*) and others; 
  *Cucumis* - cucumber (*C. sativus*), various melons; 
  *Luffa* - luffa, loofah</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03414466">
        <obo:IAO_0000115 xml:lang="en">Tunicates, previously known as *Urochordata* or urochordates, are members of the *Tunicata*, a subphylum of the phylum *Chordata*. They are marine filter feeders with a saclike morphology. In their respiration and feeding they take in water through an incurrent (or inhalant) siphon and expel the filtered water through an excurrent (or exhalant) siphon. Most adult tunicates are sessile and attached to rocks or similarly suitable surfaces on the ocean floor; others such as salps, doliolids and pyrosomes swim in the pelagic zone as adults. Various species are commonly known as sea squirts or sea pork.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420103">
        <obo:IAO_0000115 xml:lang="en">Edible flesh of any type of animal, including poultry and seafood. Excludes parts containing only animal fat, which is indexed under *FAT OR OIL* or under *FAT, TRIM*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420108">
        <obo:IAO_0000115 xml:lang="en">A broad term that includes the nutritive sweeteners dextrose, fructose, galactose, lactose, maltose and sucrose, which are simple carbohydrates with molecules composed of one or two saccharide units. Note that on a product label or in a recipe, &apos;sugar&apos; means *SUCROSE* and should be so indexed. Use the broad term *SUGAR* only if the specific sugar used is not known or not listed in the vocabulary.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420116">
        <obo:IAO_0000115 xml:lang="en">Anatomical part of the plant or animal from which a food product or its major ingredient is derived.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420122">
        <obo:IAO_0000115 xml:lang="en">Bone, feathers, shell, skin or trim fat.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420127">
        <obo:IAO_0000115 xml:lang="en">Includes carcass meat, organ meat, and nonmeat parts of animals, as well as the whole animal.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420152">
        <obo:IAO_0000115 xml:lang="en">Extract, concentrate or isolate high in sugar, oligosaccharide or polysaccharide.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420164">
        <obo:IAO_0000115 xml:lang="en">Anatomical part of an animal; includes eggs and milk that, although separated from the animal, are produced as integral parts and are affected by the animal&apos;s food intake and metabolism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420167">
        <obo:IAO_0000115 xml:lang="en">The fleshy fruit of any plant. *FRUIT* includes vegetables berries and pods as well. The bulk of a fruit is its fleshy part, which is covered by a peel (skin) and which encloses a core, pit or seeds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420168">
        <obo:IAO_0000115 xml:lang="en">Bone (endoskeleton) or shell (exoskeleton) of animals, or any part thereof.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420175">
        <obo:IAO_0000115 xml:lang="en">Carcass meat from any type of animal including poultry and seafood. Includes retail and wholesale cuts other than organ meat. Refers to the whole carcass or parts.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420177">
        <obo:IAO_0000115 xml:lang="en">Extract, concentrate or isolate high in gluten, the predominant protein of wheat or corn.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420190">
        <obo:IAO_0000115 xml:lang="en">Food substance or component consisting predominantly of mixed glycerol esters of fatty acids and, in far lesser amounts, of fatty acids, sterols and pigments. A fat is a solid at room temperature, an oil is a liquid at room temperature (20 degrees C.). Excludes essential oils.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-20T05:09:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420194">
        <obo:IAO_0000115 xml:lang="en">Poultry, game bird or turtle eggs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420218">
        <obo:IAO_0000115 xml:lang="en">Edible organ meat, including blood and bone marrow.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420225">
        <obo:IAO_0000115 xml:lang="en">The egg yolk and albumen component of one or more eggs with shell removed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420228">
        <obo:IAO_0000115 xml:lang="en">A physical-chemical component separated from the food source or its parts by extraction, centrifugation, filtration, heat processing, expressing or a similar process. The separated component may be converted through further processing. If this is done, the final substance is indexed. A water-extracted component may remain in aqueous dispersion. The extract, concentrate or isolate is indexed in preference to the anatomic part from which it is derived. For example, peanut oil is indexed under *PEANUT* combined wih *FAT OR OIL* rather than with *SEED OR KERNEL*. On the other hand, fruit and vegetable juices can be indexed under *FRUIT JUICE OR NECTAR* or *VEGETABLE JUICE* (A. PRODUCT TYPE); therefore the anatomic part of the plant should be indexed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420236">
        <obo:IAO_0000115 xml:lang="en">Extract, concentrate or isolate high in protein; may contain amino acids, polypeptides and enzymes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420255">
        <obo:IAO_0000115 xml:lang="en">Meat from organs that do not belong to the cardiovascular, digestive or urogenital system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03420307">
        <obo:IAO_0000115 xml:lang="en">The oil produced by pressing or extracting lipids from plant seeds (e.g. grapeseed oil, rapeseed oil, linseed oil) /AM</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03430113">
        <obo:IAO_0000115 xml:lang="en">The physical state of the food product (liquid, semiliquid, semisolid, or solid). Solid food products are further subdivided by shape or form. Terms are provided for products that have both liquid and solid components or that incorporate air or other gases. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03430130">
        <obo:IAO_0000115 xml:lang="en">A state of matter between a solid and a gas, in which a substance has the capacity to flow and conforms to the shape of the container. Liquids range from water to honey, corresponding to a range in viscosity (or apparent viscosity) from 1 to 500 centipoise (viscosity is a measure of a liquid&apos;s resistance to flow). Products that are pourable but have a higher viscosity are *SEMILIQUID*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03430131">
        <obo:IAO_0000115 xml:lang="en">Refers to natural or formed shape as appropriate, regardless of size, which may vary from very large (e.g., beef carcass) to very small (e.g., poppy seed, yeast cell).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03460111">
        <obo:IAO_0000115 xml:lang="en">Used to specifically characterize a food product based on the treatment or processes applied to the product or any indexed ingredient. The processes include adding, substituting or removing components or modifying the food or component, e.g., through fermentation. Multiple values can be assigned.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03460119">
        <obo:IAO_0000115 xml:lang="en">Modified by microbial or enzymatic action resulting in molecular changes in any food component. If salt, sugar or other food additive is used to aid in the modification process, index it by the appropriate term under *INGREDIENT ADDED*.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03460263">
        <obo:IAO_0000115 xml:lang="en">A fat or oil derived from vegetable material</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03470107">
        <obo:IAO_0000115 xml:lang="en">The methods contributing to the prevention or retardation of microbial, enzymatic or oxidative spoilage and thus to the extension of shelf life. Index all methods for which information is available, even if a corresponding descriptor has already been used in *H. TREATMENT APPLIED*. Preservation descriptors refer to the finished food as a whole with these exceptions: (1) if the components of a multi-component food, such as cream pie, are preservation by different methods, index all methods; (2)  if chemical preservatives are declared on the label, always index them even if it is known that the preservative was introduced through or is only present in a component or ingredient of the food; and (3) if the preservation method for an ingredient is declared on the label (such as brie cheese made from pasteurized milk) index it. Also use *INGREDIENT preservation by THERMAL PROCESSING* or *INGREDIENT preservation by IRRADIATION* when ingredients have been pasteurized, ultrapasteurized, sterilized or irradiated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/FOODON_03500010">
        <obo:IAO_0000115 xml:lang="en">The specific container or coating materials in direct contact with the food. [FDA CFSAN 1995]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_0019814">
        <obo:IAO_0000115>A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_0019815">
        <obo:IAO_0000115>An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_0032991">
        <obo:IAO_0000115>A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_0042101">
        <obo:IAO_0000115>A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_0042571">
        <obo:IAO_0000115>An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0000040">
        <obo:IAO_0000115>Penile length more than 2 SD above the mean for age.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001098">
        <obo:IAO_0000115>Any structural abnormality of the fundus of the eye.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001172">
        <obo:IAO_0000115>An abnormal structure of the first digit of the hand.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001211">
        <obo:IAO_0000115>An abnormal structure of the tip (end) of a finger.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001513">
        <obo:IAO_0000115>Accumulation of substantial excess body fat.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001637">
        <obo:IAO_0000115>A structural anomaly of the muscle layer of the heart wall.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0001739">
        <obo:IAO_0000115>A structural anomaly of the nasopharynx.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0002037">
        <obo:IAO_0000115>Inflammation, or an inflammatory state in the large intestine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0002204">
        <obo:IAO_0000115>An embolus (that is, an abnormal particle circulating in the blood) located in the pulmonary artery and thereby blocking blood circulation to the lung. Usually the embolus is a blood clot that has developed in an extremity (for instance, a deep venous thrombosis), detached, and traveled through the circulation before becoming trapped in the pulmonary artery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0002219">
        <obo:IAO_0000115>Excessive, increased hair growth located in the facial region.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0003107">
        <obo:IAO_0000115>Any deviation from the normal concentration of cholesterol in the blood circulation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0003312">
        <obo:IAO_0000115>Abnormal morphology of vertebral body.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0003758">
        <obo:IAO_0000115>A reduced amount of fat tissue in the lowest layer of the integument. This feature can be appreciated by a reduced skinfold thickness.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004324">
        <obo:IAO_0000115>Abnormally increased body weight.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004325">
        <obo:IAO_0000115>Abnormally low body weight.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004352">
        <obo:IAO_0000115>Any deviation from the normal concentration of a purine in the blood circulation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004368">
        <obo:IAO_0000115>Abnormally elevated concentration of a purine compound. Purine compounds are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004369">
        <obo:IAO_0000115>Abnormally reduced concentration of a purine compound. Purine compounds are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004386">
        <obo:IAO_0000115>Inflammation of the alimentary part of the gastrointestinal system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0004426">
        <obo:IAO_0000115>An abnormality of the cheek- one of two bilateral soft tissue facial structures in the region of the face inferior to the eyes and between the nose and the ear. &quot;Buccal&quot; means relating to the cheek. The cheek is part of the midface</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0005156">
        <obo:IAO_0000115>Underdeveloped, small left heart atrium</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0005344">
        <obo:IAO_0000115>Any structural abnormality of the carotid arteries, including the common carotid artery and its&apos; arterial branches.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0005345">
        <obo:IAO_0000115>An abnormality of the structure of the veins that return deoxygenated blood from the body into the heart, i.e., the superior vena cava and the inferior vena cava.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0006500">
        <obo:IAO_0000115>An anomaly of one or more epiphyses of one or both legs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0006505">
        <obo:IAO_0000115>An anomaly of one or more epiphyses of a limb.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0007343">
        <obo:IAO_0000115>Any structural anomaly of the limbic system, a set of midline structures surrounding the brainstem of the mammalian brain, originally described anatomically, e.g., hippocampal formation, amygdala, hypothalamus, cingulate cortex. Although the original designation was anatomical, the limbic system has come to be associated with the system in the brain subserving emotional functions. As such, it is very poorly defined and doesn&apos;t correspond closely to the anatomical meaning any longer. [BirnLex].</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0008339">
        <obo:IAO_0000115>An increased urine level of any amino acid carrying two amino groups (Asparagine, glutamine and lysine, cystine, ornithine).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0008633">
        <obo:IAO_0000115>Absence of sex glands (gonads are the organs that produce gametes; testis in males and ovary in females).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0010253">
        <obo:IAO_0000115>A secondary ossification center in the distal phalanges of the hand that is distinct from the normal epiphysis that does not contribute to the longitudinal growth of a tubular bone.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0010264">
        <obo:IAO_0000115>A secondary ossification center in the middle phalanges of the hand that is distinct from the normal epiphysis that does not contribute to the longitudinal growth of a tubular bone.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0011450">
        <obo:IAO_0000115>A type of infection of the central nervous system that can be regarded as a sign of a pathological susceptibility to infection.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0011723">
        <obo:IAO_0000115>Defect or defects of the morphogenesis of the right heart identifiable at birth.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0020006">
        <obo:IAO_0000115 xml:lang="en">A coloboma of the ciliary body.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025015">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-12T11:24:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025016">
        <obo:IAO_0000115>A structural anomaly of the tiny blood vessels that connect arterioles with venules and whose walls act as semipermeable membranes that mediate the diffusion of fluids and gases between the blood circulation and body tissues.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-12T11:42:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025018">
        <obo:IAO_0000115>A functional anomaly of the tiny blood vessels that connect arterioles with venules and whose walls act as semipermeable membranes that mediate the diffusion of fluids and gases between the blood circulation and body tissues.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-12T11:56:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025031">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-27T13:44:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025032">
        <obo:IAO_0000115>A functional anomaly of the digestive system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-27T13:58:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025033">
        <obo:IAO_0000115>A structural anomaly of the digestive system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-08-27T13:58:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025038">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-09-21T11:02:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025044">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-09-25T14:30:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025059">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-09-26T09:11:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025079">
        <obo:IAO_0000115>A circumscribed area of pus or necrotic debris in the parenchyma of the pancreas.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-09-26T11:01:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025085">
        <obo:IAO_0000115>Passage of many stools containing blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-10-15T13:58:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025098">
        <obo:IAO_0000115>Structural abnormality of the hypothalamus related to defective development.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-10-28T06:41:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025155">
        <obo:IAO_0000115>A functional anomaly of the hepatobiliary system</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-12-04T12:05:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025245">
        <obo:IAO_0000115>A hollow mass located in the skin that is surrounded by an epithelium-lined wall and is well demarcated from the adjacent tissue. Cysts are often said to be sac-like and may contain serous liquid or semisolid material.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-12-17T13:11:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025270">
        <obo:IAO_0000115>Any physiological abnormality of the esophagus.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-12-18T13:39:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025323">
        <obo:IAO_0000115>An anomaly of arterial function.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-03T12:08:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025348">
        <obo:IAO_0000115>An anomaly of the margin of the cornea overlapped by the sclera.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-12T23:58:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025354">
        <obo:IAO_0000115>An anomaly of cellular morphology or physiology.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-13T00:29:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025408">
        <obo:IAO_0000115>Any anomaly of the structure of the spleen.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T10:55:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025409">
        <obo:IAO_0000115>Any anomaly of the function of the spleen.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T10:56:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025423">
        <obo:IAO_0000115>Any anomaly of the structure of the larynx.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T12:44:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025424">
        <obo:IAO_0000115>Any anomaly of the function of the larynx.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T12:46:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025426">
        <obo:IAO_0000115>Any anomaly of the morphology of the bronchi.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T12:50:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025427">
        <obo:IAO_0000115>Any anomaly of the function of the bronchi.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-23T12:51:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025439">
        <obo:IAO_0000115>Inflammation (due to infection or irritation) of the pharynx.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-24T00:03:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025454">
        <obo:IAO_0000115>Any deviation from the normal range of concentration of a metabolite in the cerebrospinal fluid.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-05T10:24:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025461">
        <obo:IAO_0000115>Any anomaly of cell structure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-07T11:14:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025487">
        <obo:IAO_0000115>Any structural anomaly of the bladder.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-14T17:07:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025489">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-14T17:16:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025575">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-15T23:00:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025576">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-15T23:02:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025579">
        <obo:IAO_0000115>Any structural abnormality of the left atrium.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-15T23:54:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025580">
        <obo:IAO_0000115>Any structural abnormality of the right atrium.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-15T23:56:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025615">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-08T22:41:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025633">
        <obo:IAO_0000115>A structural abnormality of the ureter. The ureter is the duct by which urine passes from the kidney to the bladder.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T17:40:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0025634">
        <obo:IAO_0000115>A functional abnormality of the ureter. The ureter is the duct by which urine passes from the kidney to the bladder.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T17:43:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030008">
        <obo:IAO_0000115>Congenital absence of the cervix.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030044">
        <obo:IAO_0000115>A bent (flexed) finger or toe joint that cannot be straightened actively or passively. It is thus a chronic loss of joint motion due to structural changes in muscle, tendons, ligaments, or skin that prevents normal movement of joints.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030049">
        <obo:IAO_0000115>A collection of pus, immune cells, and other material in the brain.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030669">
        <obo:IAO_0000115>A structural anomaly of the adjacent structures (i.e., adnexa) of the eye, defined as the lacrimal apparatus, the extraocular muscles and the eyelids, eyelashes, eyebrows and the conjunctiva.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030680">
        <obo:IAO_0000115>Any structural anomaly of the heart and great vessels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030683">
        <obo:IAO_0000115>Inflammation of the vagina that can result from a spectrum of conditions that cause vaginal and sometimes vulvar symptoms, such as itching, burning, irritation, odor, and vaginal discharge.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030809">
        <obo:IAO_0000115>Any structural anomaly of the tongue.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030912">
        <obo:IAO_0000115>Supernumerary clitoris.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030962">
        <obo:IAO_0000115>A structural anomaly affecting a blood vessel involved in the circulation of the heart, i.e., the superior or inferior vena cava, the pulmonary arteries, the pulmonary veins, and the aorta.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:00:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030964">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:14:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030966">
        <obo:IAO_0000115>An abnormality of the structure of the pulmonary artery.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:29:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030968">
        <obo:IAO_0000115>An abnormality of the structure of the pulmonary veins.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:38:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030969">
        <obo:IAO_0000115>An abnormality of the function of the pulmonary veins.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:38:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0030972">
        <obo:IAO_0000115>A chronic deviation from normal pressure in the systemic arterial system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-18T13:55:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031051">
        <obo:IAO_0000115>An elevation in bone density in one or more tarsal bones of the foot. Sclerosis is normally detected on a radiograph as an area of increased opacity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-27T14:41:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031065">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-28T22:32:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031066">
        <obo:IAO_0000115>Any anomaly of ovarian function.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-28T22:33:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031071">
        <obo:IAO_0000115>Any anomaly of the structure of an organ ofthe endocrine system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-28T23:11:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031072">
        <obo:IAO_0000115>Any anomaly of the function of the endocrine system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-28T23:12:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031093">
        <obo:IAO_0000115>Any anomaly of the structure of the breast.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-30T15:41:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031094">
        <obo:IAO_0000115>Any anomaly of the function of the breast.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-30T15:42:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031095">
        <obo:IAO_0000115>Any anomaly of the structure of the humerus.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-30T01:22:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031105">
        <obo:IAO_0000115>Any anomaly of the structure of the uterus</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-30T02:52:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031295">
        <obo:IAO_0000115>Increase in size of the left atrium.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-13T21:38:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031306">
        <obo:IAO_0000115>An accumulation of calcium and phosphate in arteries with mineral deposits in the intimal or medial layer of the vessel wall in an artery that is located within the skull (intracranial).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-26T21:30:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031307">
        <obo:IAO_0000115>An accumulation of calcium and phosphate in arteries with mineral deposits in the intimal or medial layer of the vessel wall in the internal carotid artery.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-26T21:32:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031309">
        <obo:IAO_0000115>An accumulation of calcium and phosphate in arteries with mineral deposits in the intimal or medial layer of the vessel wall in a cerebral artery.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-26T21:34:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031314">
        <obo:IAO_0000115>An accumulation of calcium and phosphate in arteries with mineral deposits in the intimal or medial layer of the vessel wall in a carotid artery.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-26T21:52:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031315">
        <obo:IAO_0000115>An accumulation of calcium and phosphate in arteries with mineral deposits in the intimal or medial layer of the vessel wall in the external carotid artery.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-08-26T21:53:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031466">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-09-17T16:30:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031605">
        <obo:IAO_0000115>Any anomaly of the pigmentation of the fundus, the posterior part of the eye including the retina and optic nerve.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-01T11:02:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031685">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-17T21:04:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031703">
        <obo:IAO_0000115>Any structural anomaly of the ear.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-18T00:20:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031704">
        <obo:IAO_0000115>Any functional anomaly of the ear.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-18T00:20:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031783">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-01-28T12:02:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031795">
        <obo:IAO_0000115>Any deviation from the normal concentration of glycerol in the blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-02-25T14:28:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031803">
        <obo:IAO_0000115>Bleeding within the fundus of the eye.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-03-07T15:30:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031815">
        <obo:IAO_0000115>A functional anomaly of the mouth (which is also known as the oral cavity).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-29T14:50:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031816">
        <obo:IAO_0000115>Any structural anomaly of the mouth, which is also known as the oral cavity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-29T14:55:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031910">
        <obo:IAO_0000115>A functional abnormality affecting one or more of the cranial nerves, which emerge directly from the brain stem.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-06-23T13:49:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031979">
        <obo:IAO_0000115>Any deviation from the normal concentration of a carbohydrate in the urine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-07-08T12:53:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0031980">
        <obo:IAO_0000115>Any deviation from the normal concentration of a carboxylic acid in the urine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-07-08T13:01:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032039">
        <obo:IAO_0000115>An anomaly of the adjacent structures (i.e., adnexa) of the eye, defined as the lacrimal apparatus, the extraocular muscles and the eyelids, eyelashes, eyebrows and the conjunctiva.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-03T00:17:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032040">
        <obo:IAO_0000115>A functional anomaly of the adjacent structures (i.e., adnexa) of the eye, defined as the lacrimal apparatus, the extraocular muscles and the eyelids, eyelashes, eyebrows and the conjunctiva.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-03T00:18:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032045">
        <obo:IAO_0000115>Underdevelopment of the carotid canal, which normally is a circular aperture in the temporal bone of the skull through which the internal carotid artery and the carotid plexus of nerves traverse.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-16T10:47:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032101">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-04T22:23:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032120">
        <obo:IAO_0000115>Any functional abnormality of the part of the nervous system that consists of the nerves and ganglia outside of the brain and spinal cord.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-17T16:57:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032158">
        <obo:IAO_0000115>An unusual infection classified by the affected body part.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-12-09T12:17:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032164">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-12-09T14:04:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032180">
        <obo:IAO_0000115>An abnormal level of an analyte measured in the blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-12T13:45:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032207">
        <obo:IAO_0000115>Any deviation from the normal concentration of a metabolite in cerebrospinal fluid.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T15:49:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032226">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-26T14:26:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032243">
        <obo:IAO_0000115>Any deviation from the normal concentration of a metabolite in a tissue.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-27T11:56:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032245">
        <obo:IAO_0000115>An abnormality in the function of the chemical reactions related to processes including conversion of food to enter, synthesis of proteins, lipids, nucleic acids, and carbohydrates, or the elimination of waste products.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-27T12:48:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032251">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-27T16:44:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032263">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-27T20:07:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032351">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-23T16:46:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032368">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-23T18:37:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032369">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-23T18:42:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032445">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-03-03T17:31:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032446">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-03-03T17:45:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032453">
        <obo:IAO_0000115>Abnormal coloring of the lip, whereby the lip discolored, blotchy, or darker or lighter than normal.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-03-08T11:06:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032464">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-04T09:26:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032599">
        <obo:IAO_0000115>Any structural anomaly of the renal tubular epithelial cells (RTEC), a layer of cells in the outer layer of the renal tubule. These cells play a role in the absorption of substances such as glucose and amino from the primary urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0032943">
        <obo:IAO_0000115>A deviation of urine pH from the normal range of 4.5 to 7.8.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033020">
        <obo:IAO_0000115>A neoplasm that affects the female reproductive system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033079">
        <obo:IAO_0000115>Absence or underdevelopment of the thyroid gland.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033090">
        <obo:IAO_0000115>An elevated level of an aromatic amino acid in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033091">
        <obo:IAO_0000115>An abnormally increased level of tyrosine in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033093">
        <obo:IAO_0000115>An elevated level of an glutamine family amino acid in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033098">
        <obo:IAO_0000115>An increased level in the urine of an alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033099">
        <obo:IAO_0000115>An increased level of a serine family amino acid in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033100">
        <obo:IAO_0000115>An elevated level of a proteinogenic amino acid in the urine. These are the 23 alpha-amino acids that are precursors to proteins, and are incorporated into proteins during translation. The group includes the 20 amino acids encoded by the nuclear genes of eukaryotes together with selenocysteine, pyrrolysine, and N-formylmethionine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033107">
        <obo:IAO_0000115>An elevated level of a proteinogenic amino acid in the blood circulation. These are the 23 alpha-amino acids that are precursors to proteins, and are incorporated into proteins during translation. The group includes the 20 amino acids encoded by the nuclear genes of eukaryotes together with selenocysteine, pyrrolysine, and N-formylmethionine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-08-29T11:59:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033109">
        <obo:IAO_0000115>Any deviation from the normal concentration in the blood circulation of an alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-08-29T12:04:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033117">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-09-03T12:01:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033127">
        <obo:IAO_0000115>An anomaly of the musculoskeletal system, which consists of the bones of the skeleton, muscles, cartilage, tendons, ligaments, joints, and other connective tissue. The musculoskeletal system supports the weight of the body, maintains body position and produces movements of the body or of parts of the body.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-09-05T13:35:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033151">
        <obo:IAO_0000115>A structural anomaly of the pharynx.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-09-20T11:17:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033152">
        <obo:IAO_0000115>A functional anomaly of the pharynx.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-09-20T11:18:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033353">
        <obo:IAO_0000115>Any structural anomaly of a blood vessel (artery, arteriole, capillary, venule, or vein).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-12-01T11:42:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0033354">
        <obo:IAO_0000115>Any deviation from the normal concentration of a metabolite in urine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-12-01T12:00:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040087">
        <obo:IAO_0000115>Any deviation from the normal concentration of folate in the blood circulation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040090">
        <obo:IAO_0000115>An abnormality of the tympanic membrane</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040156">
        <obo:IAO_0000115>An increased amount of carboxylic acid in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040194">
        <obo:IAO_0000115>An abnormally increased head circumference in a growing child. Head circumference is measured with a nonelastic tape and comprises the distance from above the eyebrows and ears and around the back of the head. The measured HC is then plotted on an appropriate growth chart.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040256">
        <obo:IAO_0000115>Absence or underdevelopment of the nasopharyngeal adenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040258">
        <obo:IAO_0000115>Underdevelopment of the nasopharyngeal adenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040261">
        <obo:IAO_0000115>An abnormal increase in the size of nasopharyngeal adenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040286">
        <obo:IAO_0000115>A structural anomaly of the muscles of the trunk and head.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0040301">
        <obo:IAO_0000115>An increased concentration of glycerol in the urine.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0045017">
        <obo:IAO_0000115>Defect or defects of the morphogenesis of the left heart identifiable at birth.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0045058">
        <obo:IAO_0000115>An anomaly of the size of the testicle (the male gonad).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0046508">
        <obo:IAO_0000115>Any morphological abnormality of the cervical vertebral column.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0100512">
        <obo:IAO_0000115>A reduced concentration of Vitamin D.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0100524">
        <obo:IAO_0000115>Congenital duplication of all or part of a limb.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0100734">
        <obo:IAO_0000115>An anomaly of one or more epiphyses of one or more vertebrae.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410030">
        <obo:IAO_0000115>A gap in the lip or lips.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-20T22:17:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410042">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-09-20T00:22:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410043">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-09-20T00:25:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410068">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-01-29T22:56:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410072">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-01-30T00:47:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410073">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-01-30T00:47:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410167">
        <obo:IAO_0000115>Any abnormality of the chest muscles.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-05-01T17:37:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410168">
        <obo:IAO_0000115>Any abnormality of the back muscles.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-05-01T17:38:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410169">
        <obo:IAO_0000115>Any abnormality of the shoulder muscles.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-05-01T17:39:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410209">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-12T00:12:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410210">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-12T00:35:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0410211">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-09-12T00:44:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500026">
        <obo:IAO_0000115>Underdevelopment of the musculature of the pelvis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-25T16:53:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500031">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-01T16:54:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500132">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-01T14:47:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500133">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-01T15:01:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500138">
        <obo:IAO_0000115>An increased amount of serine in the blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-01T16:54:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500141">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-03T19:58:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500142">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-03T20:04:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500143">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-04T13:17:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500144">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-04T13:22:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500148">
        <obo:IAO_0000115>Any deviation from the normal concentration of glutamate in the blood circulation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-04T14:22:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500153">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-05T14:45:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500163">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-12T13:25:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500165">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-10-17T15:14:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500183">
        <obo:IAO_0000115>Any deviation from the normal concentration of a carboxylic acid in the cerebrospinal fluid.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:15:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500184">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:20:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500185">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:24:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500186">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:28:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500187">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:37:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500188">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:40:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500189">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:52:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500190">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:52:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500191">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T15:53:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500192">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:24:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500193">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:25:11Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500194">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:25:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500195">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:41:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500199">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:56:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500200">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:57:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500201">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T16:57:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500202">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T17:12:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500203">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T17:12:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500204">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T17:12:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500205">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:30:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500206">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:31:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500207">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:31:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500208">
        <obo:IAO_0000115>Abnormally increased levels of lysine in cerebrospinal fluid.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:32:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500209">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:58:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500210">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T18:58:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500214">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T19:28:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500215">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T19:28:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500219">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T19:48:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500220">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T19:53:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500221">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T19:53:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500223">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:13:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500224">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:13:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500225">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:27:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500226">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:30:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500227">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:32:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500228">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:32:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500229">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:40:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500230">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-25T20:40:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500243">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-26T15:36:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500244">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-26T15:36:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500245">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-26T15:48:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500246">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-02-26T15:49:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_0500262">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-21T15:12:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/HP_3000033">
        <obo:IAO_0000115>Any abnormality of nasopharyngeal adenoids.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000003">
        <obo:IAO_0000115 xml:lang="en">A measurement unit label is as a label that is part of a scalar measurement datum and denotes a unit of measure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000005">
        <obo:IAO_0000115 xml:lang="en">A directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000007">
        <obo:IAO_0000115 xml:lang="en">A directive information entity that describes an action the bearer will take.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000009">
        <obo:IAO_0000115 xml:lang="en">A label is a symbol that is part of some other datum and is used to either partially define  the denotation of that datum or to provide a means for identifying the datum as a member of the set of data with the same label</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000010">
        <obo:IAO_0000115 xml:lang="en">Software is a plan specification composed of a series of instructions that can be 
interpreted by or directly executed by a processing unit.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000015">
        <obo:IAO_0000115 xml:lang="en">A quality of an information bearer that imparts the information content</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000027">
        <obo:IAO_0000115 xml:lang="en">An information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000028">
        <obo:IAO_0000115 xml:lang="en">An information content entity that is a mark(s) or character(s) used as a conventional representation of another entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000030">
        <obo:IAO_0000115 xml:lang="en">A generically dependent continuant that is about some thing.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000033">
        <obo:IAO_0000115 xml:lang="en">An information content entity whose concretizations indicate to their bearer how to realize them in a process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000037">
        <obo:IAO_0000115 xml:lang="en">A dot plot is a report graph which is a graphical representation of data where each data point is represented by a single dot placed on coordinates corresponding to data point values in particular dimensions.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000038">
        <obo:IAO_0000115 xml:lang="en">A diagram that presents one or more tuples of information by mapping those tuples in to a two dimensional space in a non arbitrary way.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000064">
        <obo:IAO_0000115 xml:lang="en">A plan specification which describes the inputs and output of mathematical functions as well as workflow of execution for achieving an predefined objective. Algorithms are realized usually by means of implementation as computer programs for execution by automata.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000078">
        <obo:IAO_0000115 xml:lang="en">The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000096">
        <obo:IAO_0000115 xml:lang="en">A source code module is a directive information entity that specifies, using a programming language, some algorithm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000098">
        <obo:IAO_0000115 xml:lang="en">A data format specification is the information content borne by the document published defining the specification.
Example: The ISO document specifying what encompasses an XML document; The instructions in a XSD file</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000100">
        <obo:IAO_0000115 xml:lang="en">A data item that is an aggregate of other data items of the same type that have something in common. Averages and distributions can be determined for data sets.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000101">
        <obo:IAO_0000115 xml:lang="en">An image is an affine projection to a two dimensional surface, of measurements of some quality of an entity or entities repeated at regular intervals across a spatial range, where the measurements are represented as color and luminosity on the projected on surface.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000102">
        <obo:IAO_0000115 xml:lang="en">Data about an ontology part is a data item about a part of an ontology, for example a term</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">data about an ontology part is a data item about a part of an ontology, for example a term</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000103">
        <obo:IAO_0000115 xml:lang="en">The term was used in an attempt to structure part of the ontology but in retrospect failed to do a good job</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000104">
        <obo:IAO_0000115 xml:lang="en">A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
        <obo:IAO_0000115 xml:lang="en">A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000120">
        <obo:IAO_0000115 xml:lang="en">Class has all its metadata, but is either not guaranteed to be in its final location in the asserted IS_A hierarchy or refers to another class that is not complete.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000121">
        <obo:IAO_0000115 xml:lang="en">Term created to ease viewing/sort terms for development purpose, and will not be included in a release</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">term created to ease viewing/sort terms for development purpose, and will not be included in a release</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000122">
        <obo:IAO_0000115 xml:lang="en">Class has undergone final review, is ready for use, and will be included in the next release. Any class lacking &quot;ready_for_release&quot; should be considered likely to change place in hierarchy, have its definition refined, or be obsoleted in the next release.  Those classes deemed &quot;ready_for_release&quot; will also derived from a chain of ancestor classes that are also &quot;ready_for_release.&quot;</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000123">
        <obo:IAO_0000115 xml:lang="en">Class is being worked on; however, the metadata (including definition) are not complete or sufficiently clear to the branch editors.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000124">
        <obo:IAO_0000115 xml:lang="en">Nothing done yet beyond assigning a unique class ID and proposing a preferred term.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000125">
        <obo:IAO_0000115 xml:lang="en">All definitions, placement in the asserted IS_A hierarchy and required minimal metadata are complete. The class is awaiting a final review by someone other than the term editor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
        <obo:IAO_0000115 xml:lang="en">A (currently) primitive relation that relates an information artifact to an entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000178">
        <obo:IAO_0000115 xml:lang="en">A material entity in which a concretization of an information content entity inheres.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000179">
        <obo:IAO_0000115 xml:lang="en">A histogram is a report graph which is a statistical description of a
distribution in terms of occurrence frequencies of different event classes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000180">
        <obo:IAO_0000115 xml:lang="en">A heatmap is a report graph which is a graphical representation of data
where the values taken by a variable(s) are shown as colors in a
two-dimensional map.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000183">
        <obo:IAO_0000115 xml:lang="en">A dendrogram is a report graph which is a tree diagram
frequently used to illustrate the arrangement of the clusters produced by a
clustering algorithm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000184">
        <obo:IAO_0000115 xml:lang="en">A scatterplot is a graph which uses Cartesian coordinates to display values for two variables for a set of data. The data is displayed as a collection of points, each having the value of one variable determining the position on the horizontal axis and the value of the other variable determining the position on the vertical axis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000219">
        <obo:IAO_0000115 xml:lang="en">A primitive, instance-level, relation obtaining between an information content entity and some portion of reality. Denotation is what happens when someone creates an information content entity E in order to specifically refer to something. The only relation between E and the thing is that E can be used to &apos;pick out&apos; the thing. This relation connects those two together. Freedictionary.com sense 3: To signify directly; refer to specifically</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000225">
        <obo:IAO_0000115 xml:lang="en">The reason for which a term has been deprecated. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000235">
        <obo:IAO_0000115 xml:lang="en">inverse of the relation &apos;denotes&apos;</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000308">
        <obo:IAO_0000115 xml:lang="en">An information content entity consisting of a two dimensional arrangement of information content entities such that the arrangement itself is about something.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000309">
        <obo:IAO_0000115 xml:lang="en">A figure that expresses one or more propositions</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000310">
        <obo:IAO_0000115 xml:lang="en">A collection of information content entities intended to be understood together as a whole</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000409">
        <obo:IAO_0000115 xml:lang="en">A denotator type indicates how a term should be interpreted from an ontological perspective.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000420">
        <obo:IAO_0000115 xml:lang="en">A defined class is a class that is defined by a set of logically necessary and sufficient conditions but is not a universal</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000421">
        <obo:IAO_0000115 xml:lang="en">A named class expression is a logical expression that is given a name. The name can be used in place of the expression.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000423">
        <obo:IAO_0000115 xml:lang="en">Terms with this status should eventually replaced with a term from another ontology.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000428">
        <obo:IAO_0000115 xml:lang="en">A term that is metadata complete, has been reviewed, and problems have been identified that require discussion before release. Such a term requires editor note(s) to identify the outstanding issues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000577">
        <obo:IAO_0000115 xml:lang="en">A symbol that is part of a CRID and that is sufficient to look up a record from the CRID&apos;s registry.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000578">
        <obo:IAO_0000115 xml:lang="en">An information content entity that consists of a CRID symbol and additional information about the CRID registry to which it belongs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000579">
        <obo:IAO_0000115 xml:lang="en">A CRID registry is a dataset of CRID records, each consisting of a CRID symbol and additional information which was recorded in the dataset through a assigning a centrally registered identifier process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0020000">
        <obo:IAO_0000115 xml:lang="en">An identifier is an information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0100001">
        <obo:IAO_0000115 xml:lang="en">Add as annotation triples in the granting ontology</obo:IAO_0000115>
        <obo:IAO_0000115 xml:lang="en">Use on obsolete terms, relating the term to another term that can be used as a substitute</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000003">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:10:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000004">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:10:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000005">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:10:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000006">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:11:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000009">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:12:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000010">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:12:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000011">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:12:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000013">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-07T19:24:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000014">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:20:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000015">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:20:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000016">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:21:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000018">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:22:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000020">
        <obo:IAO_0000115>A behavioral modification or implementation of a behavior designed to prevent disease or ailment.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:22:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000022">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-11-16T20:23:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000025">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-09T20:15:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000031">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-09T20:25:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000042">
        <obo:IAO_0000115>A clinical recommendation to avoid preventable diseases by vaccination or otherwise lowering risk for certain diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T19:39:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000043">
        <obo:IAO_0000115>Avoidance of an illness or infection that can be spread from person to person, animal to person, animal to animal or person to animal by taking precautionary measures, such as good hygiene practices or vaccines.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T19:39:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000044">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T19:59:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000045">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid dehydration.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T19:59:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000046">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid hypertension.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T19:59:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000047">
        <obo:IAO_0000115>A medical recommendation to avoid obesity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:01:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000048">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid skin inflammation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:03:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000049">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:11:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000050">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:12:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000051">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:13:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000053">
        <obo:IAO_0000115>A clinical recommendation to avoid or refrain from certain environmental exposures in order to maintain health or ameliorate symptoms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:50:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000054">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:50:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000055">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:56:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000056">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-11T20:56:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000058">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T18:20:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000061">
        <obo:IAO_0000115>Use of a drug to treat or prevent bacterial infections.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T18:59:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000062">
        <obo:IAO_0000115>Use of a substance that inhibits or prevents the proliferation of neoplasms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:01:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000065">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:02:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000066">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:14:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000067">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:14:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000068">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:15:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000070">
        <obo:IAO_0000115>The surgical transfer of a healthy liver to a patient.</obo:IAO_0000115>
        <dc:date>2020-06-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000071">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:31:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000072">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the human body.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:32:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000074">
        <obo:IAO_0000115>A procedure to measure pancreatic secretion to discriminate between pancreatic and nonpancreatic causes of malabsorption.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:35:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000075">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:35:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000077">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T19:44:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000078">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T19:46:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000079">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T19:48:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000080">
        <obo:IAO_0000115>A wide range of techniques and psychotherapies aimed at controlling a person&apos;s level of stress.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T19:49:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000081">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T19:51:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000083">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:30:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000084">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:32:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000085">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:34:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000086">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:35:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000087">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:36:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000088">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000089">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:39:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000090">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:40:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000092">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:54:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000093">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:55:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000095">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T20:59:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000096">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:00:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000097">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:01:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000098">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:01:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000104">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:05:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000106">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:07:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000107">
        <obo:IAO_0000115>Addition of multivitamin preparation to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:08:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000108">
        <obo:IAO_0000115>Addition of iron atom to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:09:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000109">
        <obo:IAO_0000115>Addition of vitamin C to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:09:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000110">
        <obo:IAO_0000115>Addition of vitamin D to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:09:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000112">
        <obo:IAO_0000115>Addition of food antioxidant to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:12:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000113">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:13:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000114">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:16:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000115">
        <obo:IAO_0000115>Any action taken for the purpose of improving or maintaining an individual&apos;s memory.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:26:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000116">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:33:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000117">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:34:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000118">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-19T21:36:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000120">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:31:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000121">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:31:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000123">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:36:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000124">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:39:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000125">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:42:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000126">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:45:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000127">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:46:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000128">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:51:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000129">
        <obo:IAO_0000115>An examination of tissue removed from the body to assess the presence, cause, or extent of a disease.</obo:IAO_0000115>
        <dc:creator rdf:resource="http://orcid.org/0000-0001-7941-2961"/>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T00:52:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000130">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T01:01:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000131">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T01:03:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000132">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T01:03:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000133">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T18:48:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000134">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T18:51:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000136">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T19:03:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000137">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-20T19:19:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000138">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:17:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000139">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:33:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000140">
        <obo:IAO_0000115>A  procedure to examine and define cellular anatomy or function. The test results are often used by a clinician to diagnose disease or disordered function.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:36:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000141">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:38:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000142">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:45:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000143">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T20:47:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000144">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T21:04:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000146">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T21:16:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000147">
        <obo:IAO_0000115>A lprocedure to measure hematopoietic components and investigate hematologic disorders in a blood sample.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T21:22:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000148">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T21:29:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000149">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-21T21:32:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000151">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-07T19:23:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000152">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:27:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000157">
        <obo:IAO_0000115>Treatment with a drug used in the treatment of Parkinson&apos;s disease.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:52:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000158">
        <obo:IAO_0000115>Use of a substance used to treat or prevent parasitic infections.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:53:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000159">
        <obo:IAO_0000115>A therapy capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:53:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000160">
        <obo:IAO_0000115>Treatment with a mood-stimulating drug used primarily in the treatment of affective disorders and related conditions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:53:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000161">
        <obo:IAO_0000115>Use of a substance that attaches to and blocks cell receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:54:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000162">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:54:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000163">
        <obo:IAO_0000115>Treatment with a drug that alleviates anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting the clarity of consciousness or neurologic conditions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:54:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000164">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:55:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000165">
        <obo:IAO_0000115>Therapy using an agent that promotes the excretion of urine through its effects on kidney function</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:55:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000166">
        <obo:IAO_0000115>Treatment with an agent that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:57:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000167">
        <obo:IAO_0000115>Treatment with a drug used to prevent seizures or reduce their severity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:57:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000168">
        <obo:IAO_0000115>Treatment with a substance used in the prophylaxis or therapy of virus diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:57:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000169">
        <obo:IAO_0000115>Use of a compound that has anti-inflammatory effects.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:58:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000170">
        <obo:IAO_0000115>A therapy utilizing a substance which produces loss of feeling or sensation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T17:59:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000171">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:00:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000172">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:01:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000173">
        <obo:IAO_0000115>Treatment with a drug used to prevent nausea or vomiting.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:01:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000174">
        <obo:IAO_0000115>Use of a drug to prevent or treat fungal infections in humans or animals.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:02:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000175">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:11:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000176">
        <obo:IAO_0000115>Use of a drug that acts on blood and blood-forming organs and those that affect the hemostatic system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:11:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000177">
        <obo:IAO_0000115>Treatment with a drug that promotes coagulation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:11:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000178">
        <obo:IAO_0000115>Use of an agent that prevents blood clotting.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:12:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000179">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:12:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000180">
        <obo:IAO_0000115>Use of a drug which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:12:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000181">
        <obo:IAO_0000115>Use of a drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:13:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000182">
        <obo:IAO_0000115>Treatment with a drug that acts on an alpha-adrenergic receptor.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:14:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000183">
        <obo:IAO_0000115>Treatment with an agent that selectively binds to and activates alpha-adrenergic receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:15:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000184">
        <obo:IAO_0000115>Treatment with an agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:15:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000185">
        <obo:IAO_0000115>Treatment with a drug for prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:17:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000186">
        <obo:IAO_0000115>Treatment with a drug that acts on beta-adrenergic receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:17:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000187">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:17:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000189">
        <obo:IAO_0000115>Therapy using an agent that reduces plasma lipids, such as cholesterol or low density lipoproteins (LDL), acting systemically or locally (intestines) to decrease fat digestion, absorption, production, and accumulation in the plasma and reducing pathogenic atherosclerosis and thrombosis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:19:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000190">
        <obo:IAO_0000115>Treatment with Renin-angiotensin-aldosterone system (RAAS) inhibitors, a group of drugs that act by inhibiting the renin-angiotensin-aldosterone system and include angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs), and direct renin inhibitors</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:19:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000191">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:20:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000193">
        <obo:IAO_0000115>Use of a drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:22:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000194">
        <obo:IAO_0000115>Use of a narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:22:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000195">
        <obo:IAO_0000115>Treatment with any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:24:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000196">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:25:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000197">
        <obo:IAO_0000115>Use of a class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:25:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000198">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:26:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000200">
        <obo:IAO_0000115>Use of a drug with a macrocyclic lactone with a ring of twelve or more members which exhibits antibiotic activity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:26:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000201">
        <obo:IAO_0000115>Use of an organonitrogen heterocyclic antibiotic whose structure contains a quinolone or quinolone-related skeleton.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:26:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000202">
        <obo:IAO_0000115>Use of a class of sulfonamides whose members generally have bacteriostatic antibiotic properties.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:27:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000203">
        <obo:IAO_0000115>Treatment with a broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:28:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000205">
        <obo:IAO_0000115>Treatment with a drug that can regulate intracellular calcium levels.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:28:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000206">
        <obo:IAO_0000115>Treatment with a substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:29:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000207">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:29:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000208">
        <obo:IAO_0000115>Use of a drug that inhibits sodium influx through cell membranes.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:30:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000210">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:32:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000211">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:33:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000213">
        <obo:IAO_0000115>A drug that acts as an inhibitor that interferes with the action of monoamine oxidase (EC 1.4.3.4).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:36:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000214">
        <obo:IAO_0000115>Treatment with a medication that increases the extracellular level of the neurotransmitter serotonin (5-HT) and norepinephrine by inhibiting their reuptake into the presynaptic cell.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:40:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000215">
        <obo:IAO_0000115>Treatment with mood-stimulating agents which contain a tricyclic structure and are used primarily in the treatment of affective disorders and related conditions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:41:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000217">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:41:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000218">
        <obo:IAO_0000115>Medication given to prevent or deter a patient from using a substance.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:42:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000219">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:42:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000220">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:44:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000221">
        <obo:IAO_0000115>Treatment with an anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:44:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000222">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:45:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000223">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:45:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000224">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:45:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000225">
        <obo:IAO_0000115>Medication given by mouth or by injection to treat myasthenia gravis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:47:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000226">
        <obo:IAO_0000115>Treatment with a drug to activate the parasympathetic nervous system (PSNS). They can act as direct agonists of acetylcholine receptors (ACh) or indirect agonists of ACh. While direct agonists act by binding directly to muscarinic or nicotinic ACh receptors, indirect agonists prolong the action of endogenous acetylcholine by inhibiting acetylcholinesterase.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:47:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000227">
        <obo:IAO_0000115>Use of a treat or prevent infections caused by Mycobacteria, a genus of actinobacteria.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:48:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000228">
        <obo:IAO_0000115>Use of a substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:49:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000229">
        <obo:IAO_0000115>Use of a substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:49:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000230">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:50:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000231">
        <obo:IAO_0000115>Use of an agent or endogenous substance that inhibits the formation of capillaries from existing blood vessels.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:50:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000233">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:51:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000234">
        <obo:IAO_0000115>Treatment with an EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor which interferes with the action of aromatase (EC 1.14.14.14) and so reduces production of estrogenic steroid hormones.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:54:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000235">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:55:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000236">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:55:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000237">
        <obo:IAO_0000115>Use of any of a group of agents that includes retinol (Vitamin A) and related compounds with potential antineoplastic and/or chemopreventive activities.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:56:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000239">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:57:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000240">
        <obo:IAO_0000115>Treatment with an antimicrobial drug which is used to treat or prevent protozoal infections.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:57:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000241">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:58:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000242">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T18:59:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000243">
        <obo:IAO_0000115>Treatment with a drug which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson&apos;s disease-type movements.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T19:00:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000244">
        <obo:IAO_0000115>Treatment with a drug which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson&apos;s disease-type movements; such body movements can become permanent even after treatment has ceased.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T19:01:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000245">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T19:02:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000246">
        <obo:IAO_0000115>Use of a drug for the treatment and prophylaxis of infection with hepatitis virus(es).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:15:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000247">
        <obo:IAO_0000115>Use of any drug that counters herpes.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:15:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000248">
        <obo:IAO_0000115>Treatment with an antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:16:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000249">
        <obo:IAO_0000115>Treatment with a drug which interferes with the binding, fusion and entry of an HIV virion to a human cell. By blocking this step in HIV&apos;s replication cycle, such agents slow the progression from HIV infection to AIDS.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:18:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000250">
        <obo:IAO_0000115>Treatment with a substance structurally unlike a nucleoside molecule that is capable of inhibiting the function of a reverse transcriptase. These compounds do not bind to the active site of the polymerase but in a less conserved pocket near the active site, causing a distortion in the shape of the active site and resulting in inhibition of enzymatic function, chain termination, and inhibition of viral replication.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:18:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000251">
        <obo:IAO_0000115>Nucleoside reverse transcriptase inhibitors (NRTIs) block reverse transcriptase (an HIV enzyme).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:20:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000252">
        <obo:IAO_0000115>Use of an inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:21:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000253">
        <obo:IAO_0000115>Treatment with a drug used for the treatment and prophylaxis of infection with influenza viruses.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:21:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000255">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:32:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000256">
        <obo:IAO_0000115>Treatment with used to treat bipolar disorders or mania associated with other affective disorders.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:33:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000257">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:33:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000258">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:33:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000259">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:33:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000260">
        <obo:IAO_0000115>Treatment with drugs producing both physiological and psychological effects through a variety of mechanisms involving the central nervous system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:34:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000261">
        <obo:IAO_0000115>Treatment with a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:35:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000262">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:35:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000264">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:35:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000265">
        <obo:IAO_0000115>Use of a drug to treat or prevent skin disorders or for the routine care of skin.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:36:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000267">
        <obo:IAO_0000115>Use of a drug for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:36:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000268">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:37:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000269">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:37:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000270">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:37:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000271">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:38:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000272">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:38:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000274">
        <obo:IAO_0000115>Use of a drug to treat conditions of the reproductive organs and excretory system or urinary tract.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:39:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000275">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:39:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000276">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:40:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000277">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:40:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000279">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:42:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000280">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:44:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000281">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:45:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000282">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:46:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000283">
        <obo:IAO_0000115>Use of any agent that can alter hormone levels or modulate hormone effects.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:49:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000284">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:51:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000285">
        <obo:IAO_0000115>Use of a compound which stimulates anabolism and inhibits catabolism. Anabolic agents stimulate the development of muscle mass, strength, and power.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:51:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000286">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:51:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000287">
        <obo:IAO_0000115>A drug which acts to modulates estrogenic activity in the body, either by modulating the amount of estrogen or by modulating the activity of whatever estrogen is present.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:52:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000288">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:52:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000289">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:52:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000290">
        <obo:IAO_0000115>Use of a drug to treat hyperparathyroidism by reducing the excessive production of parathyroid hormones.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:53:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000291">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:54:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000292">
        <obo:IAO_0000115>Use of a compound which inhibits or antagonizes the biosynthesis or actions of androgens.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:55:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000293">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:59:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000294">
        <obo:IAO_0000115>Use of a drug to treat hyperthyroidism by reducing the excessive production of thyroid hormones.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T20:59:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000295">
        <obo:IAO_0000115>Use of a drug that induces, enhances, restores or suppresses the host&apos;s immune system, or an agent that utilizes or is derived from a component of the immune system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000296">
        <obo:IAO_0000115>Use of a substance that augments, stimulates, activates, potentiates, or modulates the immune response at either the cellular or humoral level.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:00:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000297">
        <obo:IAO_0000115>Use of an agent that suppresses immune function by one of several mechanisms of action.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:00:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000298">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:00:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000300">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:01:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000302">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:02:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000304">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:04:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000305">
        <obo:IAO_0000115>Use of a drug to treat eye conditions or eye diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:04:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000306">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:04:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000307">
        <obo:IAO_0000115>Use of a drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:05:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000308">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:05:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000309">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:06:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000311">
        <obo:IAO_0000115>Treatment with a substance intended for administration either on the outer ear or into the auditory canal.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:08:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000312">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:08:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000313">
        <obo:IAO_0000115>Use of drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:09:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000314">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:09:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000315">
        <obo:IAO_0000115>Use of a drug designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:09:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000316">
        <obo:IAO_0000115>Use of an agent that causes an increase in the expansion of a bronchus or bronchial tubes.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:10:11Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000317">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:10:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000318">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:11:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000319">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:11:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000320">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:12:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000321">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:12:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000323">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:14:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000324">
        <obo:IAO_0000115>Use of a drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-22T21:14:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000325">
        <obo:IAO_0000115>Use of a substance for the prophylaxis or therapy of infectious diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-10T19:56:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000326">
        <obo:IAO_0000115>Removal of tissue from the head.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000327">
        <obo:IAO_0000115>Removal of tissue from the abdomen.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000328">
        <obo:IAO_0000115>Removal of tissue from the adipose tissue.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000329">
        <obo:IAO_0000115>Removal of tissue from the adrenal cortex.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000330">
        <obo:IAO_0000115>Removal of tissue from the adrenal gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000331">
        <obo:IAO_0000115>Removal of tissue from the anal canal.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000332">
        <obo:IAO_0000115>Removal of tissue from the anus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000333">
        <obo:IAO_0000115>Removal of tissue from the aorta.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000334">
        <obo:IAO_0000115>Removal of tissue from the body of uterus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000335">
        <obo:IAO_0000115>Removal of tissue from the bone element.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000336">
        <obo:IAO_0000115>Removal of tissue from the bone marrow.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000337">
        <obo:IAO_0000115>Removal of tissue from the bone tissue.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000338">
        <obo:IAO_0000115>Removal of tissue from the brain.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000339">
        <obo:IAO_0000115>Removal of tissue from the brainstem.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000340">
        <obo:IAO_0000115>Removal of tissue from the breast.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000341">
        <obo:IAO_0000115>Removal of tissue from the bronchus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000342">
        <obo:IAO_0000115>Removal of tissue from the caecum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000343">
        <obo:IAO_0000115>Removal of tissue from the cardiac ventricle.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000344">
        <obo:IAO_0000115>Removal of tissue from the cerebellum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000345">
        <obo:IAO_0000115>Removal of tissue from the cerebral cortex.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000346">
        <obo:IAO_0000115>Removal of tissue from the chest wall.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000347">
        <obo:IAO_0000115>Removal of tissue from the chordate pharynx.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000348">
        <obo:IAO_0000115>Removal of tissue from the choroid plexus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000349">
        <obo:IAO_0000115>Removal of tissue from the cochlea.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000350">
        <obo:IAO_0000115>Removal of tissue from the colon.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000351">
        <obo:IAO_0000115>Removal of tissue from the colorectum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000352">
        <obo:IAO_0000115>Removal of tissue from the dermis.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000353">
        <obo:IAO_0000115>Removal of tissue from the diaphragm.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000354">
        <obo:IAO_0000115>Removal of tissue from the dorsal plus ventral thalamus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000355">
        <obo:IAO_0000115>Removal of tissue from the duodenum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000356">
        <obo:IAO_0000115>Removal of tissue from the endocardium.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000357">
        <obo:IAO_0000115>Removal of tissue from the endocrine pancreas.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000358">
        <obo:IAO_0000115>Removal of tissue from the endometrium.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000359">
        <obo:IAO_0000115>Removal of tissue from the esophagus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000360">
        <obo:IAO_0000115>Removal of tissue from the eye.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000361">
        <obo:IAO_0000115>Removal of tissue from the fallopian tube.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000362">
        <obo:IAO_0000115>Removal of tissue from the frontal lobe.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000363">
        <obo:IAO_0000115>Removal of tissue from the gall bladder.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000364">
        <obo:IAO_0000115>Removal of tissue from the genitourinary system.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000365">
        <obo:IAO_0000115>Removal of tissue from the gonad.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000366">
        <obo:IAO_0000115>Removal of tissue from the heart.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000367">
        <obo:IAO_0000115>Removal of tissue from the hypopharynx.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000368">
        <obo:IAO_0000115>Removal of tissue from the hypothalamus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000369">
        <obo:IAO_0000115>Removal of tissue from the intestine.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000370">
        <obo:IAO_0000115>Removal of tissue from the jaw skeleton.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000371">
        <obo:IAO_0000115>Removal of tissue from the lacrimal apparatus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000372">
        <obo:IAO_0000115>Removal of tissue from the large intestine.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000373">
        <obo:IAO_0000115>Removal of tissue from the larynx.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000374">
        <obo:IAO_0000115>Removal of tissue from the limb.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000375">
        <obo:IAO_0000115>Removal of tissue from the lip.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000376">
        <obo:IAO_0000115>Removal of tissue from the liver.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000377">
        <obo:IAO_0000115>Removal of tissue from the lower respiratory tract.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000378">
        <obo:IAO_0000115>Removal of tissue from the lower urinary tract.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000379">
        <obo:IAO_0000115>Removal of tissue from the lumbar region of vertebral column.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000380">
        <obo:IAO_0000115>Removal of tissue from the lung.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000381">
        <obo:IAO_0000115>Removal of tissue from the lymph node.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000382">
        <obo:IAO_0000115>Removal of tissue from the lymphatic part of lymphoid system.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000383">
        <obo:IAO_0000115>Removal of tissue from the mammalian vulva.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000384">
        <obo:IAO_0000115>Removal of tissue from the medulla oblongata.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000385">
        <obo:IAO_0000115>Removal of tissue from the mouth.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000386">
        <obo:IAO_0000115>Removal of tissue from the muscle organ.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000387">
        <obo:IAO_0000115>Removal of tissue from the muscle tissue.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000388">
        <obo:IAO_0000115>Removal of tissue from the nasolacrimal duct.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000389">
        <obo:IAO_0000115>Removal of tissue from the nasopharynx.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000390">
        <obo:IAO_0000115>Removal of tissue from the neck.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000391">
        <obo:IAO_0000115>Removal of tissue from the ovary.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000392">
        <obo:IAO_0000115>Removal of tissue from the pancreas.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000393">
        <obo:IAO_0000115>Removal of tissue from the penis.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000394">
        <obo:IAO_0000115>Removal of tissue from the perianal skin.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000395">
        <obo:IAO_0000115>Removal of tissue from the peritoneum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000396">
        <obo:IAO_0000115>Removal of tissue from the pituitary gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000397">
        <obo:IAO_0000115>Removal of tissue from the pleura.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000398">
        <obo:IAO_0000115>Removal of tissue from the rectum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000399">
        <obo:IAO_0000115>Removal of tissue from the retina.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000400">
        <obo:IAO_0000115>Removal of tissue from the saliva-secreting gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000401">
        <obo:IAO_0000115>Removal of tissue from the scrotum.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000402">
        <obo:IAO_0000115>Removal of tissue from the sebaceous gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000403">
        <obo:IAO_0000115>Removal of tissue from the small intestine.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000404">
        <obo:IAO_0000115>Removal of tissue from the spinal cord.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000405">
        <obo:IAO_0000115>Removal of tissue from the spleen.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000406">
        <obo:IAO_0000115>Removal of tissue from the stomach.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000407">
        <obo:IAO_0000115>Removal of tissue from the subglottis.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000408">
        <obo:IAO_0000115>Removal of tissue from the submandibular gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000409">
        <obo:IAO_0000115>Removal of tissue from the testis.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000410">
        <obo:IAO_0000115>Removal of tissue from the thymus.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000411">
        <obo:IAO_0000115>Removal of tissue from the thyroid gland.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000412">
        <obo:IAO_0000115>Removal of tissue from the tongue.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000413">
        <obo:IAO_0000115>Removal of tissue from the tonsil.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000414">
        <obo:IAO_0000115>Removal of tissue from the trachea.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000415">
        <obo:IAO_0000115>Removal of tissue from the upper digestive tract.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000416">
        <obo:IAO_0000115>Removal of tissue from the upper respiratory tract.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000417">
        <obo:IAO_0000115>Removal of tissue from the ureter.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000418">
        <obo:IAO_0000115>Removal of tissue from the urethra.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000419">
        <obo:IAO_0000115>Removal of tissue from the urinary bladder.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000420">
        <obo:IAO_0000115>Removal of tissue from the uterine cervix.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000421">
        <obo:IAO_0000115>Removal of tissue from the vagina.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000422">
        <obo:IAO_0000115>Removal of tissue from the vermiform appendix.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000423">
        <obo:IAO_0000115>Removal of tissue from the zone of skin.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000424">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T17:25:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000425">
        <obo:IAO_0000115>A medical examination performed using of magnetic resonance imaging to image the head.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000426">
        <obo:IAO_0000115>A medical examination performed using of magnetic resonance imaging to image the abdomen.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000427">
        <obo:IAO_0000115>A medical examination performed using of magnetic resonance imaging to image the brain.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000428">
        <obo:IAO_0000115>A medical examination performed using of magnetic resonance imaging to image the chest.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000429">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T19:28:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000430">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T19:28:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000431">
        <obo:IAO_0000115>A medical examination performed using of magnetic resonance imaging to image the breast.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000432">
        <obo:IAO_0000115>Use of an organonitrogen heterocyclic antibiotic that contains a beta-lactam ring.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-08-29T18:00:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000434">
        <obo:IAO_0000115>Treatment with a pharmaceutical agent that inhibits the movement of calcium across through calcium channels in the cell membrane, preventing or decreasing the amount of calcium able to enter the cell. These drugs are used for their chronotropic, antihypertensive and vasodilatory effects.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-27T19:41:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000436">
        <obo:IAO_0000115>Treatment with  a drug that inhibits the action of N-methyl-D-aspartate (NMDA) receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-01T19:23:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000437">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-02T15:59:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000438">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-02T16:01:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000439">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-02T18:41:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000440">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T17:41:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000441">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T18:06:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000442">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T18:37:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000443">
        <obo:IAO_0000115>Use of a recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T18:38:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000444">
        <obo:IAO_0000115>Use of a drug that inhibits erythropoietin, a glycoprotein hormone that controls erythropoiesis (red blood cell production).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T18:49:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000445">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T19:21:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000446">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-10-08T19:26:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000447">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of a structure or organ.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-12-27T17:21:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000448">
        <obo:IAO_0000115>Surgical removal (cutting out or off) without replacement of all of a body part or structure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-12-27T17:45:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000449">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-02T19:00:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000450">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T16:44:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000451">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T18:21:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000452">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T19:26:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000453">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T19:30:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000454">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T19:35:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000455">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T19:45:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000456">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-06T19:50:11Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000457">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T17:26:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000458">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T17:32:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000459">
        <obo:IAO_0000115>Thermal hydrotherapy uses external or internal use of water in any of its forms (water, ice, steam) at temperatures above or below room temperature for health promotion or treatment of various diseases with various temperatures, pressure, duration, and site.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T17:39:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000460">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T17:42:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000461">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T18:05:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000462">
        <obo:IAO_0000115>Therapy where a substantial part of the body is immersed in cold water to produce a variety of therapeutic effects.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T18:06:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000463">
        <obo:IAO_0000115>A form of treatment where a limb or significant portion of the body is immersed in hot water immediately followed by the immersion into cold water. This procedure is repeated several times.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T18:06:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000465">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T18:07:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000466">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T19:03:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000467">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T19:03:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000468">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T19:03:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000469">
        <obo:IAO_0000115>The process in which the nasal cavity is washed to flush out mucus and debrise from the nose and sinuses with water or saline.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-08T19:04:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000470">
        <obo:IAO_0000115>Avoid the administration or use of therapeutic procedure.</obo:IAO_0000115>
        <dc:date>2020-01-12T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000471">
        <obo:IAO_0000115>Avoid the administration or use of diagnostic procedure.</obo:IAO_0000115>
        <dc:date>2020-01-12T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000472">
        <obo:IAO_0000115>Avoid the administration or use of preventative therapeutics.</obo:IAO_0000115>
        <dc:date>2020-01-12T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000473">
        <obo:IAO_0000115>The implantation of a piece of mechanical or electronic equipment that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T14:58:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000474">
        <obo:IAO_0000115>Implantation of a battery-powered device that is placed under the skin (typically in the left upper chest) with electrode wires that lead into the heart (typically lodging in the apex or septum of the right ventricle). The device can detect abnormal heart rhythms and deliver low-energy or high-energy shocks to interrupt malignant arrhythmia and thereby prevent sudden death.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T16:54:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000475">
        <obo:IAO_0000115>The resection or complete surgical removal of a nerve.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T17:09:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000476">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T17:11:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000477">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T17:50:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000478">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T17:50:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000479">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T17:51:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000481">
        <obo:IAO_0000115>Orthotic services provide prescription insoles, braces, splints, callipers, footwear, spinal jackets and helmets which help people recover from or avoid injury, or live with lifelong conditions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T18:01:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000482">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T18:02:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000483">
        <obo:IAO_0000115>A procedure where a healthcare provider reviews a patient&apos;s medical history, examines the patient, and makes recommendations as to care and treatment.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-20T18:30:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000484">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T19:47:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000485">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T19:52:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000486">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:01:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000487">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:29:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000488">
        <obo:IAO_0000115>An assessment of body temperature.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:35:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000489">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:43:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000490">
        <obo:IAO_0000115>An assessment of the number of heartbeats per unit time, usually expressed as beats per minute.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:47:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000491">
        <obo:IAO_0000115>Assessment and recording of arterial pulses in any of a number of locations. The observer should note its intensity, rate, rhythm, and if any blood vessel tenderness, tortuosity, or nodularity exists.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T20:59:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000492">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T21:04:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000493">
        <obo:IAO_0000115>Procedure to evaluate the structure and/or function of the cardiovascular system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T21:09:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000494">
        <obo:IAO_0000115>Measurement of the pressure on the walls of the vessels as blood moves around the body. Systolic blood pressure is the pressure when the heart beats – while the heart muscle is contracting (squeezing) and pumping oxygen-rich blood into the blood vessels. Diastolic blood pressure is the pressure on the blood vessels when the heart muscle relaxes. The diastolic pressure is always lower than the systolic pressure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-21T21:13:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000495">
        <obo:IAO_0000115>Monitoring blood pressure with a sphygmomanometer and a stethoscope to hear blood flow.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-22T15:29:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000496">
        <obo:IAO_0000115>A blood pressure measurement using a sphygmomanometer and an electronic pressure sensor (transducer) that detects blood flow by the presence of oscillations in the cuff pressure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-22T20:49:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000497">
        <obo:IAO_0000115>A method for monitoring blood pressure without requiring instruments introduced into the body.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-22T21:01:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000498">
        <obo:IAO_0000115>An intra-arterial method of monitoring blood pressure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-22T21:18:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000499">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T15:55:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000500">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T15:56:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000501">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T16:07:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000502">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T16:16:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000503">
        <obo:IAO_0000115>Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have respiratory insufficiency to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T16:34:17Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000504">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T16:48:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000505">
        <obo:IAO_0000115>A manual method for maintaining oxygenation using a mask.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T17:41:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000506">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T17:52:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000507">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T17:57:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000508">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T18:01:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000509">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T18:06:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000510">
        <obo:IAO_0000115>Assisted ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T18:22:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000511">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T18:27:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000512">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T18:31:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000513">
        <obo:IAO_0000115>A rehabilitation therapy for removal of copious mucus secretion from the lung of patients with diseases. The patient&apos;s head is placed in a downward incline (so the trachea is inferior to the affected area) for 15 to 20 minute sessions.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T19:45:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000514">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T20:18:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000515">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T20:23:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000516">
        <obo:IAO_0000115>Chest physical therapy (CPT or Chest PT) is an airway clearance technique (ACT) to drain the lungs, and may include percussion (clapping), vibration, deep breathing, and huffing or coughing.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T20:32:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000517">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T20:44:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000518">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-23T20:48:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000520">
        <obo:IAO_0000115>Use of medical ultrasonography in pregnancy where sound waves are used to create a real-time visual image of the developing fetus in the uterus. Imaging can include the mother&apos;s ovaries and uterus as well.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-24T19:29:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000521">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-28T19:01:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000525">
        <obo:IAO_0000115>A clinical recommendation to avoid or refrain from certain behaviors in order to maintain health or ameliorate symptoms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-29T17:35:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000526">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-04T17:09:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000527">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-04T17:45:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000528">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-17T18:13:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000529">
        <obo:IAO_0000115>Testing of fetal DNA during pregnancy to determine if the fetus has chromosomal aberrations, fetal aneuploidy, or other detectable genetic disorders.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-17T18:55:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000530">
        <obo:IAO_0000115>A genetic test to whether a healthy person harbors a recessive mutation in one of their copies of a gene or genes.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-17T20:04:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000531">
        <obo:IAO_0000115>A test that analyzes small fragments of DNA that are circulating in a pregnant woman’s blood to determine the risk that the fetus will be born with genetic abnormalities.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-17T20:22:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000532">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-18T19:16:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000533">
        <obo:IAO_0000115>A diverse set of techniques used to identify the molecular basis of genetic disease. Examples of molecular genetic tests include: genotyping to detect specific pathogenic variants; sequencing of a gene to detect pathogenic variants; amplification or hybridization methods (e.g., qPCR, array CGH, MLPA) to detect copy number variants involving one or more genes; methylation-specific techniques to detect epigenetic changes that influence gene expression; and exome and genome sequencing.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-18T19:19:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000534">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T19:24:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000535">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T19:39:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000536">
        <obo:IAO_0000115>A prenatal test in which a sample of chorionic villi is removed from the placenta for testing. The sample can be taken through the cervix (transcervical) or the abdominal wall (transabdominal). Mayo Clinic</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T19:51:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000537">
        <obo:IAO_0000115>A procedure conducted during pregnancy for the presence of Gardnerella vaginalis, Ureaplasma urealyticum, Mycoplasma hominis, Mobiluncus, Prevotella and anaerobic bacteria.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T20:17:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000538">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T20:22:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000539">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T20:47:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000540">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T21:03:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000541">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-19T21:11:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000543">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-26T19:53:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000544">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-26T19:56:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000545">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-26T20:00:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000546">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-26T20:07:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000547">
        <obo:IAO_0000115>A procedure by which biological material is obtained from a subject for testing, diagnostic, treatment, or research purposes.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-27T15:53:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000549">
        <obo:IAO_0000115>Measuring a person&apos;s own body temperature usually at home using any of a number of types of thermometers.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-29T18:25:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000550">
        <obo:IAO_0000115>A characteristic that can be objectively measured and serves as an indicator for the inflammatory response.  It could be used to indicate the normal inflammatory processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-29T18:32:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000551">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-29T18:33:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000552">
        <obo:IAO_0000115>Detection of circultating interleukin-6, which stimulates the inflammatory and auto-immune processes in many diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-29T18:44:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000553">
        <obo:IAO_0000115>A chemokine that can be objectively measured and serves as an indicator for the inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T15:51:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000554">
        <obo:IAO_0000115>Detection of interleukin-1 beta levels, an IL-1 cytokine family protein, secreted by macrophages and a mediator of inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:03:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000555">
        <obo:IAO_0000115>Detection of interleukin-1 alpha, a mediator of the inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:05:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000556">
        <obo:IAO_0000115>Detection of interleukin-2, a mediator of inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:08:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000557">
        <obo:IAO_0000115>Detection of interleukin-8 levels, a mediator of inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:09:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000558">
        <obo:IAO_0000115>Detection of interleukin-12 levels, an inflammatory cytokine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:24:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000559">
        <obo:IAO_0000115>Detection of TNF-alpha levels, a cytokine involved in systemic inflammation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:28:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000560">
        <obo:IAO_0000115>Detection of interferon-gamma, a cytokine that indicates an inflammatory response.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T16:31:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000561">
        <obo:IAO_0000115>Detection of interleukin-4, a cytokine identified as an inflammation suppressant.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T18:59:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000562">
        <obo:IAO_0000115>Detection of interleukin-5, a cytokine identified as an inflammation suppressant.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:04:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000563">
        <obo:IAO_0000115>Detection of interleukin-10, a cytokine identified as an inflammation suppressant.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:05:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000564">
        <obo:IAO_0000115>Detection of tumor necrosis factor-beta (TNF-beta), a cytokine identified as an inflammation suppressant.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:07:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000565">
        <obo:IAO_0000115>Detection of serum levels of amyloid A (SAA) in response to inflammation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:37:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000566">
        <obo:IAO_0000115>A clinical laboratory procedure designed for the quantification of an organic or inorganic chemical within a biological specimen required for diagnostics or monitoring of treatments.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:49:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000567">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T19:58:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000568">
        <obo:IAO_0000115>Glucose Plasma Concentration (GPC) measurement is an essential diagnostic modality for different types of carbohydrate metabolism derangements including diabetes mellitus.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T20:02:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000569">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T20:05:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000570">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T20:17:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000571">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-30T20:32:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000572">
        <obo:IAO_0000115>Use of a drug that lower the level of glucose in the blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T00:42:37Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000573">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T00:49:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000574">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T00:59:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000575">
        <obo:IAO_0000115>Determination if a patient&apos;s background or demographic characteristics makes the patient susceptible to disease.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T01:03:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000576">
        <obo:IAO_0000115>Determination if patient&apos;s travel history may impact current health.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T01:05:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000577">
        <obo:IAO_0000115>A questionnaire designed to determine if patient&apos;s travel history may impact current health.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T01:05:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000578">
        <obo:IAO_0000115>Determination if the patient may have been exposed to something which would impact the health of the patient.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T01:11:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000579">
        <obo:IAO_0000115>A test that measures the amount of oxygen and carbon dioxide in the blood. It may also be used to determine the pH of the blood.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:11:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000580">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:16:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000581">
        <obo:IAO_0000115>A quantitative measurement of the amount of calcium present in a sample, usually serum or urine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:19:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000582">
        <obo:IAO_0000115>A quantitative measurement of the amount of an electrolyte present in urine or serum.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:32:42Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000583">
        <obo:IAO_0000115>A quantitative measurement of the amount of an electrolyte present in serum.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:33:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000584">
        <obo:IAO_0000115>A quantitative measurement of the amount of an electrolyte present in urine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T19:34:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000585">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T20:08:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000586">
        <obo:IAO_0000115>A type of mechanical ventilation using endotracheal intubation.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-03-31T20:23:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000587">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-01T20:00:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000588">
        <obo:IAO_0000115>A technique that detects a particular nucleic acid sequence in order to identify a pathogen (organism or virus) in blood, tissue, urine, or other bodily fluids.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-02T20:59:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000589">
        <obo:IAO_0000115>A  tecnique that uses an amplification of nucleic acids  to detect a pathogen.  Some amplification methods include polymerase chain reaction (PCR), strand displacement assay (SDA), or transcription mediated assay (TMA) to detect a virus, bacteria or other pathogen.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-02T21:17:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000590">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-02T21:43:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000591">
        <obo:IAO_0000115>A technique that detects a particular DNA sequence in order to identify a pathogen (organism or virus) in blood, tissue, urine, or other bodily fluids.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-03T00:29:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000592">
        <obo:IAO_0000115>A technique that detects a particular RNA sequence in order to identify a pathogen (organism or virus) in blood, tissue, urine, or other bodily fluids.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-03T00:30:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000593">
        <obo:IAO_0000115>A clinical assay that amplifies and quantifies a specific DNA molecule based on in tissue, blood, sputum, urine, or any other bodily fluid to detect the presence of a pathogen.  It enables both detection and quantification of one or more specific sequences in a DNA sample.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-03T00:38:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000594">
        <obo:IAO_0000115>A method to measure very small amounts of RNA transcripts as cDNA targets from tissue, blood, sputum or other body fluids.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-03T00:47:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000595">
        <obo:IAO_0000115>A procedure producing an image on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure in order to diagnose or treat a patient.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T15:49:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000596">
        <obo:IAO_0000115>The process of taking a thorough history and physical exam to determine if a patient has been exposed to an infectious disease.  Close attention is paid to travel history, environmental exposures, and vaccination history.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T18:27:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000597">
        <obo:IAO_0000115>The administration of oxygen to an individual, usually to aid in respiration by means of a mask.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T19:00:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000598">
        <obo:IAO_0000115>The administration of oxygen to an individual, usually to aid in respiration by means of a nasal cannula.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T19:01:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000599">
        <obo:IAO_0000115>Therapy using a substance used in the treatment of hypotension. A vasopressor agent increases reduced blood pressure.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T19:23:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000600">
        <obo:IAO_0000115>Treatments that substitute for the blood-filtering function of the kidneys.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T19:42:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000601">
        <obo:IAO_0000115>A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T19:57:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000602">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T20:03:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000603">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T20:04:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000604">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T20:40:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000605">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T20:51:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000606">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T21:30:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000607">
        <obo:IAO_0000115>A quantification of a fibrin degradation product in blood used in the diagnosis of thrombosis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T21:37:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000608">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-07T21:53:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000609">
        <obo:IAO_0000115>Testing blood serum for the presence of specifc antibody or antibodies to a specific antigen.  Often used when an infection is suspected.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T14:34:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000610">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T14:51:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000611">
        <obo:IAO_0000115>A type of lateral flow assay that qualitatively detect IgG and IgM antibodies of an infectious disease within human serum, plasma or whole blood in vitro.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T15:03:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000612">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T15:06:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000613">
        <obo:IAO_0000115>Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label and are typically used for diagnostics or disease progression.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T15:17:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000614">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T15:46:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000615">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T15:46:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000616">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T18:45:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000617">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T18:54:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000618">
        <obo:IAO_0000115>A therapy of replenishing bodily fluids lost through sweating, bleeding, fluid shifts or other pathological processes, such as sepsis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T19:29:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000619">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T19:45:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000620">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T20:12:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000621">
        <obo:IAO_0000115>A thin catheter inserted into an artery to monitor blood pressure directly and obtain blood samples.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-08T20:20:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000622">
        <obo:IAO_0000115>Allows delivery of positive-pressure ventilation with a tight-fitting nasal or facial mask that is attached to a continuous positive airway pressure (CPAP) or a bilevel positive airway pressure (BiPAP) machine.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-27T20:57:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000623">
        <obo:IAO_0000115>Nutrition intervention for nutrition counseling is a supportive process, characterized by a collaborative counselor–patient/client relationship to establish food, nutrition and physical activity priorities, goals, and individualized action plans that acknowledge and foster responsibility for self-care to treat an existing condition and promote health.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-28T16:03:29Z</dc:date>
    </rdf:Description>
    <owl:Axiom>
        <owl:annotatedSource rdf:resource="http://purl.obolibrary.org/obo/MAXO_0000623"/>
        <owl:annotatedProperty rdf:resource="http://purl.obolibrary.org/obo/IAO_0000115"/>
        <owl:annotatedTarget>Nutrition intervention for nutrition counseling is a supportive process, characterized by a collaborative counselor–patient/client relationship to establish food, nutrition and physical activity priorities, goals, and individualized action plans that acknowledge and foster responsibility for self-care to treat an existing condition and promote health.</owl:annotatedTarget>
        <rdfs:comment>Reference: Academy of Nutrition and Dietetics. Nutrition Terminology Reference Manual (eNCPT): Dietetics Language for Nutrition Care 2014, Nutrition Intervention/Terms and Definitions/Nutrition Counseling (C), page-064, http://ncpt.webauthor.com</rdfs:comment>
    </owl:Axiom>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000624">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-04-28T16:12:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000625">
        <obo:IAO_0000115>A therapy utilizing an inhaled substance that produces loss of consciousness.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T16:13:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000626">
        <obo:IAO_0000115>A therapy utilizing an intravenous substance that produces loss of consciousness.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T18:19:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000627">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T18:25:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000628">
        <obo:IAO_0000115>Use of an agent that modulates the physiologic angiogenesis process.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T19:04:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000629">
        <obo:IAO_0000115>Use of an agent that induces or stimulates the physiologic angiogenesis process.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T19:05:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000630">
        <obo:IAO_0000115>Use of a compound that promotes the growth of new blood vessels from pre-existing vessels.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T19:22:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000631">
        <obo:IAO_0000115>A therapy used to neutralize stomach acidity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T19:41:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000632">
        <obo:IAO_0000115>A therapy used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T20:00:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000633">
        <obo:IAO_0000115>Treatment of allergic reactions with medications.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T20:23:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000634">
        <obo:IAO_0000115>Usage of a drug to treat asthma.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T20:37:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000635">
        <obo:IAO_0000115>Treatment with a drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-26T21:17:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000636">
        <obo:IAO_0000115>Use of a compound which can be used to treat or alleviate the symptoms of dyskinesia.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-27T14:13:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000637">
        <obo:IAO_0000115>Treatment with an antiviral agent that destroys or inhibits the replication of the herpes simplex virus.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T13:49:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000638">
        <obo:IAO_0000115>Treatment with an antiviral agent that destroys or inhibits the replication of the herpes simplex virus-1.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T14:07:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000639">
        <obo:IAO_0000115>Treatment with an antiviral agent that destroys or inhibits the replication of the herpes simplex virus-2.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T14:07:27Z</dc:date>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T14:20:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000640">
        <obo:IAO_0000115>Use of a natural or synthetic analog of the hormones secreted by the adrenal gland as a type of anti-inflammatory treatment.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T15:10:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000642">
        <obo:IAO_0000115>Treatment to induce vomiting and nausea usually administered in emergency situations after ingestion of a toxin.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T18:31:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000643">
        <obo:IAO_0000115>Treatment with a drug to alleviate rheumatoid arthritis and its symptoms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T18:46:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000644">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T19:11:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000645">
        <obo:IAO_0000115>Use of an inhibitor that interferes with the action of enzyme acetylcholinesterase, which helps breaking down of acetylcholine into choline and acetic acid</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-28T19:16:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000646">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-05-29T20:29:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000647">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-02T13:10:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000648">
        <obo:IAO_0000115>A therapy using a compound or agent that combines with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-02T18:44:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000649">
        <obo:IAO_0000115>Use of a drug which increases blood glucose level.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-02T20:39:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000650">
        <obo:IAO_0000115>Treatment with a cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-03T14:37:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000651">
        <obo:IAO_0000115>Treatment with a cardiovascular drug that prevents atherosclerosis, a disease in which the inside of an artery narrows due to the build-up of plaque.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-03T14:51:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000652">
        <obo:IAO_0000115>Use of a drug that inhibits angiotensin-converting enzyme (ACE), an enzyme that catalyzes the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in a reduction in angiotensin II and angiotensin II-induced aldosterone secretion, causing vasodilation and natriuresis.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-04T17:31:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000653">
        <obo:IAO_0000115>Treatment with a class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-04T17:31:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000654">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-04T17:32:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000655">
        <obo:IAO_0000115>Use of a drug that inhibits angiotensin-converting enzyme (ACE) 1, an enzyme that catalyzes the conversion of angiotensin I to angiotensin II.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-04T18:03:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000656">
        <obo:IAO_0000115>Use of a drug that inhibits angiotensin-converting enzyme (ACE) 2, an enzyme that catalyzes the conversion of angiotensin I to angiotensin II.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-04T18:17:34Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000657">
        <obo:IAO_0000115>Use of a drug that selectively binds to and inhibits metabotropic glutamate receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-05T20:18:05Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000658">
        <obo:IAO_0000115>Use of a drug that modulates the action of N-methyl-D-aspartate (NMDA) receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-08T17:47:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000659">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-08T17:48:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000660">
        <obo:IAO_0000115>Use of a drug that selectively binds to and regulates metabotropic glutamate receptors (mGluR).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-08T17:48:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000661">
        <obo:IAO_0000115>Use of a drug that activates the action of N-methyl-D-aspartate (NMDA) receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-08T18:14:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000662">
        <obo:IAO_0000115>Use of a drug that selectively binds to and activates AMPA receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-09T13:52:30Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000663">
        <obo:IAO_0000115>Use of a drug that selectively binds to and inhibits AMPA receptors.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-09T13:52:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000664">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-09T15:32:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000665">
        <obo:IAO_0000115>An evaluation by healthcare provider who is a specialist in a particular medical area.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T18:18:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000666">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T18:29:08Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000667">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T18:42:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000669">
        <obo:IAO_0000115>An evaluation by an anesthesiologist who specializes in Pediatric Anesthesiology. This specialist provides anesthesia for neonates, infants, children and adolescents undergoing surgical, diagnostic or therapeutic procedures as well as appropriate pre- and post-operative care, advanced life support, and acute pain management.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T18:48:51Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000670">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:08:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000671">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:12:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000672">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:23:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000673">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:39:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000675">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:52:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000676">
        <obo:IAO_0000115>An evaluation by a physician who specializes in Hospice and Palliative Medicine who provides care to prevent and relieve the suffering experienced by patients with life-limiting illnesses. This specialist works with an interdisciplinary hospice or palliative care team to optimize quality of life while addressing the physical, psychological, social and spiritual needs of both patient and family.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:53:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000677">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:56:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000678">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T19:59:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000679">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:01:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000680">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:07:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000681">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:13:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000682">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:16:52Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000683">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:30:10Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000684">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:35:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000685">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:43:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000686">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T20:46:33Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000688">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-01T21:00:28Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000690">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T17:10:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000691">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T17:50:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000692">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T18:23:18Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000693">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T18:32:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000694">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T19:00:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000697">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T20:14:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000698">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T20:16:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000699">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-02T20:29:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000700">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T15:24:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000701">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T17:46:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000702">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T17:53:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000703">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T20:14:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000704">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T20:31:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000705">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-08T20:34:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000706">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T16:10:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000707">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T17:48:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000709">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T18:05:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000710">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T18:48:58Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000711">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T18:54:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000712">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T19:45:07Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000713">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T19:54:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000714">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T20:37:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000715">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-09T20:41:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000716">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T16:33:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000717">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T18:35:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000718">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T19:06:21Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000719">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T19:33:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000720">
        <obo:IAO_0000115>An evaluation by a specialist who performs preoperative, operative, and postoperative management of patients with disorders of the arterial, venous and lymphatic systems, excluding vessels of the brain and the heart.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T19:54:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000721">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T20:40:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000722">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-10T20:44:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000723">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-13T17:01:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000725">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-13T17:57:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000726">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-16T14:18:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000727">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-16T14:31:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000728">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-16T14:38:38Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000729">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-07-16T14:46:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000731">
        <obo:IAO_0000115>An evaluation or treatment by a professional who provides a range of diagnostic, technical, therapeutic, and support services in connection with health care. This is care provided by health care practitioners who are distinct providers from dentistry, nursing, medicine, and pharmacy health care professionals.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-06T17:59:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000732">
        <obo:IAO_0000115>An evaluation or assessment by a health professional trained to help people who are ill or disabled learn to manage their daily activities.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-06T19:51:46Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000733">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-08T15:24:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000734">
        <obo:IAO_0000115>An assessment by a trained non-medical health professional who specializes in the identification, testing, habilitation and rehabilitation of hearing loss and other auditory and balance disorders. Particularly, an audiologist may be involved in diagnostic and screening procedures to determine hearing deficits, as well as in assessment of amplification devices and instruction in their care, training in speechreading, and may serve as consultant to government and industry on issues concerning environmental, noise-induced hearing loss.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-08T20:20:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000737">
        <obo:IAO_0000115>A therapy derived from fibric acid that lowers serum LDL cholesterol levels by activating peroxisome proliferator activated receptor alpha (PPARa).</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T21:12:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000738">
        <obo:IAO_0000115>Therapy using a highly charged polymeric agent to bind bile acids in the gastrointestinal tract and prevent their reabsorption from the gut. The bound bile acids are excreted with the feces and plasma cholesterol is converted to bile acid to reestablish normal bile acid levels, resulting in a lowering of plasma cholesterol concentrations.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T21:21:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000739">
        <obo:IAO_0000115>Therapy that inhibits HMG-CoA reductase inhibitor.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T21:37:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000740">
        <obo:IAO_0000115>Treatment with an agent that works through, or mimics, the action of niacin.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T21:45:22Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000741">
        <obo:IAO_0000115>Treatment with a diuretic agent that produces diuresis without increasing potassium excretion.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-18T16:10:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000742">
        <obo:IAO_0000115>Treatment with a benzothiadiazide derivative or other thiazide-like agent with diuretic and anti-hypertensive activity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-18T16:16:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000743">
        <obo:IAO_0000115>Treatment with sulfonamide urea derivatives with antihyperglycemic activity.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-18T16:22:03Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000744">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T16:03:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000745">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T19:13:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000746">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T19:24:16Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000747">
        <obo:IAO_0000115>Transfer of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood into the body.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T19:56:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000748">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:03:04Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000749">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:07:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000750">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:12:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000751">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:25:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000752">
        <obo:IAO_0000115>Removal of a small amount of liquid bone marrow through a needle.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:31:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000753">
        <obo:IAO_0000115>The pathologic analysis of samples of bone marrow obtained by bone marrow biopsy and bone marrow aspiration.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:33:41Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000754">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:39:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000755">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:45:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000756">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T20:58:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000757">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T21:01:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000758">
        <obo:IAO_0000115>Avoid sexual intercourse without the use of precautions to prevent conception or the transmission of sexually transmitted diseases.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T21:20:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000759">
        <obo:IAO_0000115>Vaccination against human papillomavirus infection.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-19T21:22:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000760">
        <obo:IAO_0000115>Addition of vitamin b12 to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000761">
        <obo:IAO_0000115>Addition of vitamin B to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000762">
        <obo:IAO_0000115>Intake of nutrients intravenously.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T16:40:53Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000763">
        <obo:IAO_0000115>Intake of nutrients intravenously as well as enterically.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T16:43:26Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000764">
        <obo:IAO_0000115>Intravenous nutrition intake administered via vein access in a limb.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T16:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000765">
        <obo:IAO_0000115>Intravenous nutrition administration via the central vein.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T16:46:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000766">
        <obo:IAO_0000115>A recommendation to alter dietary intake where 30% or less of the calories come from fat.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:13:24Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000767">
        <obo:IAO_0000115>Recommendation of a specific diet to adhere to prevent, relieve, or alleviate symptoms.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:15:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000768">
        <obo:IAO_0000115>A recommendation to alter a standard diet from 2-3 large meals per day to many frequent smaller meals throughout the day.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:19:06Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000769">
        <obo:IAO_0000115>A recommendation to maintain a vegetarian diet for health reasons.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:26:23Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000770">
        <obo:IAO_0000115>Dietary recommendation to closely control the amount of carbohydrates consumed.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:38:43Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000771">
        <obo:IAO_0000115>A dietary recommendation to restrict the amount of carbohydrates consumed.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:41:20Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000772">
        <obo:IAO_0000115>A recommendation to consume food low in purine content.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T17:50:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000773">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T18:26:25Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000775">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T18:51:35Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000776">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-30T19:48:31Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0000777">
        <obo:IAO_0000115>Addition of iron to the diet by taking ferrous sulfate supplements.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-12-07T19:35:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001000">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-04-26T20:04:29Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001001">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-07T16:28:50Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001002">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-07T16:32:45Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001003">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-15T16:33:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001004">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-15T16:44:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001005">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-15T16:45:09Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001006">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-16T18:09:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001007">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-16T18:18:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001008">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-16T18:20:55Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001009">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-16T18:24:56Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001010">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-05-16T18:25:40Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001014">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-12T14:22:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001015">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-12T14:23:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001016">
        <obo:IAO_0000115>Avoid the administration or use of aerobic exercise therapy.</obo:IAO_0000115>
        <dc:date>2019-05-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001017">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-14T15:47:12Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001018">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-23T18:14:54Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001019">
        <obo:IAO_0000115>Addition of vitamin supplement, prenatal to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-23T19:56:32Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001020">
        <obo:IAO_0000115>A therapy utilizing a substance that produces loss of consciousness.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-24T15:53:13Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001021">
        <obo:IAO_0000115>Use of a drug or therapy to treat or prevent microbial infections.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-24T16:13:47Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001022">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-24T19:33:44Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001023">
        <obo:IAO_0000115>Treatment with a traditional grouping of drugs said to have a soothing or calming effect on mood, thought or behavior.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-24T19:39:15Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001025">
        <obo:IAO_0000115>Therapy using any agent that acts on an adrenergic receptor or affects adrenergic signal transduction.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-25T14:32:48Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001026">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-25T14:42:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001027">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-12T14:23:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001028">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-12T14:23:27Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001029">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of pharyngeal tonsil.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001030">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of adrenal gland.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001031">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of tooth root.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001032">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of vermiform appendix.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001033">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of skeletal joint.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001034">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of ear.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001035">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of synovial bursa.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001036">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of cardia of stomach.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001037">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of head.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001038">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of uterine cervix.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001039">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of gall bladder.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001040">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of optic choroid.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001041">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of clitoris.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001042">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of colon.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001043">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of cranium.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001044">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of urinary bladder.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001045">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of bony vertebral centrum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001046">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of intervertebral disk.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001047">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of digestive tract diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001048">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of thyroid diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001049">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of hepatic diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001050">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of duodenum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001051">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of sympathetic nerve trunk.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001052">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of esophagus.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001053">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of stomach.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001054">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of tongue.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001055">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of gonad.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001056">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of liver.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001057">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of pituitary gland.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001058">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of uterus.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001059">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of iris.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001060">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of cornea.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001061">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of vertebra.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001062">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of larynx.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001063">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of lymph node.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001064">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of breast.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001065">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of kidney.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001066">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of nerve.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001067">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of ovary.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001068">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of testis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001069">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of bone tissue.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001070">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of pancreas.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001071">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of panniculus adiposus.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001072">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of parathyroid gland.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001073">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of pineal body.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001074">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of lung.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001075">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of skin of prepuce of penis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001076">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of fallopian tube.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001077">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of spleen.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001078">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of synovial membrane of synovial joint.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001079">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of thymus.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001080">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of thyroid gland.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001081">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of palatine tonsil.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001082">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of eye trabecular meshwork.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001083">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of vagina.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001084">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of vas deferens.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001085">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of vitreous humor.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001086">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of mammalian vulva.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001087">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of penis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001088">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Pulmonary bulla.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001089">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Hallux valgus.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001091">
        <obo:IAO_0000115>Surgical removal of an abnormal pouch of the lining of the small intestine (bowel).</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001092">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Cardiac diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001093">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Esophageal diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001094">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Gastric diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001095">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Renal diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001096">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Bladder diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001097">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Urethral diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001098">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Fibrous cardiac diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001099">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Muscular cardiac diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001100">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Spinal meningeal diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001101">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Coronary sinus diverticulum.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001102">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Thromboembolism.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001103">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Pulmonary embolism.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001104">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Arterial calcification.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001105">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Neoplasm of the breast.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001106">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Uterine leiomyoma.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001107">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Arterial thrombosis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001108">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Venous thrombosis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001109">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Abnormal thrombosis.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001110">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of Neoplasm.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001111">
        <obo:IAO_0000115>The surgical removal (cutting out) of part or all of gland.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001113">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid abnormal phenotypes.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001114">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid ketosis.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001115">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid diabetes.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001116">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid a febrile state.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001117">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid seizures.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001118">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid hypotension.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001119">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid hyperglycemia.</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001120">
        <obo:IAO_0000115>A medical requirement or recommendation to avoid weight loss</obo:IAO_0000115>
        <dc:date>2020-09-15T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001121">
        <obo:IAO_0000115>Removal of tissue from the kidney.</obo:IAO_0000115>
        <dc:date>2020-06-23T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001122">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the kidney.</obo:IAO_0000115>
        <dc:date>2020-06-9T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001123">
        <obo:IAO_0000115>Addition of potassium atom to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-17T02:36:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001124">
        <dc:date>2020-11-17T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001125">
        <obo:IAO_0000115>Therapy with an agent that inhibits the function of the sodium-potassium-chloride (Na+, K+, Cl-) cotransporter system in the thick ascending limb of the loop of Henle, thereby inhibiting the reabsorption of sodium, potassium, and chloride ions. This leads to an increase in the excretion of sodium, potassium, chloride, calcium, magnesium, ammonium and water.</obo:IAO_0000115>
        <dc:date>2020-11-17T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001126">
        <obo:IAO_0000115>Avoid the administration or use of blood transfusion.</obo:IAO_0000115>
        <dc:date>2020-11-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001127">
        <obo:IAO_0000115>Avoid the administration or use of radiograph imaging procedure.</obo:IAO_0000115>
        <dc:date>2020-11-19T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001128">
        <obo:IAO_0000115>Addition of folic acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001129">
        <obo:IAO_0000115>Addition of Vitamin to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001130">
        <obo:IAO_0000115>Addition of nicotinic acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001131">
        <obo:IAO_0000115>Addition of pyridoxine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001132">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of purine.</obo:IAO_0000115>
        <dc:date>2020-11-30T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001133">
        <obo:IAO_0000115>Addition of ascorbic acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001134">
        <obo:IAO_0000115>Addition of sodium pyruvate to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001135">
        <obo:IAO_0000115>Addition of fat-soluble vitamin to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001136">
        <obo:IAO_0000115>Addition of S-adenosyl-L-methionine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001137">
        <obo:IAO_0000115>Addition of isoleucine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001138">
        <obo:IAO_0000115>Addition of valine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001139">
        <obo:IAO_0000115>Addition of calcium atom to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001140">
        <obo:IAO_0000115>Addition of calcium carbonate to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001141">
        <obo:IAO_0000115>Addition of glucose to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001142">
        <obo:IAO_0000115>Addition of docosahexaenoic acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001143">
        <obo:IAO_0000115>Addition of omega-3 fatty acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001144">
        <obo:IAO_0000115>Addition of lutein to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001145">
        <obo:IAO_0000115>Addition of ribose to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001146">
        <obo:IAO_0000115>Addition of fluoride to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001147">
        <obo:IAO_0000115>Addition of dietary supplement, fibre to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001148">
        <obo:IAO_0000115>Addition of fish oil to the diet for adequate and complete nutrition.</obo:IAO_0000115>
        <dc:date>2020-11-23T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0001149">
        <obo:IAO_0000115>Addition of magnesium atom to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2020-11-30T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002000">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding cannabis consumption.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002001">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding tobacco consumption.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002002">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding smoking behavior.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002003">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding consumption of an addictive substance.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002004">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding agitation behavior.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002005">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding fear/anxiety related behavior.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002006">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding sexual activity.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002007">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding copulation.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0002008">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding stress related behavior.</obo:IAO_0000115>
        <dc:date>2020-01-28T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010000">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of gluten.</obo:IAO_0000115>
        <dc:date>2019-07-11T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010001">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of liquid.</obo:IAO_0000115>
        <dc:date>2019-07-11T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010002">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of protein extract, concentrate or isolate.</obo:IAO_0000115>
        <dc:date>2019-11-13T02:36:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010003">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of fat or oil.</obo:IAO_0000115>
        <dc:date>2019-11-13T02:36:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010004">
        <obo:IAO_0000115>Addition of amino-acid betaine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-07-11T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010005">
        <obo:IAO_0000115>Addition of folates to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-07-11T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010006">
        <obo:IAO_0000115>Addition of carnitine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T02:36:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010007">
        <obo:IAO_0000115>Addition of methionine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T02:36:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010008">
        <obo:IAO_0000115>Addition of creatine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010009">
        <obo:IAO_0000115>Addition of arginine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010010">
        <obo:IAO_0000115>Addition of biotins to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010011">
        <obo:IAO_0000115>Addition of chenodeoxycholic acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010012">
        <obo:IAO_0000115>Addition of coenzyme Q10 to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010013">
        <obo:IAO_0000115>Addition of glycine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010014">
        <obo:IAO_0000115>Addition of N-acetyl-L-cysteine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010015">
        <obo:IAO_0000115>Addition of ornithine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010016">
        <obo:IAO_0000115>Addition of riboflavin to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010017">
        <obo:IAO_0000115>Addition of vitamin B6 to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010018">
        <obo:IAO_0000115>Addition of citrulline to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010019">
        <obo:IAO_0000115>Addition of thiamine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010020">
        <obo:IAO_0000115>Addition of amino acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010021">
        <obo:IAO_0000115>Addition of L-serine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010022">
        <obo:IAO_0000115>Addition of uridine to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010023">
        <obo:IAO_0000115>Addition of medium-chain fatty acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010024">
        <obo:IAO_0000115>Addition of essential fatty acid to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010025">
        <obo:IAO_0000115>Addition of cholesterol to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010026">
        <obo:IAO_0000115>Addition of elemental zinc to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010027">
        <obo:IAO_0000115>Addition of hydroxocobalamin to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010028">
        <obo:IAO_0000115>Addition of cyanocob(III)alamin to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010029">
        <obo:IAO_0000115>Addition of methylcobalamin to a the diet for complete nutrition support.</obo:IAO_0000115>
        <dc:date>2019-11-13T04:45:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010030">
        <obo:IAO_0000115>The surgical transfer of a healthy bone marrow to a patient.</obo:IAO_0000115>
        <dc:date>2019-07-11T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010031">
        <obo:IAO_0000115>The surgical transfer of a healthy bone tissue to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010032">
        <obo:IAO_0000115>The surgical transfer of a healthy heart to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010033">
        <obo:IAO_0000115>The surgical transfer of a healthy umbilical cord blood to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010034">
        <obo:IAO_0000115>The surgical transfer of a healthy cornea to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010035">
        <obo:IAO_0000115>The surgical transfer of a healthy dura mater to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010036">
        <obo:IAO_0000115>The surgical transfer of a healthy intestine to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010037">
        <obo:IAO_0000115>The surgical transfer of a healthy small intestine to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010038">
        <obo:IAO_0000115>The surgical transfer of a healthy lung to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010039">
        <obo:IAO_0000115>The transfer of an organ, or organ subpart, from one body to another.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010040">
        <obo:IAO_0000115>The surgical transfer of a healthy ovary to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010041">
        <obo:IAO_0000115>The surgical transfer of a healthy zone of skin to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010042">
        <obo:IAO_0000115>The surgical transfer of a healthy thymus to a patient.</obo:IAO_0000115>
        <dc:date>2020-01-20T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010043">
        <obo:IAO_0000115>The surgical transfer of a healthy kidney to a patient.</obo:IAO_0000115>
        <dc:date>2020-04-07T10:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010050">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of alcoholic beverage.</obo:IAO_0000115>
        <dc:date>2019-11-18T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010051">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of broad bean (whole).</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010052">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of meat food product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010053">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of nut food product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010054">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of saffron food product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010055">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of seafood product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010056">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of mussel food product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010057">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of clove food product.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010058">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of dark chocolate.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010059">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of pumpkin seed (shell off).</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010060">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sesame seed.</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010061">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sunflower seed (whole kernel, raw).</obo:IAO_0000115>
        <dc:date>2020-01-13T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010062">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of liver (whole, raw).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010063">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of egg or egg component.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010064">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of kidney (whole, raw).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010065">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of peas (whole, rehydrated, canned).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010066">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of bean food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010067">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of peanut (whole).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010068">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of soybean refined food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010069">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of 010  brassica (cole or cabbage) vegetables, head cabbage, flowerhead brassicas (vb) (ccpr).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010070">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of brussels sprout vegetable food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010071">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of broccoli vegetable food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010072">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cabbage vegetable food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010073">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cauliflower vegetable food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010074">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of rapeseed food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010075">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of rapeseed oil.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010076">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of rapeseed meal.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010077">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cephalopod.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010078">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of crustacean.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010079">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of beer.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010080">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of corn syrup (high fructose).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010081">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sorbitol syrup.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010082">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of human milk based food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010083">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cow milk based food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010084">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of fruit (whole, raw).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010085">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of hen egg (whole, shell off, raw).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010086">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of fruit juice food product.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010087">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sugar cane juice (pure).</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010088">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of organ meat.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010089">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of isoleucine.</obo:IAO_0000115>
        <dc:date>2020-05-12T09:00:01Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010090">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of arginine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010091">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of lysine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010092">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of methionine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010093">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of glycine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010094">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of phenylalanine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010095">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of tyrosine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010096">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sodium atom.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010097">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of galactose.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010098">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cholesterol.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010099">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of cholesterol.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010100">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of iron atom.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010101">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of ascorbic acid.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010102">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of branched-chain amino acid.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010103">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of trimethylamine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010104">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of choline.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010105">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of trimethylamine N-oxide.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010106">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of lecithin.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010107">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sterol.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010108">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of purine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010109">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of fructose.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010110">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of lactose.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010111">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of leucine.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010112">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of oxalate.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010113">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of phosphate.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010114">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of saturated fatty acid.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010115">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of calcium atom.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010116">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of sucrose.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010117">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of triglyceride.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010118">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of riboflavin.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010119">
        <obo:IAO_0000115>A medical requirement or recommendation of avoiding the consumption of phytanic acid.</obo:IAO_0000115>
        <dc:date>2020-05-12T11:00:00Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010200">
        <obo:IAO_0000115>A method of ultrasound imaging in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010201">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the body of uterus.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010202">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the breast.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010203">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the heart.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010204">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the liver.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010205">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the lung.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010206">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the lymph node.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010207">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the musculoskeletal system.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010208">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the neck.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010209">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the pancreas.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010210">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the rectum.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010211">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the scrotum.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010212">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the spleen.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010213">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the stomach.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010214">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the thyroid gland.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010215">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the urinary bladder.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010216">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the vagina.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010217">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the kidney.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010218">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the carotid artery segment.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010219">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the pelvic region of trunk.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010220">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the prostate gland.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010221">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the testis.</obo:IAO_0000115>
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the venous blood vessel.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010222">
        <obo:IAO_0000115>The use of ultrasound to produce images of structures in the brain.</obo:IAO_0000115>
        <dc:date>2020-01-24T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010301">
        <obo:IAO_0000115>Collection biological material from within the rectum with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010302">
        <obo:IAO_0000115>Collection biological material from within the vagina with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010303">
        <obo:IAO_0000115>Collection biological material from within the buccal mucosa with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010304">
        <obo:IAO_0000115>Collection biological material from within the nasal turbinal with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010305">
        <obo:IAO_0000115>Collection biological material from within the nasopharynx with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010306">
        <obo:IAO_0000115>Collection biological material from within the nasal vestibule with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010307">
        <obo:IAO_0000115>Collection biological material from within the zone of skin with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010308">
        <obo:IAO_0000115>Collection biological material from within the oropharynx with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010309">
        <obo:IAO_0000115>Collection biological material from within the external naris with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010310">
        <obo:IAO_0000115>Collection biological material from within the throat with a cotton swab.</obo:IAO_0000115>
        <dc:date>2020-03-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010311">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the abdomen.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010312">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the head.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010313">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the liver.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010314">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the lung.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010315">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the neck.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010316">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the brain.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010317">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the chest.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010318">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the skull.</obo:IAO_0000115>
        <dc:date>2020-03-31T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010319">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the blood vasculature.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010320">
        <obo:IAO_0000115>The use of computed tomography to produce images of structures of the pulmonary vascular system.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010321">
        <obo:IAO_0000115>Avoid the administration or use of computed tomography procedure.</obo:IAO_0000115>
        <dc:date>2020-03-30T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010322">
        <obo:IAO_0000115>Avoid the administration or use of ketogenic diet intake.</obo:IAO_0000115>
        <dc:date>2020-05-12T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010351">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of abdomen.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010352">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of head.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010353">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of liver.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010354">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of lung.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010355">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of neck.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010356">
        <obo:IAO_0000115>Use of an imaging test that uses small amounts of radiation to produce pictures of chest.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010357">
        <obo:IAO_0000115>The X-ray examination of the lower limbs of the body.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010358">
        <obo:IAO_0000115>The X-ray examination of the blood vessels or chambers of the heart.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010359">
        <obo:IAO_0000115>An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation.</obo:IAO_0000115>
        <dc:date>2020-04-07T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010360">
        <obo:IAO_0000115>The radiographic examination of the tracheobronchial tree following the injection of a radiopaque material.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010361">
        <obo:IAO_0000115>The radiographic examination of the bile ducts after a contrast medium has been injected.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010362">
        <obo:IAO_0000115>A radiographic procedure to obtain an image of the urinary bladder by filling the bladder with contrast medium.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010363">
        <obo:IAO_0000115>A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. A mammography exam or mammogram, is used as a screening tool to detect early breast cancer in women experiencing no symptoms and to detect and diagnose breast disease.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010364">
        <obo:IAO_0000115>The radiographic examination of the spinal cord and nerve roots following the injection of a contrast medium into the spinal subarachnoid space. The X-rays taken may highlight conditions such as spinal tumors, spinal cord swelling and herniated discs.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010365">
        <obo:IAO_0000115>A radiologic test that involves the examination of the entire body in a single procedure.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0010366">
        <obo:IAO_0000115>A radiographic examination of the vagina using the intravaginal injection of contrast medium.</obo:IAO_0000115>
        <dc:date>2020-04-27T20:39:14Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/MAXO_0030018">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-05T20:57:49Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000010">
        <obo:IAO_0000115>Behavior directly related to the production of offspring [NBO:AC]</obo:IAO_0000115>
        <dc:date>2011-04-14T01:03:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000018">
        <obo:IAO_0000115>&quot;Emotional behavior related to fear or anxiety.&quot; [NBO:GVG]</obo:IAO_0000115>
        <dc:date>2011-04-14T01:03:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000034">
        <obo:IAO_0000115>&quot;Behaviour related to the activity which primary purpose is the sexual reproduction.&quot; [NBO:GVG]</obo:IAO_0000115>
        <dc:date>2011-04-14T01:03:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000060">
        <obo:IAO_0000115>Male&apos;s insertion of sperm-transfer organ into the body of the female [NBO:SMAC]</obo:IAO_0000115>
        <dc:date>2011-04-14T01:03:39Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000129">
        <obo:IAO_0000115>&quot;Emotional behavior related to excitement or restlessness.&quot; [NBO:GVG]</obo:IAO_0000115>
        <dc:date>2011-03-31T12:22:11Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0000469">
        <obo:IAO_0000115>&quot;Behavior related to how the body reacts to a stressor ( a stimulus that causes stress), real or imagined.&quot; [wikipedia:Stress_(biological)]</obo:IAO_0000115>
        <dc:date>2011-04-08T01:52:36Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0001786">
        <obo:IAO_0000115>&quot;Any process that modulates the frequency, rate or extent of behavior, the specific actions or reactions of an organism in response to external or internal stimuli.&quot; [GO:0050795]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0001884">
        <obo:IAO_0000115>&quot;Behavior related to the intake of addictive substances.&quot; [NBOC:GVG]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0002169">
        <obo:IAO_0000115>&quot;Any process that modulates the frequency, rate or extent of consumption behavior, the specific actions or reactions of an organism in response to external or internal stimuli.&quot; [NBOC:GVG]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0002234">
        <obo:IAO_0000115>&quot;Any process that modulates the frequency, rate or extent of consumption of an addictive substance, the specific actions or reactions of an organism in response to external or internal stimuli.&quot; [NBOC:GVG]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0002603">
        <obo:IAO_0000115>&quot;Any process that modulates the frequency, rate or extent of sexual activity, the specific actions or reactions of an organism in response to external or internal stimuli.&quot; [NBOC:GVG]</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0015005">
        <obo:IAO_0000115>Consumption behavior that involves inhaling a material (such as finely ground tobacco leaves) through the nose.</obo:IAO_0000115>
        <dc:date>2019-09-06T10:51:02Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0045000">
        <obo:IAO_0000115>Any habitual use of the tobacco plant leaf and its products.</obo:IAO_0000115>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-27T20:46:57Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NBO_0045004">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-01-27T21:03:19Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NCBITaxon_3712">
        <obo:IAO_0000115 xml:lang="en">Kale or borecole is a form of cabbage (*Brassica oleracea* Acephala Group), green or purple, in which the central leaves do not form a head.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NCBITaxon_3847">
        <obo:IAO_0000115 xml:lang="en">The soybean or soya bean (Glycine max) is a species of legume native to East Asia, widely grown for its edible bean, which has numerous uses.  Traditional unfermented food uses of soybeans include soy milk, from  which tofu and tofu skin are made. Fermented soy foods include soy sauce, fermented bean paste, nattō, and tempeh.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/NCIT_C944">
        <obo:IAO_0000115>A group of organic food substances found in animals and plants in small quantities. They must be supplied in diet or dietary supplement and are essential for normal metabolism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000011">
        <obo:IAO_0000115 xml:lang="en">A process that realizes a plan which is the concretization of a plan specification.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000014">
        <obo:IAO_0000115 xml:lang="en">a regulatory role involved with making and/or enforcing relevant legislation and governmental orders</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000017">
        <obo:IAO_0000115 xml:lang="en">a role which inheres in material entities and is realized in the processes of making, enforcing or being defined by legislation or orders issued by a governmental body.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000018">
        <obo:IAO_0000115 xml:lang="en">a role realized through the process of supplying materials such as animal subjects, reagents or other materials used in an investigation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000023">
        <obo:IAO_0000115 xml:lang="en">A data set that is produced as the output of a class prediction data transformation and consists of a data set with assigned class labels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000047">
        <obo:IAO_0000115 xml:lang="en">Is a material entity that is created or changed during material processing.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000067">
        <obo:IAO_0000115 xml:lang="en">a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000070">
        <obo:IAO_0000115 xml:lang="en">A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000086">
        <obo:IAO_0000115 xml:lang="en">A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000094">
        <obo:IAO_0000115 xml:lang="en">A planned process which results in physical changes in a specified input material</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000112">
        <obo:IAO_0000115 xml:lang="en">a role borne by a material entity that is gained during a specimen collection process and that can be realized by use of the specimen in an investigation</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000245">
        <obo:IAO_0000115 xml:lang="en">An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000293">
        <obo:IAO_0000115 xml:lang="en">A relation between a planned process and a continuant participating in that process that is not created during  the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000295">
        <obo:IAO_0000115 xml:lang="en">A relation between a planned process and a continuant participating in that process that is not created during  the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000299">
        <obo:IAO_0000115 xml:lang="en">A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
        <obo:IAO_0000115 xml:lang="en">A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000317">
        <obo:IAO_0000115 xml:lang="en">Transformation-ML is a format standard of a digital entity that is conformant with the Transformation-ML standard.(http://wiki.ficcs.org/ficcs/Transformation-ML?action=AttachFile&amp;do=get&amp;target=Transformation-ML_v1.0.26.pdf)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000321">
        <obo:IAO_0000115 xml:lang="en">ACS is a format standard of a digital entity that is conformant with the Analytical Cytometry Standard. (http://www.isac-net.org/content/view/607/150/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000322">
        <obo:IAO_0000115 xml:lang="en">XML is a format standard of a digital entity that is conformant with the W3C Extensible Markup Language Recommendation.(http://www.w3.org/XML/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000324">
        <obo:IAO_0000115 xml:lang="en">RDF is a format standard of a digital entity that is conformant with the W3C Resource Description Framework RDF/XML Syntax specification.(http://www.w3.org/RDF/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000325">
        <obo:IAO_0000115 xml:lang="en">zip is a format standard of a digital entity that is conformant with the PKWARE .ZIP file format specification  (http://www.pkware.com/index.php?option=com_content&amp;task=view&amp;id=59&amp;Itemid=103/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000326">
        <obo:IAO_0000115 xml:lang="en">tar is a format standard of a digital entity that is conformant with the tape archive file format as standardized by POSIX.1-1998, POSIX.1-2001, or any other tar format compliant with the GNU tar specification. (http://www.gnu.org/software/tar/manual/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000327">
        <obo:IAO_0000115 xml:lang="en">FCS is a format standard of a digital entity that is conformant with the Flow Cytometry Data File Standard.(http://www.fcspress.com/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000329">
        <obo:IAO_0000115 xml:lang="en">Compensation-ML is a format standard of a digital entity that is conformant with the Compensation-ML standard. (http://wiki.ficcs.org/ficcs/Compensation-ML?action=AttachFile&amp;do=get&amp;target=Compensation-ML_v1.0.24.pdf)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000330">
        <obo:IAO_0000115 xml:lang="en">Gating-ML is a format standard of a digital entity that is conformant with the Gating-ML standard. (http://www.flowcyt.org/gating/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000332">
        <obo:IAO_0000115 xml:lang="en">OWL is a format standard of a digital entity that is conformant with the W3C Web Ontology Language specification.(http://www.w3.org/2004/OWL/)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000417">
        <obo:IAO_0000115>This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000437">
        <obo:IAO_0000115 xml:lang="en">an assay objective to determine the presence or concentration of an analyte in the evaluant</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000441">
        <obo:IAO_0000115 xml:lang="en">an objective specification to determine a specified type of information about an evaluated entity (the material entity bearing evaluant role)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000443">
        <obo:IAO_0000115>An assay with the objective to capture information about the presence, concentration, or amount of an analyte in an evaluant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000450">
        <obo:IAO_0000115 xml:lang="en">A regulatory agency is a organization that has responsibility over or for  the legislation (acts and regulations) for a given sector of the government.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000456">
        <obo:IAO_0000115 xml:lang="en">an objective specifiction that creates an specific output object from input materials.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000457">
        <obo:IAO_0000115 xml:lang="en">Manufacturing is a process with the intent to produce a processed material which will have a function for future use. A person or organization (having manufacturer role) is a participant in this process</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000458">
        <obo:IAO_0000115 xml:lang="en">is the objective to manufacture a material of a certain function (device)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000462">
        <obo:IAO_0000115>An organization which supplies technology, tools and protocols for use in high throughput applications</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000571">
        <obo:IAO_0000115>Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000648">
        <obo:IAO_0000115 xml:lang="en">A data set that is produced as the output of a class discovery data transformation and consists of a data set with assigned discovered class labels.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000659">
        <obo:IAO_0000115>A planned process with the objective of collecting a specimen.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000661">
        <obo:IAO_0000115>An analyte assay where binding of an enzyme linked antibody to a material entity that is immobilized on solid support is detected utilizing a chemiluminescent reaction. Depending on the setup, the enzyme-linked antibody could be binding directly to the analyte, or it serves as a secondary antibody detecting binding of the primary antibody to the analyte.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000663">
        <obo:IAO_0000115 xml:lang="en">A class prediction data transformation (sometimes called supervised classification) is a data transformation that has objective class prediction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000684">
        <obo:IAO_0000115>A objective specification to obtain a material entity for potential use as an input during an investigation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000700">
        <obo:IAO_0000115>A support vector machine is a data transformation with a class prediction objective based on the construction of a separating hyperplane that maximizes the margin between two data sets of vectors in n-dimensional space.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000704">
        <obo:IAO_0000115>A decision tree induction objective is a data transformation objective in which a tree-like graph of edges and nodes is created and from which the selection of each branch requires that some type of logical decision is made.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000707">
        <obo:IAO_0000115 xml:lang="en">A decision tree building data transformation is a data transformation that has objective decision tree induction.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000713">
        <obo:IAO_0000115>a software that provides access to more than 100 tools for gene expression analysis, proteomics, SNP analysis and common data processing tasks.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000726">
        <obo:IAO_0000115>Peak matching is a data transformation performed on a dataset of a graph of ordered data points (e.g. a spectrum) with the objective of pattern matching local maxima above a noise threshold</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000727">
        <obo:IAO_0000115 xml:lang="en">A k-nearest neighbors is a data transformation which achieves a class discovery or partitioning objective, in which an input data object with vector y is assigned to a class label based upon the k closest training data set points to y; where k is the largest value that class label is assigned.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000749">
        <obo:IAO_0000115 xml:lang="en">A CART (classification and regression trees) is a data transformation method for producing a classification or regression model with a tree-based structure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000761">
        <obo:IAO_0000115>GenePattern module SVM is a GenePattern software module which is used to run a support vector machine data transformation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000766">
        <obo:IAO_0000115>GenePattern module KMeansClustering is a GenePattern software module which is used to perform a k Means clustering data transformation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000768">
        <obo:IAO_0000115>GenePattern module CARTXValidation is a GenePattern software module which uses a CART decision tree induction with a leave one out cross validation data transformations.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000771">
        <obo:IAO_0000115>GenePattern module KNNXValidation is a GenePattern software module which uses a k-nearest neighbours clustering with a leave one out cross validation data transformations.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000773">
        <obo:IAO_0000115>GenePattern module KNN is a GenePattern software module which perform a k-nearest neighbors data transformation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000774">
        <obo:IAO_0000115>GenePattern module HierarchicalClustering is a GenePattern software module which is used to perform a hierarchical clustering data transformation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000777">
        <obo:IAO_0000115>GenePattern module PCA is a GenePattern software module which is used to perform a principal components analysis dimensionality reduction data transformation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000780">
        <obo:IAO_0000115>The GenePattern process of generating Heat Maps from clustered data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000781">
        <obo:IAO_0000115>The GenePattern process of generating hierarchical clustering visualization from clustered data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000782">
        <obo:IAO_0000115>A GenePattern software module which is used to generate a heatmap view of data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000783">
        <obo:IAO_0000115>A GenePattern software module which is used to generate a view of data that has been hierarchically clustered.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000792">
        <obo:IAO_0000115>A data transformation which assesses how the results of a statistical analysis will generalize to an independent data set.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000833">
        <obo:IAO_0000115>This relation obtains between an objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000835">
        <obo:IAO_0000115>A person or organization that has a manufacturer role</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000947">
        <obo:IAO_0000115>is a role which inheres in a person or organization and is realized in in a planned process which provides access to training, materials or execution of protocols for an organization or person</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000953">
        <obo:IAO_0000115>A specimen that has been intentionally physically modified.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000963">
        <obo:IAO_0000115>A label that is part of a categorical datum and that indicates the value of the data item on the categorical scale.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001000">
        <obo:IAO_0000115 xml:lang="en">A document with a set of printed or written questions with a choice of answers, devised for the purposes of a survey or statistical study.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001004">
        <obo:IAO_0000115 xml:lang="en">The Edinburgh Handedness Inventory is a set of questions used to assess the dominance of a person&apos;s right or left hand in everyday activities. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001213">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001224">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001287">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001312">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001320">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001321">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001338">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001340">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001347">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001355">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001372">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001375">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001424">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001428">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001431">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001434">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001443">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001458">
        <obo:IAO_0000115>A supplier of flow cytometry analyzers</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001855">
        <obo:IAO_0000115>An organization that focuses on manufacturing target enrichment probe pools for DNA sequencing.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001856">
        <obo:IAO_0000115>An organization that supplies tools for studying the synthesis and regulation of DNA, RNA and protein. It developed a powerful technology platform called single molecule real-time (SMRT) technology which enables real-time analysis of biomolecules with single molecule resolution.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001860">
        <obo:IAO_0000115>An organization that supplies life science tools for translational research and molecular diagnostics based on a novel digital molecular barcoding technology. The NanoString platform can provide simple, multiplexed digital profiling of single molecules.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001879">
        <obo:IAO_0000115>A biological or chemical entity that bears a reagent role in virtue of it being intended for application in a scientific technique  to participate in (or have molecular parts that participate in) a chemical reaction that facilitates the generation of data about some distinct entity, or the generation of some distinct material specified output.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001930">
        <obo:IAO_0000115>A value specification that is specifies one category out of a fixed number of nominal categories</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
        <obo:IAO_0000115>An information content entity that specifies a value within a classification scheme or on a quantitative scale.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001938">
        <obo:IAO_0000115>A relation between an information content entity and a value specification that specifies its value.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002076">
        <obo:IAO_0000115 xml:lang="en">A material entity that has two or more specimens as its parts.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002193">
        <obo:IAO_0000115>An organization that is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002205">
        <obo:IAO_0000115>A categorical value specification that is a histologic grade assigned to a tumor slide specimen according to the American Joint Committee on Cancer (AJCC) 7th Edition grading system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002206">
        <obo:IAO_0000115>A histologic grade according to AJCC 7th edition indicating that the tumor cells and the organization of the tumor tissue appear close to normal.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002207">
        <obo:IAO_0000115>A histologic grade according to AJCC 7th edition indicating that the tumor cells are moderately differentiated and reflect an intermediate grade.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002208">
        <obo:IAO_0000115>A histologic grade according to AJCC 7th edition indicating that the tumor cells are poorly differentiated and do not look like normal cells and tissue.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002209">
        <obo:IAO_0000115>A histologic grade according to AJCC 7th edition indicating that the tumor cells are undifferentiated and do not look like normal cells and tissue.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002210">
        <obo:IAO_0000115>A categorical value specification that is a histologic grade assigned to a tumor slide specimen according to the Fuhrman Nuclear Grading System.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002211">
        <obo:IAO_0000115>A histologic grade according to the Fuhrman Nuclear Grading System indicating that nuclei are round, uniform, approximately 10um and that nucleoli are inconspicuous or absent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002212">
        <obo:IAO_0000115>A histologic grade according to the Fuhrman Nuclear Grading System indicating that nuclei are slightly irregular, approximately 15um and nucleoli are evident.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002213">
        <obo:IAO_0000115>A histologic grade according to the Fuhrman Nuclear Grading System indicating that nuclei are very irregular, approximately 20um and nucleoli large and prominent.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002214">
        <obo:IAO_0000115>A histologic grade according to the Fuhrman Nuclear Grading System indicating that nuclei arei bizarre and multilobulated, 20um or greater and nucleoli are prominent and chromatin clumped.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002215">
        <obo:IAO_0000115>A categorical value specification that is a histologic grade assigned to a ovarian tumor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002216">
        <obo:IAO_0000115>A histologic grade for ovarian tumor that is from a two-tier histological classification of tumors. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002217">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to a two-tier grading system indicating that the tumor is low grade.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002218">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to a two-tier grading system indicating that the tumor is high grade.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002219">
        <obo:IAO_0000115>A histologic grade for ovarian tumor that is from a histological classification by the World Health Organization (WHO).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002220">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to the World Health Organization indicating that the tumor is well differentiated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002221">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to the World Health Organization indicating that the tumor is moderately differentiated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002222">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to the World Health Organization indicating that the tumor is poorly differentiated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002223">
        <obo:IAO_0000115>A histologic grade for ovarian tumor according to the World Health Organization indicating that the tumor is undifferentiated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002224">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of colorectal cancer following the rules of the TNM American Joint Committee on Cancer (AJCC) version 7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002225">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that there is no evidence of primary tumor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002226">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating carcinoma in situ (intraepithelial or invasion of lamina propria).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002227">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that the tumor invades submucosa.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002228">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that the tumor invades muscularis propria.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002229">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that the tumor invades subserosa or into non-peritionealized pericolic or perirectal tissues.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002230">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that the tumor perforates visceral peritoneum.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002231">
        <obo:IAO_0000115>A pathologic primary tumor stage for colon and rectum according to AJCC 7th edition indicating that the tumor directly invades other organs or structures.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002232">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM American Joint Committee on Cancer (AJCC) version 7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002233">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that there is no evidence of primary tumor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002234">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating carcinoma in situ.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002235">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002236">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is 2 cm or less in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002237">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is more than 2 cm but not more than 3 cm in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002238">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is more than 3 cm but not more than 7 cm or the tumor has any of the following features: involves main bronchus, 2 cm or more distal to the carina, invades visceral pleura, associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002239">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is more than 3 cm but not more than 5 cm in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002240">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is more than 5 cm but not more than 7 cm in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002241">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor is more than 7 cm or one that directly invades any of: parietal pleura, chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardiu or the tumor is in the main bronchus less than 2 cm distal to the carina but without  involvement of the carina or there is associated atelectasis or obstructive pneumonitis of the entire lung or there is separate tumor nodule(s) in the same lobe as the primary.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002242">
        <obo:IAO_0000115>A pathologic primary tumor stage for lung according to AJCC 7th edition indicating that the tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina or there is separate tumor nodule(s) in a different ipsilateral lobe to that of the primary.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002243">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002244">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that there is no evidence of primary tumor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002245">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is 7 cm or less in greatest dimension and limited to the kidney.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002246">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is 4 cm or less.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002247">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is more than 4 cm but not more than 7 cm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002248">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is more than 7 cm in greatest dimension and limited to the kidney.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002249">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is more than 7 cm but not more than 10 cm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002250">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor is more than 10 cm and limited to the kidney.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002251">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond the Gerota fascia.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002252">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or the tumor invades perirenal and/or renal sinus fat (peripelvic) fat but not beyond Gerota fascia.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002253">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor grossly extends into vena cava below diaphragm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002254">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor grossly extends into vena cava above the diaphragm or Invades the wall of the vena cava.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002255">
        <obo:IAO_0000115>A pathologic primary tumor stage for kidney according to AJCC 7th edition indicating that the tumor invades beyond Gerota fascia (including contiguous extension into the ipsilateral adrenal gland).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002256">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002257">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that there is no evidence of primary tumor.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002258">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor is limited to the ovaries (one or both).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002259">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor is limited to one ovary; capsule intact, no tumor on ovarian surface and no malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002260">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor is limited to both ovaries; capsule intact, no tumor on ovarian surface and no malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002261">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor is limited to one or both ovaries with capsule ruptured, tumor on ovarian surface, or malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002262">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor involves one or both ovaries with pelvic extension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002263">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has extension and/or implants on uterus and/or tube(s) and no malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002264">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has extension to other pelvic tissues and no malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002265">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has pelvic extension with malignant cells in ascites or peritoneal washings.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002266">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002267">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has microscopic peritoneal metastasis beyond pelvis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002268">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has macroscopic peritoneal, metastatasis beyond pelvis, 2 cm or less in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002269">
        <obo:IAO_0000115>A pathologic primary tumor stage for ovary according to AJCC 7th edition indicating that the tumor has peritoneal metastasis beyond pelvis, more than 2 cm in greatest dimension and/or regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002270">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of colorectal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002271">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating no regional lymph node metastsis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002272">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 1-3 regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002273">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 1 regional lymph node.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002274">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 2-3 regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002275">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating tumor deposit(s), i.e., satellites in the subserosa, or in non-peritonealized pericolic or perirectal soft tissue without regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002276">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 4 or more regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002277">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 4 to 6 regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002278">
        <obo:IAO_0000115>A pathologic lymph node stage for colon and rectum according to AJCC 7th edition indicating metastasis in 7 or more regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002279">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002280">
        <obo:IAO_0000115>A pathologic lymph node stage for lung according to AJCC 7th edition indicating no regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002281">
        <obo:IAO_0000115>A pathologic lymph node stage for lung according to AJCC 7th edition indicating metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002282">
        <obo:IAO_0000115>A pathologic lymph node stage for lung according to AJCC 7th edition indicating metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002283">
        <obo:IAO_0000115>A pathologic lymph node stage for lung according to AJCC 7th edition indicating metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002284">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002285">
        <obo:IAO_0000115>A pathologic lymph node stage for kidney according to AJCC 7th edition indicating that there is no regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002286">
        <obo:IAO_0000115>A pathologic lymph node stage for kidney according to AJCC 7th edition indicating that there is regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002287">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002288">
        <obo:IAO_0000115>A pathologic lymph node stage for ovary according to AJCC 7th edition indicating that there is no regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002289">
        <obo:IAO_0000115>A pathologic lymph node stage for ovary according to AJCC 7th edition indicating that there is regional lymph node metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002290">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of colon cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002291">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that there are no symptoms or signs of distant metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002292">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that there is clinical evidence of distant metastases by history, physical examination, imaging studies, or invasive procedures, but without microscopic evidence of the presumed distant metastases.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002293">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that metastasis is confined to one organ based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002294">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that metastasis is in more than one organ or the peritoneum based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002295">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that there is microscopic evidence confirming distant metastatic disease.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002296">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that metastasis is confined to one organ and histologically confirmed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002297">
        <obo:IAO_0000115>A pathologic distant metastases stage for colon according to AJCC 7th edition indicating that metastasis is in more than one organ or the peritoneum and histologically confirmed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002298">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of lung cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002299">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that there is no distant metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002300">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that there are distant metastases based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002301">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that metastasis is based on clinical assessment and a separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules OR malignant pleural or pericardial effusion.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002302">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that there is a distant metastases based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002303">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that there is a distant metastases that is histologically confirmed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002304">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that metastasis is histologically confirmed and a separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules OR malignant pleural or pericardial effusion.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002305">
        <obo:IAO_0000115>A pathologic distant metastases stage for lung according to AJCC 7th edition indicating that there is a distant metastases that is histologically confirmed and associated with distant lymph nodes or carcinomatosis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002306">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of renal cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002307">
        <obo:IAO_0000115>A pathologic distant metastases stage for kidney according to AJCC 7th edition indicating that there is no distant metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002308">
        <obo:IAO_0000115>A pathologic distant metastases stage for kidney according to AJCC 7th edition indicating that there are distant metastases based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002309">
        <obo:IAO_0000115>A pathologic distant metastases stage for kidney according to AJCC 7th edition indicating that there is a distant metastases that is histologically confirmed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002310">
        <obo:IAO_0000115>A categorical value specification that is a  pathologic finding about one or more characteristics of ovarian cancer following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases. TNM pathologic distant metastasis findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002311">
        <obo:IAO_0000115>A pathologic distant metastases stage for ovary according to AJCC 7th edition indicating that there is no distant metastasis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002312">
        <obo:IAO_0000115>A pathologic distant metastases stage for ovary according to AJCC 7th edition indicating that there is distant metastasis except peritoneal metastasis based on clinical assessment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002313">
        <obo:IAO_0000115>A pathologic distant metastases stage for ovary according to AJCC 7th edition indicating that there is distant metastasis except peritoneal metastasis that is histologically confirmed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002314">
        <obo:IAO_0000115>A categorical value specification that is an assessment of the stage of a cancer according to the American Joint Committee on Cancer (AJCC) v7 staging systems.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002315">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating a small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002316">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating a carcinoma in situ (or melanoma in situ for melanoma of the skin or germ cell neoplasia in situ for testicular germ cell tumors) and generally is considered to have no metastatic potential. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002317">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers that are smaller or less deeply invasive without regional disease or nodes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002318">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent but less than in Stage III and with differing characteristics from IIB and IIC.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002319">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent but less than in Stage III and with differing characteristics from IIA and IIC.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002320">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent but less than in Stage III and with differing characteristics from IIA and IIB.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002321">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent greater than in Stage II and with differing characteristics from IIIB and IIIC.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002322">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent greater than in Stage II and with differing characteristics from IIIA and IIIC.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002323">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent greater than in Stage II and with differing characteristics from IIIA and IIIB.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002324">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers in patients who present with distant metastases at diagnosis and with differing characteristics from IVB.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002325">
        <obo:IAO_0000115>A clinical tumor stage group according to AJCC 7th edition indicating cancers in patients who present with distant metastases at diagnosis and with differing characteristics from IVA.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002326">
        <obo:IAO_0000115>A categorical value specification that is an assessment of the stage of a gynecologic cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging systems.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002327">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating invasive carcinoma which can be diagnosed only by microscopy, with deepest invasion &lt;5 mm and the largest extension &lt;7 mm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002328">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating measured stromal invasion of &lt;3.0 mm in depth and extension of &lt;7.0 mm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002329">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating measured stromal invasion of &gt;3.0 mm and not &gt;5.0 mm with an extension of not &gt;7.0 mm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002330">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesions limited to the cervix uteri or pre-clinical cancers greater than stage IA</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002331">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesion limited to the cervix uteri or pre-clinical cancers greater than stage IA &lt;4.0 cm in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002332">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesion limited to the cervix uteri or pre-clinical cancers greater than stage IA &gt;4.0 cm in greatest dimension.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002333">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating cervical carcinoma invades beyond the uterus, but not to the pelvic wall or to the lower third of the vagina without parametrial invasion. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002334">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating cervical carcinoma invades beyond the uterus, but not to the pelvic wall or to the lower third of the vagina without parametrial invasion and clinically visible lesion &lt;4.0 cm in greatest dimension. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002335">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating cervical carcinoma invades beyond the uterus, but not to the pelvic wall or to the lower third of the vagina without parametrial invasion and clinically visible lesion &gt;4.0 cm in greatest dimension. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002336">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating cervical carcinoma invades beyond the uterus, but not to the pelvic wall or to the lower third of the vagina with obvious parametrial invasion. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002337">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating tumour involves lower third of the vagina, with no extension to the pelvic wall.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002338">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating extension to the pelvic wall and/or hydronephrosis or non-functioning kidney.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002339">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating spread of the growth to adjacent organs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002340">
        <obo:IAO_0000115>An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating spread to distant organs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002341">
        <obo:IAO_0000115>A categorical value specification that is a pathologic finding about one or more characteristics of ovarian cancer following the rules of the FIGO classification system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002342">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002343">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1a, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002344">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1b, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002345">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1c, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002346">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002347">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2a, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002348">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2b, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002349">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2c, N0, and M0.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002350">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of (T3, N0, and M0) or (T3,3a,3b, NX, and M0).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002351">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T3a, N0, and M0 .</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002352">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T3b, N0, and M0 .</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002353">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of (T3c, N0,X and M0) or (any T, N1 and M0).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002354">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of any T, any N, and M1.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002355">
        <obo:IAO_0000115>A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of (T0, N0, and M0) or (T1,1a-1c,2,2a-2c, NX, and M0) or (TX, N0,X, M0).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002356">
        <obo:IAO_0000115>A categorical value specification that is an assessment of a participant&apos;s performance status (general well-being and activities of daily life).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002357">
        <obo:IAO_0000115>A performance status value specification designed by the Eastern Cooperative Oncology Group to assess disease progression and its affect on the daily living abilities of the patient.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002358">
        <obo:IAO_0000115>An Eastern Cooperative Oncology Group score value specification indicating a patient is symptomatic and in bed for more than 50% of the day but is not bed ridden.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002359">
        <obo:IAO_0000115>An Eastern Cooperative Oncology Group score value specification indicating a patient is symptomatic but is in bed for less than 50% of the day.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002360">
        <obo:IAO_0000115>An Eastern Cooperative Oncology Group score value specification indicating a patient is symptomatic and is bed ridden.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002361">
        <obo:IAO_0000115>An Eastern Cooperative Oncology Group score value specification indicating a patient is asymptomatic.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002362">
        <obo:IAO_0000115>An Eastern Cooperative Oncology Group score value specification indicating a patient is symptomatic but is fully ambulatory.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002363">
        <obo:IAO_0000115>A performance status value specification designed for classifying patients 16 years of age or older by their functional impairment.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002364">
        <obo:IAO_0000115>A Karnofsky score vaue specification indicating that a patient is asymptomatic.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002365">
        <obo:IAO_0000115>A Karnofsky score vaue specification indicating that a patient is symptomatic but fully ambulatory.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002366">
        <obo:IAO_0000115>A Karnofsky score vaue specification indicating that a patient is symptomatic but in bed less than 50% of the day.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002367">
        <obo:IAO_0000115>A Karnofsky score vaue specification indicating that a patient is symptomatic, in bed more than 50% of the day, but not bed ridden.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002599">
        <obo:IAO_0000115>A specimen that is stored on a swab as the output of a collecting specimen with swab process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002600">
        <obo:IAO_0000115>A specimen collection process that uses a swab as the collection device. A swab is an absorbent material (e.g. cotton) on a rod (e.g., wooden stick).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002604">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a breast.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002606">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a nasopharynx.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002607">
        <obo:IAO_0000115>A specimen that is collected with a swab from the inside surface of a mouth.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002608">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a oropharynx.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002609">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a rectum.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002610">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a tongue.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002611">
        <obo:IAO_0000115>A specimen that is collected with a swab from the surface of a vagina.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0002755">
        <obo:IAO_0000115>An organization that is developing and selling nanopore sequencing products and is based in the UK.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0100026">
        <obo:IAO_0000115 xml:lang="en">A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0100051">
        <obo:IAO_0000115 xml:lang="en">A material entity that has the specimen role.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200000">
        <obo:IAO_0000115 xml:lang="en">A planned process that produces output data from input data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200033">
        <obo:IAO_0000115>is a data transformation :  leave-one-out cross-validation (LOOCV) involves using a single observation from the original sample as the validation data, and the remaining observations as the training data. This is repeated such that each observation in the sample is used once as the validation data</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200041">
        <obo:IAO_0000115 xml:lang="en">A k-means clustering is a data transformation which achieves a class discovery or partitioning objective, which takes as input a collection of objects (represented as points in multidimensional space) and which partitions them into a specified number k of clusters. The algorithm attempts to find the centers of natural clusters in the data. The most common form of the algorithm starts by partitioning the input points into k initial sets, either at random or using some heuristic data. It then calculates the mean point, or centroid, of each set. It constructs a new partition by associating each point with the closest centroid. Then the centroids are recalculated for the new clusters, and the algorithm repeated by alternate applications of these two steps until convergence, which is obtained when the points no longer switch clusters (or alternatively centroids are no longer changed).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200042">
        <obo:IAO_0000115 xml:lang="en">A hierarchical clustering is a data transformation which achieves a class discovery objective, which takes as input data item and builds a hierarchy of clusters. The traditional representation of this hierarchy is a tree (visualized by a dendrogram), with the individual input objects at one end (leaves) and a single cluster containing every object at the other (root).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200050">
        <obo:IAO_0000115 xml:lang="en">A dimensionality reduction is data partitioning which transforms each input m-dimensional vector (x_1, x_2, ..., x_m) into an output n-dimensional vector (y_1, y_2, ..., y_n), where n is smaller than m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200051">
        <obo:IAO_0000115 xml:lang="en">A principal components analysis dimensionality reduction is a dimensionality reduction achieved by applying principal components analysis and by keeping low-order principal components and excluding higher-order ones.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200111">
        <obo:IAO_0000115 xml:lang="en">An planned process that creates images, diagrams or animations from the input data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200166">
        <obo:IAO_0000115 xml:lang="en">An objective specification to transformation input data into output data</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200171">
        <obo:IAO_0000115 xml:lang="en">A partitioning data transformation is a data transformation that has objective partitioning.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200172">
        <obo:IAO_0000115 xml:lang="en">A partitioning objective is a data transformation objective where the aim is to generate a collection of disjoint non-empty subsets whose union equals a non-empty input set.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200175">
        <obo:IAO_0000115 xml:lang="en">A class discovery data transformation (sometimes called unsupervised classification) is a data transformation that has objective class discovery.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200178">
        <obo:IAO_0000115 xml:lang="en">A class discovery objective (sometimes called unsupervised classification) is a data transformation objective where the aim is to organize input data  (typically vectors of attributes) into classes, where the number of classes and their specifications are not known a priori. Depending on usage, the class assignment can be definite or probabilistic.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200179">
        <obo:IAO_0000115 xml:lang="en">A class prediction objective (sometimes called supervised classification) is a data transformation objective where the aim is to create a predictor from training data through a machine learning technique. The training data consist of pairs of objects (typically vectors of attributes) and
class labels for these objects. The resulting predictor can be used to attach class labels to any valid novel input object. Depending on usage, the prediction can be definite or probabilistic. A classification is learned from the training data and can then be tested on test data.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200188">
        <obo:IAO_0000115 xml:lang="en">A cross validation objective is a data transformation objective in which the aim is to partition a sample of data into subsets such that the analysis is initially performed on a single subset, while the other subset(s) are retained for subsequent use in confirming and validating the initial analysis.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0200190">
        <obo:IAO_0000115>A data visualization which has input of a clustered data set and produces an output of a report graph which is capable of rendering data of this type.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_1110022">
        <obo:IAO_0000115 xml:lang="en">is a receptor produced by cells of the adaptive immune system with the purpose of binding epitopes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000186">
        <obo:IAO_0000115>An organismal quality inhering in a bearer by virtue of the bearer&apos;s behavior aggregate of the responses or reactions or movements in a given situation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0002201">
        <obo:IAO_0000115>A behavioral quality inhering ina bearer by virtue of the bearer&apos;s unequal distribution of fine motor skill between its left and right hands or feet.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0002202">
        <obo:IAO_0000115>Handedness where the organism preferentially uses the left hand or foot for tasks requiring the use of a single hand or foot or a dominant hand or foot.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0002203">
        <obo:IAO_0000115>Handedness where the organism preferentially uses the right hand or foot for tasks requiring the use of a single hand or foot or a dominant hand or foot.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0002204">
        <obo:IAO_0000115>Handedness where the organism exhibits no overall dominance in the use of right or left hand or foot in the performance of tasks that require one hand or foot or a dominant hand or foot.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0000003">
        <obo:IAO_0000115>A plant structure (PO:0005679) which is a whole organism.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009001">
        <obo:IAO_0000115>A multi-tissue plant structure (PO:0025496) that develops from a gynoecium (PO:0009062), or a single carpel (PO:0009030), and at maturity may have as parts one or more seeds (PO:0009010).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009008">
        <obo:IAO_0000115>A multi-tissue plant structure (PO:0025496) that is a functional unit, is a proper part of a whole plant (PO:0000003), and includes portions of plant tissue (PO:0009007) of at least two different types that derive from a common developmental path.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009009">
        <obo:IAO_0000115>A whole plant (PO:0000003) that participates in the plant embryo stage (PO:0007631).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009010">
        <obo:IAO_0000115>A multi-tissue plant structure (PO:0025496) that develops from a plant ovule (PO:0020003) and has as parts a plant embryo (PO:0009009) enclosed in a seed coat (PO:0009088).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009011">
        <obo:IAO_0000115>A plant anatomical entity (PO:0025131) that is, or was, part of a plant, or was derived from a part of a plant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0009062">
        <obo:IAO_0000115>A collective phyllome structure (PO:0025023) composed all of the carpels (PO:0009030) in a flower (PO:0009046).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0020003">
        <obo:IAO_0000115>A plant organ (PO:0009008) that has as parts a nucellus (PO:0020020) in which a female gametophyte (PO:0025279) is located, one or two integuments (PO:0020021), and a funicle (PO:0020006).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0025007">
        <obo:IAO_0000115>A collective plant structure (PO:0025497) that is a proper part of a whole plant (PO:0000003), and is composed of two or more adjacent plant organs (PO:0009008) and the associated portions of plant tissue (PO:0009007).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0025023">
        <obo:IAO_0000115>A collective plant organ structure (PO:0025007) that consists of two or more phyllomes (PO:0006001) originating from the same node or from one or more adjacent nodes with compressed shoot internodes (PO:0005005).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0025099">
        <obo:IAO_0000115>A plant structure (PO:0009011) that is part of an plant embryo (PO:0009009).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0025496">
        <obo:IAO_0000115>A plant structure (PO:0009011) that has as parts two or more portions of plant tissue (PO:0009007) of at least two different types and which through specific morphogenetic processes forms a single structural unit demarcated by primarily bona-fide boundaries from other structural units of different types.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PO_0025497">
        <obo:IAO_0000115>A plant structure (PO:0009011) that is a proper part of a whole plant (PO:0000003) and includes two or more adjacent plant organs (PO:0009008) or adjacent cardinal organ parts (PO:0025001), along with any associated portions of plant tissue (PO:0009007).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PR_000000001">
        <obo:IAO_0000115>An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA, and any derivatives thereof.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000052">
        <obo:IAO_0000115 xml:lang="en">a relation between a specifically dependent continuant (the dependent) and an independent continuant (the bearer), in which the dependent specifically depends on the bearer for its existence</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
        <obo:IAO_0000115 xml:lang="en">a relation between an independent continuant (the bearer) and a specifically dependent continuant (the dependent), in which the dependent specifically depends on the bearer for its existence</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000056">
        <obo:IAO_0000115 xml:lang="en">a relation between a continuant and a process, in which the continuant is somehow involved in the process</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000057">
        <obo:IAO_0000115 xml:lang="en">a relation between a process and a continuant, in which the continuant is somehow involved in the process</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000058">
        <obo:IAO_0000115 xml:lang="en">A relationship between a generically dependent continuant and a specifically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. A generically dependent continuant may be concretized as multiple specifically dependent continuants.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000059">
        <obo:IAO_0000115 xml:lang="en">A relationship between a specifically dependent continuant and a generically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. Multiple specifically dependent continuants can concretize the same generically dependent continuant.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000081">
        <obo:IAO_0000115 xml:lang="en">a relation between a role and an independent continuant (the bearer), in which the role specifically depends on the bearer for its existence</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000086">
        <obo:IAO_0000115 xml:lang="en">a relation between an independent continuant (the bearer) and a quality, in which the quality specifically depends on the bearer for its existence</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000087">
        <obo:IAO_0000115 xml:lang="en">a relation between an independent continuant (the bearer) and a role, in which the role specifically depends on the bearer for its existence</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0001000">
        <obo:IAO_0000115 xml:lang="en">a relation between two distinct material entities, the new entity and the old entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0001015">
        <obo:IAO_0000115 xml:lang="en">a relation between two independent continuants, the location and the target, in which the target is entirely within the location</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0001025">
        <obo:IAO_0000115 xml:lang="en">a relation between two independent continuants, the target and the location, in which the target is entirely within the location</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002000">
        <obo:IAO_0000115 xml:lang="en">a relation between a 2D immaterial entity (the boundary) and a material entity, in which the boundary delimits the material entity</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002002">
        <obo:IAO_0000115 xml:lang="en">a relation between a material entity and a 2D immaterial entity (the boundary), in which the boundary delimits the material entity</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002007">
        <obo:IAO_0000115>X outer_layer_of Y iff:
. X :continuant that bearer_of some PATO:laminar
. X part_of Y
. exists Z :surface
. X has_boundary Z
. Z boundary_of Y

has_boundary: http://purl.obolibrary.org/obo/RO_0002002
boundary_of: http://purl.obolibrary.org/obo/RO_0002000</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002013">
        <obo:IAO_0000115>A &apos;has regulatory component activity&apos; B if A and B are GO molecular functions (GO_0003674), A has_component B and A is regulated by B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002014">
        <obo:IAO_0000115>A relationship that holds between a GO molecular function and a component of that molecular function that negatively regulates the activity of the whole.  More formally, A &apos;has regulatory component activity&apos; B iff :A and B are GO molecular functions (GO_0003674), A has_component B and A is negatively regulated by B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002015">
        <obo:IAO_0000115>A relationship that holds between a GO molecular function and a component of that molecular function that positively regulates the activity of the whole.  More formally, A &apos;has regulatory component activity&apos; B iff :A and B are GO molecular functions (GO_0003674), A has_component B and A is positively regulated by B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002018">
        <obo:IAO_0000115>w &apos;has process component&apos; p if p and w are processes,  w &apos;has part&apos; p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002019">
        <obo:IAO_0000115>A relationship that holds between between a receptor and an chemical entity, typically a small molecule or peptide, that carries information between cells or compartments of a cell and which binds the receptor and regulates its effector function.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002087">
        <obo:IAO_0000115>X immediately_preceded_by Y iff: end(X) simultaneous_with start(Y)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002131">
        <obo:IAO_0000115>A overlaps B if they share some part in common.</obo:IAO_0000115>
        <obo:IAO_0000115>x overlaps y if and only if there exists some z such that x has part z and z part of y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002134">
        <obo:IAO_0000115 xml:lang="en">Relation between a &apos;neuron projection bundle&apos; and a region in which one or more of its component neuron projections either synapses to targets or receives synaptic input.
T innervates some R
Expands_to: T has_fasciculating_neuron_projection that synapse_in some R.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002150">
        <obo:IAO_0000115>X continuous_with Y if and only if X and Y share a fiat boundary.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002158">
        <obo:IAO_0000115>two individual entities d1 and d2 stand in a shares_ancestor_with relation if and only if there exists some a such that d1 derived_by_descent_from a and d2 derived_by_descent_from a.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002160">
        <obo:IAO_0000115>x only in taxon y if and only if x is in taxon y, and there is no other organism z such that y!=z a and x is in taxon z.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002162">
        <obo:IAO_0000115>x is in taxon y if an only if y is an organism, and the relationship between x and y is one of: part of (reflexive), developmentally preceded by, derives from, secreted by, expressed.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002163">
        <obo:IAO_0000115>A is spatially_disjoint_from B if and only if they have no parts in common</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002170">
        <obo:IAO_0000115>a is connected to b if and only if a and b are discrete structure, and there exists some connecting structure c, such that c connects a and b</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002176">
        <obo:IAO_0000115>c connects a if and only if there exist some b such that a and b are similar parts of the same system, and c connects b, specifically, c connects a with b. When one structure connects two others it unites some aspect of the function or role they play within the system.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002177">
        <obo:IAO_0000115>a is attached to part of b if a is attached to b, or a is attached to some p, where p is part of b.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002178">
        <obo:IAO_0000115>Relation between an arterial structure and another structure, where the arterial structure acts as a conduit channeling fluid, substance or energy.</obo:IAO_0000115>
        <obo:IAO_0000115>relation between an artery and the structure is supplies with blood.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002179">
        <obo:IAO_0000115>Relation between an collecting structure and another structure, where the collecting structure acts as a conduit channeling fluid, substance or energy away from the other structure.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002180">
        <obo:IAO_0000115>w &apos;has component&apos; p if w &apos;has part&apos; p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002202">
        <obo:IAO_0000115>x develops from y if and only if either (a) x directly develops from y or (b) there exists some z such that x directly develops from z and z develops from y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002203">
        <obo:IAO_0000115>inverse of develops from</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002207">
        <obo:IAO_0000115>Candidate definition: x directly_develops from y if and only if there exists some developmental process (GO:0032502) p such that x and y both participate in p, and x is the output of p and y is the input of p, and a substantial portion of the matter of x comes from y, and the start of x is coincident with or after the end of y.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002210">
        <obo:IAO_0000115>inverse of directly develops from</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002211">
        <obo:IAO_0000115>process(P1) regulates process(P2) iff: P1 results in the initiation or termination of P2 OR affects the frequency of its initiation or termination OR affects the magnitude or rate of output of P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002212">
        <obo:IAO_0000115>Process(P1) negatively regulates process(P2) iff: P1 terminates P2, or P1 descreases the the frequency of initiation of P2 or the magnitude or rate of output of P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002213">
        <obo:IAO_0000115>Process(P1) postively regulates process(P2) iff: P1 initiates P2, or P1 increases the the frequency of initiation of P2 or the magnitude or rate of output of P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002215">
        <obo:IAO_0000115>A relation between a material entity (such as a cell) and a process, in which the material entity has the ability to carry out the process. </obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002216">
        <obo:IAO_0000115>c stands in this relationship to p if and only if there exists some p&apos; such that c is capable_of p&apos;, and p&apos; is part_of p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002217">
        <obo:IAO_0000115>x actively participates in y if and only if x participates in y and x realizes some active role</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002218">
        <obo:IAO_0000115>x has participant y if and only if x realizes some active role that inheres in y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002219">
        <obo:IAO_0000115>x surrounded_by y if and only if (1) x is adjacent to y and for every region r that is adjacent to x, r overlaps y (2) the shared boundary between x and y occupies the majority of the outermost boundary of x</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002220">
        <obo:IAO_0000115>x adjacent to y if and only if x and y share a boundary.</obo:IAO_0000115>
        <obo:IAO_0000115>x adjacent_to y iff: x and y share a boundary</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002221">
        <obo:IAO_0000115>inverse of surrounded by</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002223">
        <obo:IAO_0000115>inverse of starts with</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002224">
        <obo:IAO_0000115>x starts with y if and only if x has part y and the time point at which x starts is equivalent to the time point at which y starts. Formally: α(y) = α(x) ∧ ω(y) &lt; ω(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002225">
        <obo:IAO_0000115>x develops from part of y if and only if there exists some z such that x develops from z and z is part of y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002226">
        <obo:IAO_0000115>x develops_in y if x is located in y whilst x is developing</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002229">
        <obo:IAO_0000115>inverse of ends with</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002230">
        <obo:IAO_0000115>x ends with y if and only if x has part y and the time point at which x ends is equivalent to the time point at which y ends. Formally: α(y) &gt; α(x) ∧ ω(y) = ω(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002231">
        <obo:IAO_0000115>x &apos;has starts location&apos; y if and only if there exists some process z such that x &apos;starts with&apos; z and z &apos;occurs in&apos; y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002232">
        <obo:IAO_0000115>x &apos;has end location&apos; y if and only if there exists some process z such that x &apos;ends with&apos; z and z &apos;occurs in&apos; y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002233">
        <obo:IAO_0000115>p has input c iff: p is a process, c is a material entity, c is a participant in p, c is present at the start of p, and the state of c is modified during p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002234">
        <obo:IAO_0000115>p has output c iff c is a participant in p, c is present at the end of p, and c is not present at the beginning of p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002254">
        <obo:IAO_0000115 xml:lang="en">x has developmental contribution from y iff x has some part z such that z develops from y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002255">
        <obo:IAO_0000115>inverse of has developmental contribution from</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002256">
        <obo:IAO_0000115>t1 induced_by t2 if there is a process of developmental induction (GO:0031128) with t1 and t2 as interacting participants. t2 causes t1 to change its fate from a precursor anatomical structure type T to T&apos;, where T&apos; develops_from T</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002257">
        <obo:IAO_0000115 xml:lang="en">Inverse of developmentally induced by</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002258">
        <obo:IAO_0000115>Candidate definition: x developmentally related to y if and only if there exists some developmental process (GO:0032502) p such that x and y both participates in p, and x is the output of p and y is the input of p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002263">
        <obo:IAO_0000115>c acts upstream of p if and only if c enables some f that is involved in p&apos; and p&apos; occurs chronologically before p, is not part of p, and affects the execution of p. c is a material entity and f, p, p&apos; are processes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002264">
        <obo:IAO_0000115>c acts upstream of or within p if c is enables f, and f is causally upstream of or within p. c is a material entity and p is an process.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002285">
        <obo:IAO_0000115>x developmentally replaces y if and only if there is some developmental process that causes x to move or to cease to exist, and for the site that was occupied by x to become occupied by y, where y either comes into existence in this site or moves to this site from somewhere else</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002286">
        <obo:IAO_0000115>Inverse of developmentally preceded by</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002314">
        <obo:IAO_0000115>q inheres in part of w if and only if there exists some p such that q inheres in p and p part of w.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002320">
        <obo:IAO_0000115>A relationship that holds via some environmental process</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002323">
        <obo:IAO_0000115>A mereological relationship or a topological relationship</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002324">
        <obo:IAO_0000115>A relationship that holds between entities participating in some developmental process (GO:0032502)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002328">
        <obo:IAO_0000115>A grouping relationship for any relationship directly involving a function, or that holds because of a function of one of the related entities.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002329">
        <obo:IAO_0000115>this relation holds between c and p when c is part of some c&apos;, and c&apos; is capable of p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002331">
        <obo:IAO_0000115>c involved_in p if and only if c enables some process p&apos;, and p&apos; is part of p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002333">
        <obo:IAO_0000115>inverse of enables</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002334">
        <obo:IAO_0000115>inverse of regulates</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002335">
        <obo:IAO_0000115>inverse of negatively regulates</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002336">
        <obo:IAO_0000115>inverse of positively regulates</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002350">
        <obo:IAO_0000115>is member of is a mereological relation between a item and a collection.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
        <obo:IAO_0000115>has member is a mereological relation between a collection and an item.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002352">
        <obo:IAO_0000115>inverse of has input</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002353">
        <obo:IAO_0000115>inverse of has output</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002371">
        <obo:IAO_0000115>a is attached to b if and only if a and b are discrete objects or object parts, and there are physical connections between a and b such that a force pulling a will move b, or a force pulling b will move a</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002372">
        <obo:IAO_0000115 xml:lang="en">m has_muscle_origin s iff m is attached_to s, and it is the case that when m contracts, s does not move. The site of the origin tends to be more proximal and have greater mass than what the other end attaches to.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002373">
        <obo:IAO_0000115 xml:lang="en">m has_muscle_insertion s iff m is attaches_to s, and it is the case that when m contracts, s moves. Insertions are usually connections of muscle via tendon to bone.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002375">
        <obo:IAO_0000115>A relationship that holds between two material entities in a system of connected structures, where the branching relationship holds based on properties of the connecting network.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002376">
        <obo:IAO_0000115>x tributary_of y if and only if x a channel for the flow of a substance into y, where y is larger than x. If x and y are hydrographic features, then y is the main stem of a river, or a lake or bay, but not the sea or ocean. If x and y are anatomical, then y is a vein.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002379">
        <obo:IAO_0000115>x spatially_coextensive_with y if and inly if x and y have the same location</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002380">
        <obo:IAO_0000115>x is a branching part of y if and only if x is part of y and x is connected directly or indirectly to the main stem of y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002384">
        <obo:IAO_0000115 xml:lang="en">x has developmental potential involving y iff x is capable of a developmental process with output y. y may be the successor of x, or may be a different structure in the vicinity (as for example in the case of developmental induction).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002385">
        <obo:IAO_0000115 xml:lang="en">x has potential to developmentrally contribute to y iff x developmentally contributes to y or x is capable of developmentally contributing to y</obo:IAO_0000115>
        <obo:IAO_0000115>x has potential to developmentrally contribute to y iff x developmentally contributes to y or x is capable of developmentally contributing to y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002386">
        <obo:IAO_0000115 xml:lang="en">x has potential to developmentally induce y iff x developmentally induces y or x is capable of developmentally inducing y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002387">
        <obo:IAO_0000115 xml:lang="en">x has the potential to develop into y iff x develops into y or if x is capable of developing into y</obo:IAO_0000115>
        <obo:IAO_0000115>x has the potential to develop into y iff x develops into y or if x is capable of developing into y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002388">
        <obo:IAO_0000115 xml:lang="en">x has potential to directly develop into y iff x directly develops into y or x is capable of directly developing into y</obo:IAO_0000115>
        <obo:IAO_0000115>x has potential to directly develop into y iff x directly develops into y or x is capable of directly developing into y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002404">
        <obo:IAO_0000115>inverse of upstream of</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002410">
        <obo:IAO_0000115>This relation groups causal relations between material entities and causal relations between processes</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002411">
        <obo:IAO_0000115>p is causally upstream of q if and only if p precedes q and p and q are linked in a causal chain</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002412">
        <obo:IAO_0000115>p is immediately causally upstream of q iff both (a) p immediately precedes q and (b) p is causally upstream of q. In addition, the output of p  must be an input of q.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002418">
        <obo:IAO_0000115>p &apos;causally upstream or within&apos; q iff (1) the end of p is before the end of q and (2) the execution of p exerts some causal influence over the outputs of q; i.e. if p was abolished or the outputs of p were to be modified, this would necessarily affect q.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002427">
        <obo:IAO_0000115>inverse of causally upstream of or within</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002428">
        <obo:IAO_0000115>c involved in regulation of p if c is involved in some p&apos; and p&apos; regulates some p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002429">
        <obo:IAO_0000115>c involved in regulation of p if c is involved in some p&apos; and p&apos; positively regulates some p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002430">
        <obo:IAO_0000115>c involved in regulation of p if c is involved in some p&apos; and p&apos; negatively regulates some p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002431">
        <obo:IAO_0000115>c involved in or regulates p if and only if either (i) c is involved in p or (ii) c is involved in regulation of p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002433">
        <obo:IAO_0000115>p contributes to morphology of w if and only if a change in the morphology of p entails a change in the morphology of w. Examples: every skull contributes to morphology of the head which it is a part of. Counter-example: nuclei do not generally contribute to the morphology of the cell they are part of, as they are buffered by cytoplasm.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002434">
        <obo:IAO_0000115>A relationship that holds between two entities in which the processes executed by the two entities are causally connected.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002436">
        <obo:IAO_0000115>An interaction relationship in which the two partners are molecular entities that directly physically interact with each other for example via a stable binding interaction or a brief interaction during which one modifies the other.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002448">
        <obo:IAO_0000115>Holds between molecular entities A and B where A can physically interact with B and in doing so regulates a process that B is capable of.  For example, A and B may be gene products and binding of B by A regulates the kinase activity of B.</obo:IAO_0000115>
        <obo:IAO_0000115>The entity A, immediately upstream of the entity B, has an activity that regulates an activity performed by B. For example, A and B may be gene products and binding of B by A regulates the kinase activity of B.

A and B can be physically interacting but not necessarily. Immediately upstream means there are no intermediate entity between A and B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002449">
        <obo:IAO_0000115>Holds between molecular entities A and B where A can physically interact with B and in doing so negatively regulates a process that B is capable of.  For example, A and B may be gene products and binding of B by A negatively regulates the kinase activity of B.</obo:IAO_0000115>
        <obo:IAO_0000115>The entity A, immediately upstream of the entity B, has an activity that negatively regulates an activity performed by B. 
For example, A and B may be gene products and binding of B by A negatively regulates the kinase activity of B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002450">
        <obo:IAO_0000115>Holds between molecular entities A and B where A can physically interact with B and in doing so positively regulates a process that B is capable of.  For example, A and B may be gene products and binding of B by A positively regulates the kinase activity of B.</obo:IAO_0000115>
        <obo:IAO_0000115>The entity A, immediately upstream of the entity B, has an activity that positively regulates an activity performed by B. 
For example, A and B may be gene products and binding of B by A positively regulates the kinase activity of B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002473">
        <obo:IAO_0000115>x composed_primarily_of y if and only if more than half of the mass of x is made from y or units of the same type as y.</obo:IAO_0000115>
        <obo:IAO_0000115>x composed_primarily_of y iff: more than half of the mass of x is made from parts of y</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002479">
        <obo:IAO_0000115>p has part that occurs in c if and only if there exists some p1, such that p has_part p1, and p1 occurs in c.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002488">
        <obo:IAO_0000115>x existence starts during y if and only if the time point at which x starts is after or equivalent to the time point at which y starts and before or equivalent to the time point at which y ends. Formally: x existence starts during y iff α(x) &gt;= α(y) &amp; α(x) &lt;= ω(y).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002489">
        <obo:IAO_0000115>x starts ends with y if and only if the time point at which x starts is equivalent to the time point at which y starts. Formally: x existence starts with y iff α(x) = α(y).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002490">
        <obo:IAO_0000115>x existence overlaps y if and only if either (a) the start of x is part of y or (b) the end of x is part of y. Formally: x existence starts and ends during y iff (α(x) &gt;= α(y) &amp; α(x) &lt;= ω(y)) OR (ω(x) &lt;= ω(y) &amp; ω(x) &gt;= α(y))</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002491">
        <obo:IAO_0000115>x existence starts and ends during y if and only if the start of x is part of y and the end of x is part of y. Formally: x existence starts and ends during y iff α(x) &gt;= α(y) &amp; α(x) &lt;= ω(y) &amp; ω(x) &lt;= ω(y) &amp; ω(x) &gt;= α(y)</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002492">
        <obo:IAO_0000115>x existence ends during y if and only if the time point at which x ends is before or equivalent to the time point at which y ends and after or equivalent to the point at which y starts. Formally: x existence ends during y iff ω(x) &lt;= ω(y) and ω(x) &gt;= α(y).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002493">
        <obo:IAO_0000115>x existence ends with y if and only if the time point at which x ends is equivalent to the time point at which y ends. Formally: x existence ends with y iff ω(x) = ω(y).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002494">
        <obo:IAO_0000115>x transformation of y if x is the immediate transformation of y, or is linked to y through a chain of transformation relationships</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002495">
        <obo:IAO_0000115>x immediate transformation of y iff x immediately succeeds y temporally at a time boundary t, and all of the matter present in x at t is present in y at t, and all the matter in y at t is present in x at t</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002496">
        <obo:IAO_0000115>x existence starts during or after y if and only if the time point at which x starts is after or equivalent to the time point at which y starts. Formally: x existence starts during or after y iff α (x) &gt;= α (y).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002497">
        <obo:IAO_0000115>x existence ends during or before y if and only if the time point at which x ends is before or equivalent to the time point at which y ends.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002500">
        <obo:IAO_0000115>A relationship between a material entity and a process where the material entity has some causal role that influences the process</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002501">
        <obo:IAO_0000115>p is causally related to q if and only if p or any part of p and q or any part of q are linked by a chain of events where each event pair is one of direct activation or direct inhibition. p may be upstream, downstream, part of or a container of q.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002503">
        <obo:IAO_0000115>q towards e2 if and only if q is a relational quality such that q inheres-in some e, and e != e2 and q is dependent on e2</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002551">
        <obo:IAO_0000115>A relation between a segment or subdivision of an organism and the maximal subdivision of material entities that provides structural support for that segment or subdivision.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002566">
        <obo:IAO_0000115>Holds between materal entities a and b if the activity of a is causally upstream of the activity of b, or causally upstream of a an activity that modifies b</obo:IAO_0000115>
        <obo:IAO_0000115>The entity or characteristic A is causally upstream of the entity or characteristic B, A having an effect on B. An entity corresponds to any biological type of entity as long as a mass is measurable. A characteristic corresponds to a particular specificity of an entity (e.g., phenotype, shape, size).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002567">
        <obo:IAO_0000115>A relation that holds between elements of a musculoskeletal system or its analogs.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002568">
        <obo:IAO_0000115>m1 has_muscle_antagonist m2 iff m1 has_muscle_insertion s, m2 has_muscle_insection s, m1 acts in opposition to m2, and m2 is responsible for returning the structure to its initial position.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002569">
        <obo:IAO_0000115>inverse of branching part of</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002571">
        <obo:IAO_0000115>x lumen_of y iff x is the space or substance that is part of y and does not cross any of the inner membranes or boundaries of y that is maximal with respect to the volume of the convex hull.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002572">
        <obo:IAO_0000115>s is luminal space of x iff s is lumen_of x and s is an immaterial entity</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002573">
        <obo:IAO_0000115>A relation that holds between an attribute or a qualifier and another attribute.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002576">
        <obo:IAO_0000115>inverse of has skeleton</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002577">
        <obo:IAO_0000115>A material entity consisting of multiple components that are causally integrated.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002578">
        <obo:IAO_0000115>Process(P1) directly regulates process(P2) iff: P1 regulates P2 via direct physical interaction between an agent executing P1 (or some part of P1) and an agent executing P2 (or some part of P2).  For example, if protein A has protein binding activity(P1) that targets protein B and this binding  regulates the kinase activity (P2) of protein B then P1 directly regulates P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002581">
        <obo:IAO_0000115>If R &lt;- P o Q is a defining property chain axiom, then it also holds that R -&gt; P o Q. Note that this cannot be expressed directly in OWL</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002582">
        <obo:IAO_0000115>If R &lt;- P o Q is a defining property chain axiom, then (1) R -&gt; P o Q holds and (2) Q is either reflexive or locally reflexive. A corollary of this is that P SubPropertyOf R.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002584">
        <obo:IAO_0000115>s &apos;has part structure that is capable of&apos; p if and only if there exists some part x such that s &apos;has part&apos; x and x &apos;capable of&apos; p</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002595">
        <obo:IAO_0000115>A relationship that holds between a material entity and a process in which causality is involved, with either the material entity or some part of the material entity exerting some influence over the process, or the process influencing some aspect of the material entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002596">
        <obo:IAO_0000115>Holds between c and p if and only if c is capable of some activity a, and a regulates p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002597">
        <obo:IAO_0000115>Holds between c and p if and only if c is capable of some activity a, and a negatively regulates p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002598">
        <obo:IAO_0000115>Holds between c and p if and only if c is capable of some activity a, and a positively regulates p.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002608">
        <obo:IAO_0000115>Inverse of &apos;causal agent in process&apos;</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002629">
        <obo:IAO_0000115>Process(P1) directly postively regulates process(P2) iff: P1 positively regulates P2 via direct physical interaction between an agent executing P1 (or some part of P1) and an agent executing P2 (or some part of P2).  For example, if protein A has protein binding activity(P1) that targets protein B and this binding positively regulates the kinase activity (P2) of protein B then P1 directly positively regulates P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002630">
        <obo:IAO_0000115>Process(P1) directly negatively regulates process(P2) iff: P1 negatively regulates P2 via direct physical interaction between an agent executing P1 (or some part of P1) and an agent executing P2 (or some part of P2).  For example, if protein A has protein binding activity(P1) that targets protein B and this binding  negatively regulates the kinase activity (P2) of protein B then P1 directly negatively regulates P2.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0003000">
        <obo:IAO_0000115>a produces b if some process that occurs_in a has_output b, where a and b are material entities. Examples: hybridoma cell line produces monoclonal antibody reagent; chondroblast produces avascular GAG-rich matrix.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0003001">
        <obo:IAO_0000115>a produced_by b iff some process that occurs_in b has_output a.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0004031">
        <obo:IAO_0000115>Holds between an entity and an process P where the entity enables some larger compound process, and that larger process has-part P.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0004034">
        <obo:IAO_0000115>c &apos;acts upstream of, positive effect&apos; p if c is enables f, and f is causally upstream of p, and the direction of f is positive</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0004035">
        <obo:IAO_0000115>c &apos;acts upstream of, negative effect&apos; p if c is enables f, and f is causally upstream of p, and the direction of f is negative</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0009001">
        <obo:IAO_0000115 xml:lang="en">&quot;has substance added&quot; is a relation existing between a (physical) entity and a substance in which the entity has had the substance added to it at some point in time.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0011002">
        <obo:IAO_0000115>The entity A has an activity that regulates an activity of the entity B. For example, A and B are gene products where the catalytic activity of A regulates the kinase activity of B.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0000463">
        <obo:IAO_0000115 xml:lang="en">Material anatomical entity in a gaseous, liquid, semisolid or solid state; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures as they pass through the body.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0001911">
        <obo:IAO_0000115>A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only developed in females, and regresses in males.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0001913">
        <obo:IAO_0000115>An emulsion of fat globules within a fluid that is secreted by the mammary gland during lactation.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0005079">
        <obo:IAO_0000115>A product of the somatic follicle cell epithelium and a structure that supports the egg in a hostile environment, minimizing water loss whilst allowing gas exchanges essential for embryonic respiration[GO].</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0006611">
        <obo:IAO_0000115>Exoskeleton or shell, including those of mollusks, turtles, insects and crustaceans.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0007378">
        <obo:IAO_0000115>The yellow spheroidal mass of stored food that forms the inner portion of the egg of a bird or reptile and is surrounded by the white.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0007379">
        <obo:IAO_0000115>The hard-shelled reproductive body produced by a bird and especially by the common domestic chicken; also: its contents used as food.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_0008944">
        <obo:IAO_0000115>Albumen is the clear liquid contained within an egg and consists of water and proteins, among which are ovomucin and ovomucoid. It protects the egg yolk and provides additional nutrition for the growth of the embryo.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_4100000">
        <obo:IAO_0000115>Anatomical projection that is composed of bone or cartilage tissue.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_4200230">
        <obo:IAO_0000115>An anatomical surface that is part of a bone</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_4300226">
        <obo:IAO_0000115>Mesenchyme that is part of a forelimb bud.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UBERON_4300227">
        <obo:IAO_0000115>Mesenchyme that is part of a hindlimb bud.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000001">
        <obo:IAO_0000115>A unit which is a standard measure of the distance between two points.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000002">
        <obo:IAO_0000115>A unit which is a standard measure of the amount of matter/energy of a physical object.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000003">
        <obo:IAO_0000115>A unit which is a standard measure of the dimension in which events occur in sequence.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000008">
        <obo:IAO_0000115>A length unit which is equal to the length of the path traveled by light in vacuum during a time interval of 1/299 792 458 of a second.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000009">
        <obo:IAO_0000115>A mass unit which is equal to the mass of the International Prototype Kilogram kept by the BIPM at Svres, France.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000010">
        <obo:IAO_0000115>A time unit which is equal to the duration of 9 192 631 770 periods of the radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000015">
        <obo:IAO_0000115>A length unit which is equal to one hundredth of a meter or 10^[-2] m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000016">
        <obo:IAO_0000115>A length unit which is equal to one thousandth of a meter or 10^[-3] m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000017">
        <obo:IAO_0000115>A length unit which is equal to one millionth of a meter or 10^[-6] m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000018">
        <obo:IAO_0000115>A length unit which is equal to one thousandth of one millionth of a meter or 10^[-9] m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000019">
        <obo:IAO_0000115>A length unit which is equal to 10 [-10] m.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000021">
        <obo:IAO_0000115>A mass unit which is equal to one thousandth of a kilogram or 10^[-3] kg.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
        <obo:IAO_0000115>A mass unit which is equal to one thousandth of a gram or 10^[-3] g.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000023">
        <obo:IAO_0000115>A mass unit which is equal to one millionth of a gram or 10^[-6] g.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000024">
        <obo:IAO_0000115>A mass unit which is equal to one thousandth of one millionth of a gram or 10^[-9] g.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000025">
        <obo:IAO_0000115>A mass unit which is equal to 10^[-12] g.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000027">
        <obo:IAO_0000115>A temperature unit which is equal to one kelvin degree. However, they have their zeros at different points. The centigrade scale has its zero at 273.15 K.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000031">
        <obo:IAO_0000115>A time unit which is equal to 60 seconds.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000032">
        <obo:IAO_0000115>A time unit which is equal to 3600 seconds or 60 minutes.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000033">
        <obo:IAO_0000115>A time unit which is equal to 24 hours.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000034">
        <obo:IAO_0000115>A time unit which is equal to 7 days.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000035">
        <obo:IAO_0000115>A time unit which is approximately equal to the length of time of one of cycle of the moon&apos;s phases which in science is taken to be equal to 30 days.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000036">
        <obo:IAO_0000115>A time unit which is equal to 12 months which is science is taken to be equal to 365.25 days.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000039">
        <obo:IAO_0000115>A substance unit equal to a millionth of a mol or 10^[-6] mol.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000041">
        <obo:IAO_0000115>A substance unit equal to one thousandth of one millionth of a mole or 10^[-9] mol.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000042">
        <obo:IAO_0000115>A substance unit equal to 10^[-12] mol.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000062">
        <obo:IAO_0000115>A unit of concentration which expresses a concentration of 1 mole of solute per liter of solution (mol/L).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000063">
        <obo:IAO_0000115>A unit of molarity which is equal to one thousandth of a molar or 10^[-3] M.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000064">
        <obo:IAO_0000115>A unit of molarity which is equal to one millionth of a molar or 10^[-6] M.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000065">
        <obo:IAO_0000115>A unit of molarity which is equal to one thousandth of one millionth of a molar or 10^[-9] M.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000066">
        <obo:IAO_0000115>A unit of molarity which is equal to 10^[-12] M.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000097">
        <obo:IAO_0000115>A volume unit which is equal to one millionth of a cubic meter or 10^[-9] m^[3], or to 1 ml.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000098">
        <obo:IAO_0000115>A volume unit which is equal to one thousandth of a liter or 10^[-3] L, or to 1 cubic centimeter.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000099">
        <obo:IAO_0000115>A volume unit which is equal to one thousandth of a cubic meter or 10^[-3] m^[3], or to 1 decimeter.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000100">
        <obo:IAO_0000115>A volume unit which is equal to one thousand of a cubic meter or 10^[-3] m^[3], or to 1 L.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000101">
        <obo:IAO_0000115>A volume unit which is equal to one millionth of a liter or 10^[-6] L.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000102">
        <obo:IAO_0000115>A volume unit which is equal to one thousandth of one millionth of a liter or 10^[-9] L.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000103">
        <obo:IAO_0000115>A volume unit which is equal to 10^[-12] L.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000106">
        <obo:IAO_0000115>A frequency unit which is equal to 1 complete cycle of a recurring phenomenon in 1 second.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000163">
        <obo:IAO_0000115>A dimensionless concentration unit which denotes the mass of a substance in a mixture as a percentage of the mass of the entire mixture.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000164">
        <obo:IAO_0000115>A dimensionless concentration unit which denotes the mass of the substance in a mixture as a percentage of the volume of the entire mixture.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000165">
        <obo:IAO_0000115>A dimensionless concentration unit which denotes the volume of the solute in mL per 100 mL of the resulting solution.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000175">
        <obo:IAO_0000115>A mass unit density which is equal to mass of an object in grams divided by the volume in liters.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000176">
        <obo:IAO_0000115>A mass unit density which is equal to mass of an object in milligrams divided by the volume in milliliters.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000195">
        <obo:IAO_0000115>A temperature unit which is equal to 5/9ths of a kelvin. Negative 40 degrees Fahrenheit is equal to negative 40 degrees Celsius.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000196">
        <obo:IAO_0000115>A dimensionless concentration notation which denotes the acidity of a solution in terms of activity of hydrogen ions (H+).</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000207">
        <obo:IAO_0000115>A volume per unit volume unit which is equal to one millionth of a liter of solute in one liter of solution.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000208">
        <obo:IAO_0000115>A mass density unit which is equal to mass of an object in grams divided by the volume in deciliters.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000212">
        <obo:IAO_0000115>A concentration unit which a measure of viable bacterial numbers in a given volume.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000271">
        <obo:IAO_0000115>A volumetric flow rate unit which is equal to one microliter volume through a given surface in one minute.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000281">
        <obo:IAO_0000115>A rate unit which is equal to one over one nanomolar second.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000282">
        <obo:IAO_0000115>A rate unit which is equal to one over one molar second.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000284">
        <obo:IAO_0000115>A rate unit which is equal to one over one nanomolar.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000285">
        <obo:IAO_0000115>A rate unit which is equal to one over one molar.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000301">
        <obo:IAO_0000115>A mass unit density which is equal to mass of an object in micrograms divided by the volume in liters.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/c">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-01-15T19:35:59Z</dc:date>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/uberon/core#conduit_for">
        <obo:IAO_0000115>x is a conduit for y iff y passes through the lumen of x.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/uberon/core#filtered_through">
        <obo:IAO_0000115>Relationship between a fluid and a material entity, where the fluid is the output of a realization of a filtration role that inheres in the material entity.</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.obolibrary.org/obo/uberon/core#indirectly_supplies">
        <obo:IAO_0000115>a indirectly_supplies s iff a has a branch and the branch supplies or indirectly supplies s</obo:IAO_0000115>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/elements/1.1/creator">
        <dc:description xml:lang="en-us">Examples of a Creator include a person, an organisation,
         or a service.  Typically, the name of a Creator should 
         be used to indicate the entity.</dc:description>
        <rdfs:comment xml:lang="en-us">An entity primarily responsible for making the content 
         of the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
        <rdfs:label xml:lang="en-us">Creator</rdfs:label>
        <rdfs:label>Creator</rdfs:label>
        <rdfs:label>creator</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/elements/1.1/description">
        <dc:description xml:lang="en-us">Description may include but is not limited to: an abstract,
         table of contents, reference to a graphical representation
         of content or a free-text account of the content.</dc:description>
        <rdfs:comment xml:lang="en-us">An account of the content of the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
        <rdfs:label xml:lang="en-us">Description</rdfs:label>
        <rdfs:label>Description</rdfs:label>
        <rdfs:label>description</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/elements/1.1/title">
        <dc:description xml:lang="en-us">
        Typically, a Title will be a name by which the resource is
         formally known.
    </dc:description>
        <rdfs:comment xml:lang="en-us">A name given to the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
        <rdfs:label xml:lang="en-us">Title</rdfs:label>
        <rdfs:label>Title</rdfs:label>
        <rdfs:label>title</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/license">
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-05-11T13:47:29Z</dc:date>
        <rdfs:label>license</rdfs:label>
    </rdf:Description>
</rdf:RDF>



<!-- Generated by the OWL API (version 5.1.14) https://github.com/owlcs/owlapi/ -->


